{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:13:04Z","timestamp":1794777184908,"version":"4.9.1"},"reference-count":632,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82372943"],"award-info":[{"award-number":["NO. 82372943"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Youth Science and Technology Talent Project","award":["NO.2023RC3074"],"award-info":[{"award-number":["NO.2023RC3074"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oxidative stress is a pathological condition of redox signaling dysregulation and macromolecular oxidative damage arising from elevated ROS levels. Oxidative stress interacts with tumor cell growth regulation and tumor microenvironment remodeling, and has been a critical hallmark of cancer. Targeting oxidative stress has garnered great attention in cancer therapy development. However, it is still challenging due to the complexity and heterogeneity of oxidative stress regulation across different cancers, and this encourages a comprehensive understanding of the oxidative stress network in cancers to overcome this obstacle. Therefore, we introduced the oxidative stress generation and regulatory network within tumor cells and discussed their roles in both tumor cells and the tumor microenvironment. Subsequently, we summarized the current therapeutic strategies and highlighted emerging clinical applications, providing an up-to-date overview of oxidative stress-based approaches. Particularly, their cross-application with immunotherapy and nanomedicine has provided an excellent opportunity to integrate multiple effects, exhibiting surpassing advantages. This review elaborates on oxidative stress in cancer biology and its therapeutic implications. By integrating current knowledge and the emerging coordination with immunotherapy and nanomedicine, we underscore the potential of oxidative stress-targeting approaches. Future research on overcoming therapeutic resistance and developing compatible platforms to combine multiple approaches will pave the way to cancer elimination.<\/jats:p>","DOI":"10.1186\/s12943-025-02375-x","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:34:41Z","timestamp":1755844481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers"],"prefix":"10.1186","volume":"24","author":[{"given":"Xisong","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadi","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180\u20133.","journal-title":"Redox Biol"},{"key":"2375_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1215\/15228517-2008-037","volume":"10","author":"P Rajaraman","year":"2008","unstructured":"Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol. 2008;10:709\u201315.","journal-title":"Neuro Oncol"},{"key":"2375_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cbpc.2010.10.004","volume":"153","author":"VI Lushchak","year":"2011","unstructured":"Lushchak VI. Adaptive response to oxidative stress: bacteria, fungi, plants and animals. Comp Biochem Physiol C Toxicol Pharmacol. 2011;153:175\u201390.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"2375_CR4","doi-asserted-by":"publisher","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease.\u00a0Nat Revs\u00a0Nephrol. 2024;20(2):101-19. https:\/\/doi.org\/10.1038\/s41581-023-00775-0.","DOI":"10.1038\/s41581-023-00775-0"},{"key":"2375_CR5","doi-asserted-by":"publisher","unstructured":"CAndr\u00e9s CMC, P\u00e9rez de la Lastra JM, Andr\u00e9s Juan C, Plou FJ, P\u00e9rez-Lebe\u00f1a E.\u00a0Superoxide Anion Chemistry\u2014Its Role at the Core of the Innate Immunity.\u00a0Int J Mol Sci.\u00a02023;24(3):1841. https:\/\/doi.org\/10.3390\/ijms24031841.","DOI":"10.3390\/ijms24031841"},{"key":"2375_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"2375_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2375_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20:89\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.4332","volume":"233","author":"A Clavreul","year":"2014","unstructured":"Clavreul A, Guette C, Faguer R, T\u00e9taud C, Boissard A, Lemaire L, Rousseau A, Avril T, Henry C, Coqueret O, Menei P. Glioblastoma-associated stromal cells (GASCs) from histologically norm al surgical margins have a myofibroblast phenotype and angiogenic properties. J Pathol. 2014;233:74\u201388.","journal-title":"J Pathol"},{"key":"2375_CR10","doi-asserted-by":"crossref","unstructured":"Jain S, Rick JW, Joshi R, Beniwal A, Spatz J, Chang ACC, Nguyen AT, Sudhir S, Chandra A, Haddad A, et al. Identification of cancer-associated fibroblasts in glioblastoma and defining their pro-tumoral effects. Cold Spring Harbor Laboratory; 2021.","DOI":"10.1101\/2021.05.08.443250"},{"key":"2375_CR11","doi-asserted-by":"publisher","unstructured":"Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts.\u00a0Physiol\u00a0Revs. 2021;101(1):147-76. https:\/\/doi.org\/10.1152\/physrev.00048.2019.","DOI":"10.1152\/physrev.00048.2019"},{"key":"2375_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/vaccines9020094","volume":"9","author":"J Mintz","year":"2021","unstructured":"Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM, Ramasamy R, Arora H. Current advances of nitric oxide in cancer and anticancer therapeutics. Vaccines (Basel). 2021;9:94.","journal-title":"Vaccines (Basel)"},{"key":"2375_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"2375_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s43657-023-00129-7","volume":"3","author":"D Ni","year":"2023","unstructured":"Ni D, Zhou H, Wang P, Xu F, Li C. Visualizing macrophage phenotypes and polarization in diseases: from biomarkers to molecular probes. Phenomics. 2023;3:613\u201338.","journal-title":"Phenomics"},{"key":"2375_CR15","doi-asserted-by":"publisher","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13:888713.","journal-title":"Front Immunol"},{"key":"2375_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/neuonc\/nov280","volume":"18","author":"D Dubinski","year":"2016","unstructured":"Dubinski D, W\u00f6lfer J, Hasselblatt M, Schneider-Hohendorf T, Bogdahn U, Stummer W, Wiendl H, Grauer OM. CD4+ T effector memory cell dysfunction is associated with the accumul ation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. Neuro Oncol. 2016;18:807\u201318.","journal-title":"Neuro Oncol"},{"key":"2375_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/neuonc\/nox016","volume":"19","author":"X Mei","year":"2017","unstructured":"Mei X, Chen YS, Chen FR, Xi SY, Chen ZP. Glioblastoma stem cell differentiation into endothelial cells evidence d through live-cell imaging. Neuro Oncol. 2017;19:1109\u201318.","journal-title":"Neuro Oncol"},{"key":"2375_CR18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.celrep.2012.10.009","volume":"2","author":"MM Kami\u0144ski","year":"2012","unstructured":"Kami\u0144ski MM, Sauer SW, Kami\u0144ski M, Opp S, Ruppert T, Grigaravi\u010dius P, Grudnik P, Gr\u00f6ne HJ, Krammer PH, G\u00fclow K. T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep. 2012;2:1300\u201315.","journal-title":"Cell Rep"},{"key":"2375_CR19","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41467-024-46377-7","volume":"15","author":"L Simula","year":"2024","unstructured":"Simula L, Fumagalli M, Vimeux L, Rajnpreht I, Icard P, Birsen G, An D, Pendino F, Rouault A, Bercovici N, et al. Mitochondrial metabolism sustains CD8(+) T cell migration for an efficient infiltration into solid tumors. Nat Commun. 2024;15:2203.","journal-title":"Nat Commun"},{"key":"2375_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.adl4100","volume":"387","author":"SK Varanasi","year":"2025","unstructured":"Varanasi SK, Chen D, Liu Y, Johnson MA, Miller CM, Ganguly S, Lande K, LaPorta MA, Hoffmann FA, Mann TH, et al. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science. 2025;387:192\u2013201.","journal-title":"Science"},{"key":"2375_CR21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2013.75","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 2013;23:898\u2013914.","journal-title":"Cell Res"},{"key":"2375_CR22","doi-asserted-by":"publisher","first-page":"e2300191","DOI":"10.1002\/adhm.202300191","volume":"12","author":"W Mo","year":"2023","unstructured":"Mo W, Liu S, Zhao X, Wei F, Li Y, Sheng X, Cao W, Ding M, Zhang W, Chen X, et al. ROS scavenging nanozyme modulates immunosuppression for sensitized cancer immunotherapy. Adv Healthc Mater. 2023;12:e2300191.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR23","doi-asserted-by":"publisher","first-page":"1224443","DOI":"10.3389\/fimmu.2023.1224443","volume":"14","author":"Y Teng","year":"2023","unstructured":"Teng Y, Xu L, Li W, Liu P, Tian L, Liu M. Targeting reactive oxygen species and fat acid oxidation for the modulation of tumor-associated macrophages: a narrative review. Front Immunol. 2023;14:1224443.","journal-title":"Front Immunol"},{"key":"2375_CR24","doi-asserted-by":"publisher","first-page":"17686","DOI":"10.1073\/pnas.1012016107","volume":"107","author":"MD Kraaij","year":"2010","unstructured":"Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, Gelderman KA. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A. 2010;107:17686\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jconrel.2024.05.001","volume":"370","author":"J Ma","year":"2024","unstructured":"Ma J, Yuan H, Zhang J, Sun X, Yi L, Li W, Li Z, Fu C, Zheng L, Xu X, et al. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy. J Control Release. 2024;370:501\u201315.","journal-title":"J Control Release"},{"key":"2375_CR26","first-page":"956","volume":"20","author":"VI Lushchak","year":"2021","unstructured":"Lushchak VI, Storey KB. Oxidative stress concept updated: definitions, classifications, and regulatory pathways implicated. Excli J. 2021;20:956\u201367.","journal-title":"Excli J"},{"key":"2375_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/j.2040-4603.2011.tb00348.x","volume":"1","author":"SK Powers","year":"2011","unstructured":"Powers SK, Ji LL, Kavazis AN, Jackson MJ. Reactive oxygen species: impact on skeletal muscle. Compr Physiol. 2011;1:941\u201369.","journal-title":"Compr Physiol"},{"key":"2375_CR28","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1042\/CS20160897","volume":"131","author":"YM Go","year":"2017","unstructured":"Go YM, Jones DP. Redox theory of aging: implications for health and disease. Clin Sci (Lond). 2017;131:1669\u201388.","journal-title":"Clin Sci (Lond)"},{"key":"2375_CR29","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97:2499\u2013574.","journal-title":"Arch Toxicol"},{"key":"2375_CR30","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.5604\/17322693.1224259","volume":"70","author":"A Sarniak","year":"2016","unstructured":"Sarniak A, Lipi\u0144ska J, Tytman K, Lipi\u0144ska S. Endogenous mechanisms of reactive oxygen species (ROS) generation. Postepy Hig Med Dosw (Online). 2016;70:1150\u201365.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"2375_CR31","doi-asserted-by":"publisher","first-page":"2343817","DOI":"10.1155\/2020\/2343817","volume":"2020","author":"N Zhang","year":"2020","unstructured":"Zhang N, Zhao N, Xie LS, Huang B, Lin SR, Zhang Q, Zhu YB, Wu QF, Yu SG. Mitochondrial respiratory chain and its regulatory elements SIRT1 and SIRT3 play important role in the initial process of energy conversion after moxibustion at local skin. Evid Based Complement Alternat Med. 2020;2020:2343817.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2375_CR32","doi-asserted-by":"publisher","first-page":"18056","DOI":"10.1074\/jbc.M110.186841","volume":"286","author":"KR Pryde","year":"2011","unstructured":"Pryde KR, Hirst J. Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer. J Biol Chem. 2011;286:18056\u201365.","journal-title":"J Biol Chem"},{"key":"2375_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1\u201313.","journal-title":"Biochem J"},{"key":"2375_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/antiox8080285","volume":"8","author":"JO Onukwufor","year":"2019","unstructured":"Onukwufor JO, Berry BJ, Wojtovich AP. Physiologic implications of reactive oxygen species production by mitochondrial complex I reverse electron transport. Antioxidants (Basel). 2019;8:285.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR35","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.RA118.003647","volume":"293","author":"EL Robb","year":"2018","unstructured":"Robb EL, Hall AR, Prime TA, Eaton S, Szibor M, Viscomi C, James AM, Murphy MP. Control of mitochondrial superoxide production by reverse electron transport at complex I. J Biol Chem. 2018;293:9869\u201379.","journal-title":"J Biol Chem"},{"key":"2375_CR36","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674.","journal-title":"Redox Biol"},{"key":"2375_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.10.511","volume":"78","author":"L Bleier","year":"2015","unstructured":"Bleier L, Wittig I, Heide H, Steger M, Brandt U, Dr\u00f6se S. Generator-specific targets of mitochondrial reactive oxygen species. Free Radic Biol Med. 2015;78:1\u201310.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21:363\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245\u2013313.","journal-title":"Physiol Rev"},{"key":"2375_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","volume":"64","author":"I Fridovich","year":"1995","unstructured":"Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97\u2013112.","journal-title":"Annu Rev Biochem"},{"key":"2375_CR41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrd2222","volume":"6","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3 C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007;6:662\u201380.","journal-title":"Nat Rev Drug Discov"},{"key":"2375_CR42","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1021\/acs.analchem.0c00259","volume":"92","author":"W Wu","year":"2020","unstructured":"Wu W, Zhang C, Rees TW, Liao X, Yan X, Chen Y, Ji L, Chao H. Lysosome-targeting iridium(III) probe with near-infrared emission for the visualization of NO\/O(2)(\u2022-) crosstalk via in vivo peroxynitrite imaging. Anal Chem. 2020;92:6003\u20139.","journal-title":"Anal Chem"},{"key":"2375_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.freeradbiomed.2009.05.018","volume":"47","author":"L Miao","year":"2009","unstructured":"Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 2009;47:344\u201356.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR44","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1021\/bi500331y","volume":"53","author":"Y Nisimoto","year":"2014","unstructured":"Nisimoto Y, Diebold BA, Cosentino-Gomes D, Lambeth JD. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry. 2014;53:5111\u201320.","journal-title":"Biochemistry"},{"key":"2375_CR45","doi-asserted-by":"publisher","first-page":"17091","DOI":"10.1074\/jbc.R112.431916","volume":"288","author":"IA Pikuleva","year":"2013","unstructured":"Pikuleva IA, Waterman MR. Cytochromes p450: roles in diseases. J Biol Chem. 2013;288:17091\u20138.","journal-title":"J Biol Chem"},{"key":"2375_CR46","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1021\/cr0307143","volume":"105","author":"IG Denisov","year":"2005","unstructured":"Denisov IG, Makris TM, Sligar SG, Schlichting I. Structure and chemistry of cytochrome P450. Chem Rev. 2005;105:2253\u201377.","journal-title":"Chem Rev"},{"key":"2375_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cotox.2017.10.003","volume":"7","author":"A Veith","year":"2018","unstructured":"Veith A, Moorthy B. Role of cytochrome P450S in the generation and metabolism of reactive oxygen species. Curr Opin Toxicol. 2018;7:44\u201351.","journal-title":"Curr Opin Toxicol"},{"key":"2375_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2015.01.011","volume":"83","author":"E Zito","year":"2015","unstructured":"Zito E. ERO1: a protein disulfide oxidase and H2O2 producer. Free Radic Biol Med. 2015;83:299\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR49","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbadis.2011.12.001","volume":"1822","author":"M Fransen","year":"2012","unstructured":"Fransen M, Nordgren M, Wang B, Apanasets O. Role of peroxisomes in ROS\/RNS-metabolism: implications for human disease. Biochim Biophys Acta. 2012;1822:1363\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122:877\u2013902.","journal-title":"Circ Res"},{"key":"2375_CR51","doi-asserted-by":"publisher","first-page":"101503","DOI":"10.1016\/j.jbc.2021.101503","volume":"298","author":"F Orrico","year":"2022","unstructured":"Orrico F, Lopez AC, Saliwonczyk D, Acosta C, Rodriguez-Grecco I, Mouro-Chanteloup I, Ostuni MA, Denicola A, Thomson L, M\u00f6ller MN. The permeability of human red blood cell membranes to hydrogen peroxide is independent of aquaporins. J Biol Chem. 2022;298:101503.","journal-title":"J Biol Chem"},{"key":"2375_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.freeradbiomed.2024.11.031","volume":"226","author":"F Orrico","year":"2025","unstructured":"Orrico F, Lopez AC, Silva N, Franco M, Mouro-Chanteloup I, Denicola A, Ostuni MA, Thomson L, M\u00f6ller MN. Hydrogen peroxide diffusion across the red blood cell membrane occurs mainly by simple diffusion through the lipid fraction. Free Radic Biol Med. 2025;226:389\u201396.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR53","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbagen.2013.09.017","volume":"1840","author":"GP Bienert","year":"2014","unstructured":"Bienert GP, Chaumont F. Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim Biophys Acta. 2014;1840:1596\u2013604.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR54","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/ijms23031388","volume":"23","author":"K Wagner","year":"2022","unstructured":"Wagner K, Unger L, Salman MM, Kitchen P, Bill RM, Yool AJ. Signaling mechanisms and pharmacological modulators governing diverse aquaporin functions in human health and disease. Int J Mol Sci. 2022;23:1388.","journal-title":"Int J Mol Sci"},{"key":"2375_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/BCJ20240310","volume":"481","author":"J Chevriau","year":"2024","unstructured":"Chevriau J, De Palma GZ, Jozefkowicz C, Vitali V, Canessa Fortuna A, Ayub N, Soto G, Bienert GP, Zeida A, Alleva K. Permeation mechanisms of hydrogen peroxide and water through plasma membrane intrinsic protein aquaporins. Biochem J. 2024;481:1329\u201347.","journal-title":"Biochem J"},{"key":"2375_CR56","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/cancers11070932","volume":"11","author":"C Rodrigues","year":"2019","unstructured":"Rodrigues C, Pimp\u00e3o C, M\u00f3sca AF, Coxixo AS, Lopes D, da Silva IV, Pedersen PA, Antunes F, Soveral G. Human aquaporin-5 facilitates hydrogen peroxide permeation affecting adaption to oxidative stress and cancer cell migration. Cancers (Basel). 2019;11:932.","journal-title":"Cancers (Basel)"},{"key":"2375_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13046-023-02616-1","volume":"42","author":"Z Guo","year":"2023","unstructured":"Guo Z, Zhang H, Liu X, Zhao Y, Chen Y, Jin J, Guo C, Zhang M, Gu F, Ma Y. Water channel protein AQP1 in cytoplasm is a critical factor in breast cancer local invasion. J Exp Clin Cancer Res. 2023;42:49.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR58","doi-asserted-by":"publisher","first-page":"782829","DOI":"10.3389\/fonc.2022.782829","volume":"12","author":"CS Moon","year":"2022","unstructured":"Moon CS, Moon D, Kang SK. Aquaporins in cancer biology. Front Oncol. 2022;12:782829.","journal-title":"Front Oncol"},{"key":"2375_CR59","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.redox.2016.12.035","volume":"11","author":"H Sies","year":"2017","unstructured":"Sies H. Hydrogen peroxide as a central redox signaling molecule in physiologic al oxidative stress: oxidative eustress. Redox Biol. 2017;11:613\u20139.","journal-title":"Redox Biol"},{"key":"2375_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","volume":"30","author":"IS Harris","year":"2020","unstructured":"Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 2020;30:440\u201351.","journal-title":"Trends Cell Biol"},{"key":"2375_CR61","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023;11:1226044.","journal-title":"Front Cell Dev Biol"},{"key":"2375_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.freeradbiomed.2024.01.001","volume":"212","author":"A G\u0119gotek","year":"2024","unstructured":"G\u0119gotek A, Skrzydlewska E. Lipid peroxidation products\u2019 role in autophagy regulation. Free Radic Biol Med. 2024;212:375\u201383.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","volume":"617","author":"AT Dinkova-Kostova","year":"2017","unstructured":"Dinkova-Kostova AT, Kostov RV, Canning P. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Arch Biochem Biophys. 2017;617:84\u201393.","journal-title":"Arch Biochem Biophys"},{"key":"2375_CR64","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1073\/pnas.0308083100","volume":"101","author":"J Sun","year":"2004","unstructured":"Sun J, Brand M, Zenke Y, Tashiro S, Groudine M, Igarashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci U S A. 2004;101:1461\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR65","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/MCB.02415-06","volume":"27","author":"Y Zenke-Kawasaki","year":"2007","unstructured":"Zenke-Kawasaki Y, Dohi Y, Katoh Y, Ikura T, Ikura M, Asahara T, Tokunaga F, Iwai K, Igarashi K. Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol. 2007;27:6962\u201371.","journal-title":"Mol Cell Biol"},{"key":"2375_CR66","doi-asserted-by":"crossref","unstructured":"Marengo B, Nitti M, Furfaro AL, Colla R, Ciucis CD, Marinari UM, Pronzato MA, Traverso N, Domenicotti C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.\u00a0Oxid Med\u00a0Cell\u00a0Longev. 2016;2016(1). 10.1155\/omcl.v2016.1 10.155\/2016\/6235641.","DOI":"10.1155\/2016\/6235641"},{"key":"2375_CR67","doi-asserted-by":"publisher","unstructured":"Ngo V, Duennwald ML. Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease.\u00a0Antioxid. 2022;11(12):2345.\u00a0https:\/\/doi.org\/10.3390\/antiox11122345.","DOI":"10.3390\/antiox11122345"},{"key":"2375_CR68","doi-asserted-by":"publisher","first-page":"102726","DOI":"10.1016\/j.redox.2023.102726","volume":"63","author":"S Adinolfi","year":"2023","unstructured":"Adinolfi S, Patinen T, Jawahar Deen A, Pitk\u00e4nen S, H\u00e4rk\u00f6nen J, Kansanen E, K\u00fcblbeck J, Levonen AL. The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol. 2023;63:102726.","journal-title":"Redox Biol"},{"key":"2375_CR69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785\u20139.","journal-title":"Nature"},{"key":"2375_CR70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bcp.2014.09.008","volume":"92","author":"X Xu","year":"2014","unstructured":"Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou Y, Li Z, You Q, Zhao L, Guo Q. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562\/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2\/ARE signaling pathway. Biochem Pharmacol. 2014;92:220\u201334.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR71","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3390\/cells11182855","volume":"11","author":"GR You","year":"2022","unstructured":"You GR, Chang JT, Li YL, Huang CW, Tsai YL, Fan KH, Kang CJ, Huang SF, Chang PH, Cheng AJ. MYH9 facilitates cell invasion and radioresistance in head and neck cancer via modulation of cellular ROS levels by activating the MAPK-Nrf2-GCLC pathway. Cells. 2022;11:2855.","journal-title":"Cells"},{"key":"2375_CR72","doi-asserted-by":"publisher","first-page":"154899","DOI":"10.1016\/j.phymed.2023.154899","volume":"116","author":"C Li","year":"2023","unstructured":"Li C, Liu M, Deng L, Luo D, Ma R, Lu Q. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1\/Nrf2\/NF-\u03baB signaling pathways. Phytomedicine. 2023;116:154899.","journal-title":"Phytomedicine"},{"key":"2375_CR73","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/toxins11070431","volume":"11","author":"D Jerotic","year":"2019","unstructured":"Jerotic D, Matic M, Suvakov S, Vucicevic K, Damjanovic T, Savic-Radojevic A, Pljesa-Ercegovac M, Coric V, Stefanovic A, Ivanisevic J, et al. Association of Nrf2, SOD2 and GPX1 polymorphisms with biomarkers of oxidative distress and survival in end-stage renal disease patients. Toxins (Basel). 2019;11:431.","journal-title":"Toxins (Basel)"},{"key":"2375_CR74","doi-asserted-by":"publisher","first-page":"865689","DOI":"10.3389\/fphar.2022.865689","volume":"13","author":"W Yang","year":"2022","unstructured":"Yang W, Wang Y, Zhang C, Huang Y, Yu J, Shi L, Zhang P, Yin Y, Li R, Tao K. Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and Nrf2\/HO-1\/GPX4 activation. Front Pharmacol. 2022;13:865689.","journal-title":"Front Pharmacol"},{"key":"2375_CR75","doi-asserted-by":"publisher","first-page":"114002","DOI":"10.1016\/j.bcp.2020.114002","volume":"177","author":"JS Kang","year":"2020","unstructured":"Kang JS, Nam LB, Yoo OK, Keum YS. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer. Biochem Pharmacol. 2020;177:114002.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR76","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.freeradbiomed.2016.08.031","volume":"99","author":"C Glorieux","year":"2016","unstructured":"Glorieux C, Sandoval JM, Fattaccioli A, Dejeans N, Garbe JC, Dieu M, Verrax J, Renard P, Huang P, Calderon PB. Chromatin remodeling regulates catalase expression during cancer cells adaptation to chronic oxidative stress. Free Radic Biol Med. 2016;99:436\u201350.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR77","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-03-3924","volume":"64","author":"EY Park","year":"2004","unstructured":"Park EY, Cho IJ, Kim SG. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Cancer Res. 2004;64:3701\u201313.","journal-title":"Cancer Res"},{"key":"2375_CR78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res. 2011;21:103\u201315.","journal-title":"Cell Res"},{"key":"2375_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, Zhang S, Huang Q, Shi M. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79.","journal-title":"Mol Cancer"},{"key":"2375_CR80","doi-asserted-by":"publisher","unstructured":"Ross D, Siegel D. Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch.\u00a0Front\u00a0Physiol. 2017;8. https:\/\/doi.org\/10.3389\/fphys.2017.00595.","DOI":"10.3389\/fphys.2017.00595"},{"key":"2375_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 2013;14:83\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR82","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2024","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BMT. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. 2024;25:46\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR83","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1073\/pnas.1001006107","volume":"107","author":"W Hu","year":"2010","unstructured":"Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010;107:7455\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR84","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nm1320","volume":"11","author":"AA Sablina","year":"2005","unstructured":"Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med. 2005;11:1306\u201313.","journal-title":"Nat Med"},{"key":"2375_CR85","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.freeradbiomed.2008.01.011","volume":"44","author":"B Liu","year":"2008","unstructured":"Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med. 2008;44:1529\u201335.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR86","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/ars.2020.8074","volume":"33","author":"T Shi","year":"2020","unstructured":"Shi T, Dansen TB. Reactive oxygen species induced p53 activation: DNA damage, redox signaling, or both? Antioxid Redox Signal. 2020;33:839\u201359.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR87","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1089\/ars.2011.4434","volume":"16","author":"A Maillet","year":"2012","unstructured":"Maillet A, Pervaiz S. Redox regulation of p53, redox effectors regulated by p53: a subtle balance. Antioxid Redox Signal. 2012;16:1285\u201394.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR88","first-page":"3143","volume":"2013","author":"SC Lu","year":"1830","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta. 1830;2013:3143\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0891-5849(02)00791-8","volume":"32","author":"CM Jones","year":"2002","unstructured":"Jones CM, Lawrence A, Wardman P, Burkitt MJ. Electron paramagnetic resonance spin trapping investigation into the kinetics of glutathione oxidation by the superoxide radical: re-evaluation of the rate constant. Free Radic Biol Med. 2002;32:982\u201390.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR90","doi-asserted-by":"publisher","first-page":"114227","DOI":"10.1016\/j.comptc.2023.114227","volume":"1227","author":"JC Luque-Ceballos","year":"2023","unstructured":"Luque-Ceballos JC, Rodr\u00edguez-Zamora P, L\u00f3pez-Olivos JC, Garz\u00f3n IL. Revisiting the scavenging activity of glutathione: free radicals diversity and reaction mechanisms. Comput Theor Chem. 2023;1227:114227.","journal-title":"Comput Theor Chem"},{"key":"2375_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30:1\u201312.","journal-title":"Mol Aspects Med"},{"key":"2375_CR92","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/234466a0","volume":"234","author":"G Litwack","year":"1971","unstructured":"Litwack G, Ketterer B, Arias IM. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature. 1971;234:466\u20137.","journal-title":"Nature"},{"key":"2375_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0141-1136(97)00071-8","volume":"46","author":"MJ Leaver","year":"1998","unstructured":"Leaver MJ, George SG. A piscine glutathione S-transferase which efficiently conjugates the end-products of lipid peroxidation. Mar Environ Res. 1998;46:71\u20134.","journal-title":"Mar Environ Res"},{"key":"2375_CR94","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res"},{"key":"2375_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"2375_CR96","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-021-02069-4","volume":"40","author":"C Xie","year":"2021","unstructured":"Xie C, Zhou X, Liang C, Li X, Ge M, Chen Y, Yin J, Zhu J, Zhong C. Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer. J Exp Clin Cancer Res. 2021;40:266.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR97","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1073\/pnas.100114897","volume":"97","author":"L Zhong","year":"2000","unstructured":"Zhong L, Arn\u00e9r ES, Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol\/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci U S A. 2000;97:5854\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/15216540252774748","volume":"52","author":"SG Rhee","year":"2001","unstructured":"Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35\u201341.","journal-title":"IUBMB Life"},{"key":"2375_CR99","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","volume":"267","author":"ES Arn\u00e9r","year":"2000","unstructured":"Arn\u00e9r ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267:6102\u20139.","journal-title":"Eur J Biochem"},{"key":"2375_CR100","doi-asserted-by":"publisher","unstructured":"Brzozowa-Zasada M, Piecuch A, Bajdak-Rusinek K, Michalski M, Klymenko O, Matysiak N, Janelt K, Czuba Z. Glutathione Reductase Expression and Its Prognostic Significance in Colon Cancer.\u00a0Int J\u00a0Mol Sci. 2024;25(2):1097. https:\/\/doi.org\/10.3390\/ijms25021097.","DOI":"10.3390\/ijms25021097"},{"key":"2375_CR101","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fpls.2013.00460","volume":"4","author":"JJ L\u00e1zaro","year":"2013","unstructured":"L\u00e1zaro JJ, Jim\u00e9nez A, Camejo D, Iglesias-Baena I, Mart\u00ed Mdel C, L\u00e1zaro-Payo A, Barranco-Medina S, Sevilla F. Dissecting the integrative antioxidant and redox systems in plant mitochondria. Effect of stress and S-nitrosylation. Front Plant Sci. 2013;4:460.","journal-title":"Front Plant Sci"},{"key":"2375_CR102","doi-asserted-by":"publisher","unstructured":"Becker K, Gromer Shirmer RH, M\u00fcller S. Thioredoxin reductase as a pathophysiological factor and drug target.\u00a0Eur J Biochem. 2000;267(20):6118-25. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01703.x.","DOI":"10.1046\/j.1432-1327.2000.01703.x"},{"key":"2375_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms21010131","volume":"21","author":"J Qiu","year":"2019","unstructured":"Qiu J, Zhang T, Zhu X, Yang C, Wang Y, Zhou N, Ju B, Zhou T, Deng G, Qiu C. Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-\u03ba B signaling pathway. Int J Mol Sci. 2019;21:131.","journal-title":"Int J Mol Sci"},{"key":"2375_CR104","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.redox.2018.03.013","volume":"16","author":"D Ivanova","year":"2018","unstructured":"Ivanova D, Zhelev Z, Getsov P, Nikolova B, Aoki I, Higashi T, Bakalova R. Vitamin K: redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biol. 2018;16:352\u20138.","journal-title":"Redox Biol"},{"key":"2375_CR105","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"2375_CR106","doi-asserted-by":"publisher","unstructured":"Cox AG, Winterbourn CC, Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J. 2010;425(2):313-25. https:\/\/doi.org\/10.1042\/BJ20091541.","DOI":"10.1042\/BJ20091541"},{"key":"2375_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0027-5107(99)00004-4","volume":"424","author":"J Cadet","year":"1999","unstructured":"Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL, Sauvaigo S. Hydroxyl radicals and DNA base damage. Mutat Res. 1999;424:9\u201321.","journal-title":"Mutat Res"},{"key":"2375_CR108","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.aao3172","volume":"358","author":"K Somyajit","year":"2017","unstructured":"Somyajit K, Gupta R, Sedlackova H, Neelsen KJ, Ochs F, Rask MB, Choudhary C, Lukas J. Redox-sensitive alteration of replisome architecture safeguards genome integrity. Science. 2017;358:797\u2013802.","journal-title":"Science"},{"key":"2375_CR109","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1021\/acs.accounts.5b00056","volume":"48","author":"NY Tretyakova","year":"2015","unstructured":"Tretyakova NY, Groehler A, Ji S. DNA-protein cross-links: formation, structural identities, and biological outcomes. Acc Chem Res. 2015;48:1631\u201344.","journal-title":"Acc Chem Res"},{"issue":"4","key":"2375_CR110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39(4):199\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2014.02.002.","journal-title":"Trends Biochem Sci."},{"issue":"6","key":"2375_CR111","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.freeradbiomed.2010.05.009","volume":"49","author":"Y Song","year":"2010","unstructured":"Song Y, Buettner GR. Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. Free Radic Biol Med. 2010;49(6):919\u201362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.05.009.","journal-title":"Free Radic Biol Med."},{"key":"2375_CR112","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1128\/MCB.00624-06","volume":"26","author":"A Bravard","year":"2006","unstructured":"Bravard A, Vacher M, Gouget B, Coutant A, de Boisferon FH, Marsin S, Chevillard S, Radicella JP. Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol. 2006;26:7430\u20136.","journal-title":"Mol Cell Biol"},{"key":"2375_CR113","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2741\/1667","volume":"10","author":"P Storz","year":"2005","unstructured":"Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881\u201396.","journal-title":"Front Biosci"},{"key":"2375_CR114","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/cdd.2014.16","volume":"21","author":"M Ogrunc","year":"2014","unstructured":"Ogrunc M, Di Micco R, Liontos M, Bombardelli L, Mione M, Fumagalli M, Gorgoulis VG, d\u2019Adda di Fagagna F. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 2014;21:998\u20131012.","journal-title":"Cell Death Differ"},{"key":"2375_CR115","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","volume":"364","author":"X Renaudin","year":"2021","unstructured":"Renaudin X. Reactive oxygen species and DNA damage response in cancer. Int Rev Cell Mol Biol. 2021;364:139\u201361.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"2375_CR116","doi-asserted-by":"publisher","first-page":"e1006007","DOI":"10.1371\/journal.pgen.1006007","volume":"12","author":"T Wilhelm","year":"2016","unstructured":"Wilhelm T, Ragu S, Magdalou I, Machon C, Dardillac E, T\u00e9cher H, Guitton J, Debatisse M, Lopez BS. Slow Replication Fork Velocity of Homologous Recombination-Defective Cells Results from Endogenous Oxidative Stress. PLOS Genetics. 2016;12(5):e1006007. https:\/\/doi.org\/10.1371\/journal.pgen.1006007.","journal-title":"PLOS Genetics"},{"key":"2375_CR117","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1172\/JCI128644","volume":"129","author":"AJ Petty","year":"2019","unstructured":"Petty AJ, Li A, Wang X, Dai R, Heyman B, Hsu D, Huang X, Yang Y. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment. J Clin Invest. 2019;129:5151\u201362.","journal-title":"J Clin Invest"},{"key":"2375_CR118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85\u201395.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR119","doi-asserted-by":"publisher","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7:e2253.","journal-title":"Cell Death Dis"},{"key":"2375_CR120","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1742-4658.2007.06173.x","volume":"275","author":"YW Lou","year":"2008","unstructured":"Lou YW, Chen YY, Hsu SF, Chen RK, Lee CL, Khoo KH, Tonks NK, Meng TC. Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells. FEBS J. 2008;275:69\u201388.","journal-title":"FEBS J"},{"key":"2375_CR121","doi-asserted-by":"publisher","first-page":"BSR20211994","DOI":"10.1042\/BSR20211994","volume":"41","author":"O Villamar-Cruz","year":"2021","unstructured":"Villamar-Cruz O, Loza-Mej\u00eda MA, Arias-Romero LE, Camacho-Arroyo I. Recent advances in PTP1B signaling in metabolism and cancer. Biosci Rep. 2021;41:BSR20211994.","journal-title":"Biosci Rep"},{"key":"2375_CR122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2017.89","volume":"19","author":"RA Haeusler","year":"2018","unstructured":"Haeusler RA, McGraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2018;19:31\u201344.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR123","first-page":"945","volume":"21","author":"Y Xu","year":"2020","unstructured":"Xu Y, Tan M, Tian X, Zhang J, Zhang J, Chen J, Xu W, Sheng H. Leptin receptor mediates the proliferation and glucose metabolism of pancreatic cancer cells via AKT pathway activation. Mol Med Rep. 2020;21:945\u201352.","journal-title":"Mol Med Rep"},{"key":"2375_CR124","first-page":"957","volume":"12","author":"TW Moody","year":"2023","unstructured":"Moody TW, Ramos-Alvarez I, Jensen RT. Peptide G-protein-coupled receptors and ErbB receptor tyrosine kinases in cancer. Biology (Basel). 2023;12:957.","journal-title":"Biology (Basel)"},{"key":"2375_CR125","doi-asserted-by":"publisher","first-page":"792639","DOI":"10.1155\/2011\/792639","volume":"2011","author":"Y Son","year":"2011","unstructured":"Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct. 2011;2011:792639.","journal-title":"J Signal Transduct"},{"key":"2375_CR126","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1089\/ars.2006.8.1775","volume":"8","author":"JA McCubrey","year":"2006","unstructured":"McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006;8:1775\u201389.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR127","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-405881-1.00002-1","volume":"528","author":"Y Son","year":"2013","unstructured":"Son Y, Kim S, Chung HT, Pae HO. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 2013;528:27\u201348.","journal-title":"Methods Enzymol"},{"key":"2375_CR128","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2010.04.025","volume":"49","author":"E Giannoni","year":"2010","unstructured":"Giannoni E, Taddei ML, Chiarugi P. Src redox regulation: again in the front line. Free Radic Biol Med. 2010;49:516\u201327.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR129","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19:1997\u20132007.","journal-title":"Exp Ther Med"},{"key":"2375_CR130","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/ndt\/17.3.392","volume":"17","author":"FR Gonz\u00e1lez-Pacheco","year":"2002","unstructured":"Gonz\u00e1lez-Pacheco FR, Caramelo C, Castilla MA, Deudero JJ, Arias J, Yag\u00fce S, Jim\u00e9nez S, Bragado R, Alvarez-Arroyo MV. Mechanism of vascular smooth muscle cells activation by hydrogen peroxide: role of phospholipase C gamma. Nephrol Dial Transplant. 2002;17:392\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"2375_CR131","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/bab.2104","volume":"69","author":"L Kma","year":"2022","unstructured":"Kma L, Baruah TJ. The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation. Biotechnol Appl Biochem. 2022;69:248\u201364.","journal-title":"Biotechnol Appl Biochem"},{"key":"2375_CR132","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2018.00160","volume":"8","author":"N Koundouros","year":"2018","unstructured":"Koundouros N, Poulogiannis G. Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer. Front Oncol. 2018;8:160.","journal-title":"Front Oncol"},{"key":"2375_CR133","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"2375_CR134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, Cho WC. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal. 2024;22:7.","journal-title":"Cell Commun Signal"},{"key":"2375_CR135","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.3390\/ijms23126702","volume":"23","author":"DC Stieg","year":"2022","unstructured":"Stieg DC, Wang Y, Liu LZ, Jiang BH. ROS and miRNA dysregulation in ovarian cancer development, angiogenesis and therapeutic resistance. Int J Mol Sci. 2022;23:6702.","journal-title":"Int J Mol Sci"},{"key":"2375_CR136","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2008.10.049","volume":"276","author":"NV Khromova","year":"2009","unstructured":"Khromova NV, Kopnin PB, Stepanova EV, Agapova LS, Kopnin BP. p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1\/VEGF-A pathway. Cancer Lett. 2009;276:143\u201351.","journal-title":"Cancer Lett"},{"key":"2375_CR137","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.freeradbiomed.2006.08.003","volume":"41","author":"LZ Liu","year":"2006","unstructured":"Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang BH. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med. 2006;41:1521\u201333.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR138","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","volume":"8","author":"MW Dewhirst","year":"2008","unstructured":"Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008;8:425\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR139","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1074\/jbc.M110.188706","volume":"286","author":"JH Ryu","year":"2011","unstructured":"Ryu JH, Li SH, Park HS, Park JW, Lee B, Chun YS. Hypoxia-inducible factor \u03b1 subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent. J Biol Chem. 2011;286:6963\u201370.","journal-title":"J Biol Chem"},{"key":"2375_CR140","doi-asserted-by":"publisher","first-page":"e169671","DOI":"10.1172\/JCI169671","volume":"133","author":"T Wang","year":"2023","unstructured":"Wang T, Dong Y, Huang Z, Zhang G, Zhao Y, Yao H, Hu J, T\u00fcksammel E, Cai H, Liang N, et al. Antioxidants stimulate BACH1-dependent tumor angiogenesis. J Clin Invest. 2023;133:e169671.","journal-title":"J Clin Invest"},{"key":"2375_CR141","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR142","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156\u201372.","journal-title":"Cell Res"},{"key":"2375_CR143","doi-asserted-by":"publisher","first-page":"151181","DOI":"10.1016\/j.ejcb.2021.151181","volume":"100","author":"K Yazaki","year":"2021","unstructured":"Yazaki K, Matsuno Y, Yoshida K, Sherpa M, Nakajima M, Matsuyama M, Kiwamoto T, Morishima Y, Ishii Y, Hizawa N. ROS-Nrf2 pathway mediates the development of TGF-\u03b21-induced epithelial-mesenchymal transition through the activation of Notch signaling. Eur J Cell Biol. 2021;100:151181.","journal-title":"Eur J Cell Biol"},{"key":"2375_CR144","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-019-1135-x","volume":"38","author":"M Jin","year":"2019","unstructured":"Jin M, Wang J, Ji X, Cao H, Zhu J, Chen Y, Yang J, Zhao Z, Ren T, Xing J. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS\/Nrf2\/Notch pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:136.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR145","doi-asserted-by":"publisher","first-page":"154884","DOI":"10.1016\/j.phymed.2023.154884","volume":"116","author":"Q Fan","year":"2023","unstructured":"Fan Q, Liang X, Xu Z, Li S, Han S, Xiao Y, Xu Q, Yuan R, Yang S, Gao H. Pedunculoside inhibits epithelial-mesenchymal transition and overcomes gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways. Phytomedicine. 2023;116:154884.","journal-title":"Phytomedicine"},{"key":"2375_CR146","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-019-0961-y","volume":"18","author":"Z Liao","year":"2019","unstructured":"Liao Z, Chua D, Tan NS. Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol Cancer. 2019;18:65.","journal-title":"Mol Cancer"},{"key":"2375_CR147","doi-asserted-by":"publisher","first-page":"113745","DOI":"10.1016\/j.biopha.2022.113745","volume":"155","author":"JR Chen","year":"2022","unstructured":"Chen JR, Zhao JT, Xie ZZ. Integrin-mediated cancer progression as a specific target in clinical therapy. Biomed Pharmacother. 2022;155:113745.","journal-title":"Biomed Pharmacother"},{"key":"2375_CR148","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hep.27425","volume":"61","author":"L Pi","year":"2015","unstructured":"Pi L, Robinson PM, Jorgensen M, Oh SH, Brown AR, Weinreb PH, Trinh TL, Yianni P, Liu C, Leask A, et al. Connective tissue growth factor and integrin \u03b1v\u03b26: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice. Hepatology. 2015;61:678\u201391.","journal-title":"Hepatology"},{"key":"2375_CR149","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1016\/j.cell.2024.08.036","volume":"187","author":"M Jin","year":"2024","unstructured":"Jin M, Seed RI, Cai G, Shing T, Wang L, Ito S, Cormier A, Wankowicz SA, Jespersen JM, Baron JL, et al. Dynamic allostery drives autocrine and paracrine TGF-\u03b2 signaling. Cell. 2024;187:6200-6219.e6223.","journal-title":"Cell"},{"key":"2375_CR150","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00432-024-05922-z","volume":"150","author":"W Chen","year":"2024","unstructured":"Chen W, Yang H, Huang L, Fang C, Yao L, Liu F, Jin T. ROS-mediated ITGB5 promotes tongue squamous cell carcinoma metastasis through epithelial mesenchymal transition and cell adhesion signal pathway. J Cancer Res Clin Oncol. 2024;150:398.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2375_CR151","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/sigtrans.2017.36","volume":"2","author":"J Jiang","year":"2017","unstructured":"Jiang J, Wang K, Chen Y, Chen H, Nice EC, Huang C. Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy. Signal Transduct Target Ther. 2017;2:17036.","journal-title":"Signal Transduct Target Ther"},{"key":"2375_CR152","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2020.12.003","volume":"163","author":"JP Mandal","year":"2021","unstructured":"Mandal JP, Shiue CN, Chen YC, Lee MC, Yang HH, Chang HH, Hu CT, Liao PC, Hui LC, You RI, Wu WS. PKC\u03b4 mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression. Free Radic Biol Med. 2021;163:69\u201387.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR153","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41419-020-2528-7","volume":"11","author":"H Chang","year":"2020","unstructured":"Chang H, Li J, Qu K, Wan Y, Liu S, Zheng W, Zhang Z, Liu C. CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS\/NF\u03baB pathway in hepatocellular carcinoma. Cell Death Dis. 2020;11:332.","journal-title":"Cell Death Dis"},{"key":"2375_CR154","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-010-0418-5","volume":"340","author":"N Tobar","year":"2010","unstructured":"Tobar N, Villar V, Santibanez JF. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem. 2010;340:195\u2013202.","journal-title":"Mol Cell Biochem"},{"key":"2375_CR155","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13046-021-01960-4","volume":"40","author":"CH Chang","year":"2021","unstructured":"Chang CH, Pauklin S. ROS and TGF\u03b2: from pancreatic tumour growth to metastasis. J Exp Clin Cancer Res. 2021;40:152.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR156","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1096\/fba.2022-00045","volume":"5","author":"F Peng","year":"2023","unstructured":"Peng F, Xu Q, Jing X, Chi X, Zhang Z, Meng X, Liu X, Yan J, Liu X, Shao S. GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K\/AKT\/mTOR\/Snail signaling axis. FASEB Bioadv. 2023;5:233\u201350.","journal-title":"FASEB Bioadv"},{"key":"2375_CR157","doi-asserted-by":"publisher","first-page":"151073","DOI":"10.1016\/j.ejcb.2020.151073","volume":"99","author":"R Chatterjee","year":"2020","unstructured":"Chatterjee R, Chatterjee J. ROS and oncogenesis with special reference to EMT and stemness. Eur J Cell Biol. 2020;99:151073.","journal-title":"Eur J Cell Biol"},{"key":"2375_CR158","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15548627.2021.2008752","volume":"18","author":"Y Xing","year":"2022","unstructured":"Xing Y, Wei X, Liu Y, Wang MM, Sui Z, Wang X, Zhu W, Wu M, Lu C, Fei YH, et al. Autophagy inhibition mediated by MCOLN1\/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53\/p53 pathway. Autophagy. 2022;18:1932\u201354.","journal-title":"Autophagy"},{"key":"2375_CR159","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186\u201391.","journal-title":"Nature"},{"key":"2375_CR160","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","volume":"178","author":"C Wiel","year":"2019","unstructured":"Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, Ziegler DV, Xu X, Ghosh T, Mondal T, et al. BACH1 stabilization by antioxidants stimulates lung cancer metastasis. Cell. 2019;178:330-345.e322.","journal-title":"Cell"},{"key":"2375_CR161","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1089\/ars.2021.0199","volume":"36","author":"FT Ogata","year":"2022","unstructured":"Ogata FT, Sim\u00f5es Sato AY, Coppo L, Arai RJ, Stern AI, Pequeno Monteiro H. Thiol-based antioxidants and the epithelial\/mesenchymal transition in cancer. Antioxid Redox Signal. 2022;36:1037\u201350.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR162","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cell.2019.06.003","volume":"178","author":"L Lignitto","year":"2019","unstructured":"Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, Pass HI, Bhutkar AJ, Tsirigos A, Ueberheide B, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1. Cell. 2019;178:316-329.e318.","journal-title":"Cell"},{"key":"2375_CR163","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40364-024-00662-1","volume":"12","author":"H Xu","year":"2024","unstructured":"Xu H, Chai H, Chen M, Zhu R, Jiang S, Liu X, Wang Y, Chen J, Wei J, Mao Y, Shi Z. Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy. Biomark Res. 2024;12:114.","journal-title":"Biomark Res"},{"key":"2375_CR164","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.7150\/thno.92672","volume":"14","author":"SMP Vadevoo","year":"2024","unstructured":"Vadevoo SMP, Kang Y, Gunassekaran GR, Lee SM, Park MS, Jo DG, Kim SK, Lee H, Kim WJ, Lee B. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis. Theranostics. 2024;14:2605\u201321.","journal-title":"Theranostics"},{"key":"2375_CR165","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","volume":"82","author":"S Suzuki","year":"2022","unstructured":"Suzuki S, Venkatesh D, Kanda H, Nakayama A, Hosokawa H, Lee E, Miki T, Stockwell BR, Yokote K, Tanaka T, Prives C. GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma. Cancer Res. 2022;82:3209\u201322.","journal-title":"Cancer Res"},{"key":"2375_CR166","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.bbamcr.2016.12.014","volume":"1864","author":"Q Wang","year":"2017","unstructured":"Wang Q, Huang L, Yue J. Oxidative stress activates the TRPM2-Ca(2+)-CaMKII-ROS signaling loop to induce cell death in cancer cells. Biochim Biophys Acta Mol Cell Res. 2017;1864:957\u201367.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2375_CR167","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.redox.2019.101319","volume":"28","author":"S Wang","year":"2020","unstructured":"Wang S, Chen Z, Zhu S, Lu H, Peng D, Soutto M, Naz H, Peek R Jr, Xu H, Zaika A, et al. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer. Redox Biol. 2020;28:101319.","journal-title":"Redox Biol"},{"key":"2375_CR168","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-13-3456","volume":"74","author":"D Raha","year":"2014","unstructured":"Raha D, Wilson TR, Peng J, Peterson D, Yue P, Evangelista M, Wilson C, Merchant M, Settleman J. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Res. 2014;74:3579\u201390.","journal-title":"Cancer Res"},{"key":"2375_CR169","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1016\/j.molcel.2023.08.032","volume":"83","author":"L He","year":"2023","unstructured":"He L, Chen J, Deng P, Huang S, Liu P, Wang C, Huang X, Li Y, Chen B, Shi D, et al. Lysosomal cyst(e)ine storage potentiates tolerance to oxidative stress in cancer cells. Mol Cell. 2023;83:3502-3519.e3511.","journal-title":"Mol Cell"},{"key":"2375_CR170","doi-asserted-by":"publisher","first-page":"e2204438","DOI":"10.1002\/advs.202204438","volume":"10","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou T, Yang X, Cao X, Jin G, Zhang P, Guo J, Rong K, Li B, Hu Y, et al. DDRGK1 enhances osteosarcoma chemoresistance via inhibiting KEAP1-mediated NRF2 ubiquitination. Adv Sci (Weinh). 2023;10:e2204438.","journal-title":"Adv Sci (Weinh)"},{"key":"2375_CR171","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","volume":"32","author":"W Ge","year":"2017","unstructured":"Ge W, Zhao K, Wang X, Li H, Yu M, He M, Xue X, Zhu Y, Zhang C, Cheng Y, et al. iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap1 binding. Cancer Cell. 2017;32:561-573.e566.","journal-title":"Cancer Cell"},{"key":"2375_CR172","doi-asserted-by":"publisher","first-page":"e170753","DOI":"10.1172\/JCI170753","volume":"133","author":"N Zhou","year":"2023","unstructured":"Zhou N, Chen J, Ling Z, Zhang C, Zhou Y, Wang D, Zhou L, Wang Z, Sun N, Wang X, et al. Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance. J Clin Invest. 2023;133:e170753.","journal-title":"J Clin Invest"},{"key":"2375_CR173","doi-asserted-by":"publisher","first-page":"217000","DOI":"10.1016\/j.canlet.2024.217000","volume":"595","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xu Y, Cheng Z, Zhao J, Wang M, Sun Y, Mi Z, Yuan Z, Wu Z. The EGR1\/miR-139\/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis. Cancer Lett. 2024;595:217000.","journal-title":"Cancer Lett"},{"key":"2375_CR174","doi-asserted-by":"publisher","first-page":"e968434","DOI":"10.4161\/21624011.2014.968434","volume":"3","author":"I Adkins","year":"2014","unstructured":"Adkins I, Fucikova J, Garg AD, Agostinis P, \u0160p\u00ed\u0161ek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology. 2014;3:e968434.","journal-title":"Oncoimmunology"},{"key":"2375_CR175","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang H, Zhang S, Li Y, Liu Z, Mi L, Cai Y, Wang X, Chen L, Ran H, Xiao D, et al. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. Nat Commun. 2021;12:3720.","journal-title":"Nat Commun"},{"key":"2375_CR176","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12916-022-02554-3","volume":"20","author":"Y Zhan","year":"2022","unstructured":"Zhan Y, Zhang Z, Liu Y, Fang Y, Xie Y, Zheng Y, Li G, Liang L, Ding Y. NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR\/CYP signal axis in hepatocellular carcinoma. BMC Med. 2022;20:365.","journal-title":"BMC Med"},{"key":"2375_CR177","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.18632\/aging.204265","volume":"14","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang J, Gong J, Tang X, Zhang C. UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis. Aging (Albany NY). 2022;14:7003\u201313.","journal-title":"Aging (Albany NY)"},{"key":"2375_CR178","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fbioe.2020.01040","volume":"8","author":"S Bhattacharya","year":"2020","unstructured":"Bhattacharya S, Calar K, Evans C, Petrasko M, de la Puente P. Bioengineering the oxygen-deprived tumor microenvironment within a three-dimensional platform for studying tumor-immune interactions. Front Bioeng Biotechnol. 2020;8:1040.","journal-title":"Front Bioeng Biotechnol"},{"key":"2375_CR179","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2375_CR180","doi-asserted-by":"publisher","first-page":"e20220011","DOI":"10.1084\/jem.20220011","volume":"219","author":"DF Quail","year":"2022","unstructured":"Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A, et al. Neutrophil phenotypes and functions in cancer: a consensus statement. J Exp Med. 2022;219:e20220011.","journal-title":"J Exp Med"},{"key":"2375_CR181","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","volume":"20","author":"RD Leone","year":"2020","unstructured":"Leone RD, Powell JD. Metabolism of immune cells in cancer. Nat Rev Cancer. 2020;20:516\u201331.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR182","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20:485\u2013503.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR183","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/emmm.201000073","volume":"2","author":"A Toullec","year":"2010","unstructured":"Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, Richardson M, Rigaill G, Parrini MC, Lucchesi C, et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med. 2010;2:211\u201330.","journal-title":"EMBO Mol Med"},{"key":"2375_CR184","doi-asserted-by":"publisher","first-page":"e010555","DOI":"10.1136\/jitc-2024-010555","volume":"13","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Hu Y, Li H, Lu T, He X, Ma Y, Huang M, Li M, Yang L, Shi C. Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. J Immunother Cancer. 2025;13:e010555.","journal-title":"J Immunother Cancer"},{"key":"2375_CR185","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13046-024-03077-w","volume":"43","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Qu C, Zhou P, Zhou Q, Li D, Wu X, Yang L. Extracellular vesicles activated cancer-associated fibroblasts promote lung cancer metastasis through mitophagy and mtDNA transfer. J Exp Clin Cancer Res. 2024;43:158.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR186","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1089\/ars.2010.3727","volume":"14","author":"E Giannoni","year":"2011","unstructured":"Giannoni E, Bianchini F, Calorini L, Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal. 2011;14:2361\u201371.","journal-title":"Antioxid Redox Signal"},{"issue":"27","key":"2375_CR187","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","volume":"43","author":"J Zhao","year":"2024","unstructured":"Zhao J, Shen J, Mao L, Yang T, Liu J, Hongbin S. Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer. Oncogene. 2024;43(27):2104\u201314.","journal-title":"Oncogene."},{"key":"2375_CR188","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253\u201368.","journal-title":"Nat Rev Immunol"},{"key":"2375_CR189","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"2375_CR190","doi-asserted-by":"publisher","first-page":"e006272","DOI":"10.1136\/jitc-2022-006272","volume":"11","author":"T Zhao","year":"2023","unstructured":"Zhao T, Liu S, Hanna NH, Jalal S, Ding X, Wan J, Yan C, Du H. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer. J Immunother Cancer. 2023;11:e006272.","journal-title":"J Immunother Cancer"},{"key":"2375_CR191","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.4049\/jimmunol.1501785","volume":"196","author":"DW Beury","year":"2016","unstructured":"Beury DW, Carter KA, Nelson C, Sinha P, Hanson E, Nyandjo M, Fitzgerald PJ, Majeed A, Wali N, Ostrand-Rosenberg S. Myeloid-derived suppressor cell survival and function are regulated by the transcription factor Nrf2. J Immunol. 2016;196:3470\u20138.","journal-title":"J Immunol"},{"key":"2375_CR192","doi-asserted-by":"publisher","first-page":"e2779","DOI":"10.1038\/cddis.2017.192","volume":"8","author":"SL Jian","year":"2017","unstructured":"Jian SL, Chen WW, Su YC, Su YW, Chuang TH, Hsu SC, Huang LR. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Cell Death Dis. 2017;8:e2779.","journal-title":"Cell Death Dis"},{"key":"2375_CR193","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","volume":"172","author":"S Kusmartsev","year":"2004","unstructured":"Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol. 2004;172:989\u201399.","journal-title":"J Immunol"},{"key":"2375_CR194","first-page":"20","volume":"2019","author":"ML Sprouse","year":"1916","unstructured":"Sprouse ML, Welte T, Boral D, Liu HN, Yin W, Vishnoi M, Goswami-Sewell D, Li L, Pei G, Jia P, et al. PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/Notch\/Nodal signaling. Int J Mol Sci. 1916;2019:20.","journal-title":"Int J Mol Sci"},{"key":"2375_CR195","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","volume":"8","author":"H Xiang","year":"2020","unstructured":"Xiang H, Ramil CP, Hai J, Zhang C, Wang H, Watkins AA, Afshar R, Georgiev P, Sze MA, Song XS, et al. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8:436\u201350.","journal-title":"Cancer Immunol Res"},{"key":"2375_CR196","doi-asserted-by":"publisher","first-page":"2108971","DOI":"10.1002\/adfm.202108971","volume":"32","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Han Y, Wang T, Liu H, Sun Q, Hu S, Chen J, Li Z. Reprogramming tumor-associated macrophages via ROS-mediated novel mechanism of ultra-small Cu2\u2212 xSe nanoparticles to enhance anti-tumor immunity. Adv Func Mater. 2022;32:2108971.","journal-title":"Adv Func Mater"},{"key":"2375_CR197","doi-asserted-by":"publisher","first-page":"e007253","DOI":"10.1136\/jitc-2023-007253","volume":"11","author":"YN Wang","year":"2023","unstructured":"Wang YN, Wang YY, Wang J, Bai WJ, Miao NJ, Wang J. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response. J Immunother Cancer. 2023;11:e007253.","journal-title":"J Immunother Cancer"},{"key":"2375_CR198","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00262-023-03406-6","volume":"72","author":"M Ito","year":"2023","unstructured":"Ito M, Mimura K, Nakajima S, Okayama H, Saito K, Nakajima T, Kikuchi T, Onozawa H, Fujita S, Sakamoto W, et al. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment. Cancer Immunol Immunother. 2023;72:2233\u201344.","journal-title":"Cancer Immunol Immunother"},{"key":"2375_CR199","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-022-02244-1","volume":"41","author":"X Li","year":"2022","unstructured":"Li X, Wang S, Mu W, Barry J, Han A, Carpenter RL, Jiang BH, Peiper SC, Mahoney MG, Aplin AE, et al. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p\/PD-L1 pathway. J Exp Clin Cancer Res. 2022;41:41.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR200","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/ars.2012.4617","volume":"19","author":"X Lin","year":"2013","unstructured":"Lin X, Zheng W, Liu J, Zhang Y, Qin H, Wu H, Xue B, Lu Y, Shen P. Oxidative stress in malignant melanoma enhances tumor necrosis factor- \u03b1 secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal. 2013;19:1337\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR201","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1038\/s41467-018-05676-6","volume":"9","author":"X Yu","year":"2018","unstructured":"Yu X, Lao Y, Teng XL, Li S, Zhou Y, Wang F, Guo X, Deng S, Chang Y, Wu X, et al. SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation. Nat Commun. 2018;9:3157.","journal-title":"Nat Commun"},{"key":"2375_CR202","doi-asserted-by":"publisher","first-page":"e179874","DOI":"10.1172\/JCI179874","volume":"135","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Wang H, Wang X, Duo H, Tao Y, Li J, Li X, Liu J, Ni J, Wu EJ, et al. TMED4 facilitates regulatory T cell suppressive function via ROS homeostasis in tumor and autoimmune mouse models. J Clin Invest. 2024;135:e179874.","journal-title":"J Clin Invest"},{"key":"2375_CR203","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1182\/blood-2008-09-181040","volume":"113","author":"D Mougiakakos","year":"2009","unstructured":"Mougiakakos D, Johansson CC, Kiessling R. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood. 2009;113:3542\u20135.","journal-title":"Blood"},{"key":"2375_CR204","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ni.3868","volume":"18","author":"T Maj","year":"2017","unstructured":"Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, Zhao L, Vatan L, Shao I, Szeliga W, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol. 2017;18:1332\u201341.","journal-title":"Nat Immunol"},{"key":"2375_CR205","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-immunol-101819-082015","volume":"39","author":"EM Steinert","year":"2021","unstructured":"Steinert EM, Vasan K, Chandel NS. Mitochondrial metabolism regulation of T cell-mediated immunity. Annu Rev Immunol. 2021;39:395\u2013416.","journal-title":"Annu Rev Immunol"},{"key":"2375_CR206","doi-asserted-by":"publisher","first-page":"e155224","DOI":"10.1172\/JCI155224","volume":"132","author":"Z Wu","year":"2022","unstructured":"Wu Z, Huang H, Han Q, Hu Z, Teng XL, Ding R, Ye Y, Yu X, Zhao R, Wang Z, Zou Q. SENP7 senses oxidative stress to sustain metabolic fitness and antitum or functions of CD8+ T cells. J Clin Invest. 2022;132:e155224.","journal-title":"J Clin Invest"},{"key":"2375_CR207","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-014-0050-1","volume":"12","author":"AV Belikov","year":"2014","unstructured":"Belikov AV, Schraven B, Simeoni L. TCR-triggered extracellular superoxide production is not required for T-cell activation. Cell Commun Signal. 2014;12:50.","journal-title":"Cell Commun Signal"},{"key":"2375_CR208","doi-asserted-by":"publisher","first-page":"101891","DOI":"10.1016\/j.redox.2021.101891","volume":"42","author":"KB Kennel","year":"2021","unstructured":"Kennel KB, Greten FR. Immune cell - produced ROS and their impact on tumor growth and metastasis. Redox Biol. 2021;42:101891.","journal-title":"Redox Biol"},{"key":"2375_CR209","doi-asserted-by":"crossref","unstructured":"Qin Y, Huo F, Feng Z, Hou J, Ding Y, Wang Q, Gui Y, Yang Z, Yang J, Zhou G, et al. CD36 promotes iron accumulation and dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma. Clin Mol Hepatol. 2025.","DOI":"10.3350\/cmh.2024.0948"},{"key":"2375_CR210","doi-asserted-by":"publisher","first-page":"e170071","DOI":"10.1172\/JCI170071","volume":"134","author":"S Chen","year":"2024","unstructured":"Chen S, Fan J, Xie P, Ahn J, Fernandez M, Billingham LK, Miska J, Wu JD, Wainwright DA, Fang D, et al. CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione\/GPX4. J Clin Invest. 2024;134:e170071.","journal-title":"J Clin Invest"},{"key":"2375_CR211","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1172\/JCI84181","volume":"126","author":"Z Wen","year":"2016","unstructured":"Wen Z, Shimojima Y, Shirai T, Li Y, Ju J, Yang Z, Tian L, Goronzy JJ, Weyand CM. NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest. 2016;126:1953\u201367.","journal-title":"J Clin Invest"},{"key":"2375_CR212","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41565-022-01261-7","volume":"18","author":"C Shi","year":"2023","unstructured":"Shi C, Zhang Q, Yao Y, Zeng F, Du C, Nijiati S, Wen X, Zhang X, Yang H, Chen H, et al. Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics. Nat Nanotechnol. 2023;18:86\u201397.","journal-title":"Nat Nanotechnol"},{"key":"2375_CR213","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.it.2021.03.006","volume":"42","author":"HH Van Acker","year":"2021","unstructured":"Van Acker HH, Ma S, Scolaro T, Kaech SM, Mazzone M. How metabolism bridles cytotoxic CD8(+) T cells through epigenetic modifications. Trends Immunol. 2021;42:401\u201317.","journal-title":"Trends Immunol"},{"key":"2375_CR214","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-022-01669-8","volume":"21","author":"C Qu","year":"2022","unstructured":"Qu C, Zhang H, Cao H, Tang L, Mo H, Liu F, Zhang L, Yi Z, Long L, Yan L, et al. Tumor buster - where will the CAR-T cell therapy \u2018missile\u2019 go? Mol Cancer. 2022;21:201.","journal-title":"Mol Cancer"},{"key":"2375_CR215","doi-asserted-by":"publisher","first-page":"874589","DOI":"10.3389\/fimmu.2022.874589","volume":"13","author":"Y Pu","year":"2022","unstructured":"Pu Y, Ji Q. Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression. Front Immunol. 2022;13:874589.","journal-title":"Front Immunol"},{"key":"2375_CR216","doi-asserted-by":"publisher","first-page":"e2300110","DOI":"10.1002\/adhm.202300110","volume":"12","author":"S Wu","year":"2023","unstructured":"Wu S, Zhang J, Pan J, Bai S, Wang Z, Chen Y, Xu D, An Y, Liu C, Chu C, et al. Integrated nanorod-mediated PD-L1 downregulation in combination with oxidative-stress immunogene therapy against cancer. Adv Healthc Mater. 2023;12:e2300110.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR217","first-page":"275","volume":"13","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Matsunaga K. Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD). Cancer Biother Radiopharm. 1998;13:275\u201390.","journal-title":"Cancer Biother Radiopharm"},{"key":"2375_CR218","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-17-0691","volume":"24","author":"A Stiff","year":"2018","unstructured":"Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, et al. Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing Fc receptor-mediated natural killer cell function. Clin Cancer Res. 2018;24:1891\u2013904.","journal-title":"Clin Cancer Res"},{"key":"2375_CR219","doi-asserted-by":"publisher","first-page":"1506236","DOI":"10.3389\/fimmu.2024.1506236","volume":"15","author":"V Karlsson","year":"2024","unstructured":"Karlsson V, St\u00e5l E, Stoopendahl E, Ivarsson A, Leffler H, Lycke M, Sundqvist M, Sundfeldt K, Christenson K, Bernson E. Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils. Front Immunol. 2024;15:1506236.","journal-title":"Front Immunol"},{"key":"2375_CR220","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1158\/2326-6066.CIR-16-0382","volume":"5","author":"E Aydin","year":"2017","unstructured":"Aydin E, Johansson J, Nazir FH, Hellstrand K, Martner A. Role of NOX2-derived reactive oxygen species in NK cell-mediated control of murine melanoma metastasis. Cancer Immunol Res. 2017;5:804\u201311.","journal-title":"Cancer Immunol Res"},{"key":"2375_CR221","doi-asserted-by":"publisher","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","volume":"16","author":"F Jin","year":"2019","unstructured":"Jin F, Wu Z, Hu X, Zhang J, Gao Z, Han X, Qin J, Li C, Wang Y. The PI3K\/Akt\/GSK-3\u03b2\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility. Cancer Biol Med. 2019;16:38\u201354.","journal-title":"Cancer Biol Med"},{"key":"2375_CR222","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lfs.2015.01.026","volume":"126","author":"PJ Amin","year":"2015","unstructured":"Amin PJ, Shankar BS. Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis. Life Sci. 2015;126:19\u201327.","journal-title":"Life Sci"},{"key":"2375_CR223","doi-asserted-by":"publisher","first-page":"e202318530","DOI":"10.1002\/anie.202318530","volume":"63","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Yang B, Jia Y, Liu RT, Ding L, Shen Z, Chen X. Synergistic glutathione depletion and STING activation to potentiate dendritic cell maturation and cancer vaccine efficacy. Angew Chem Int Ed Engl. 2024;63:e202318530.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2375_CR224","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.molcel.2020.12.024","volume":"81","author":"Z Hu","year":"2021","unstructured":"Hu Z, Teng X-L, Zhang T, Yu X, Ding R, Yi J, Deng L, Wang Z, Zou Q. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Mol Cell. 2021;81:940-952.e945.","journal-title":"Mol Cell"},{"key":"2375_CR225","doi-asserted-by":"publisher","first-page":"883","DOI":"10.18632\/oncotarget.26608","volume":"10","author":"LM Paardekooper","year":"2019","unstructured":"Paardekooper LM, Vos W, van den Bogaart G. Oxygen in the tumor microenvironment: effects on dendritic cell function. Oncotarget. 2019;10:883\u201396.","journal-title":"Oncotarget"},{"key":"2375_CR226","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J, Bazhin AV. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231:2570\u201381.","journal-title":"J Cell Physiol"},{"key":"2375_CR227","doi-asserted-by":"publisher","first-page":"102619","DOI":"10.1016\/j.redox.2023.102619","volume":"60","author":"M Kashif","year":"2023","unstructured":"Kashif M, Yao H, Schmidt S, Chen X, Truong M, T\u00fcksammel E, Liu Y, Bergo MO. ROS-lowering doses of vitamins C and A accelerate malignant melanoma metastasis. Redox Biol. 2023;60:102619.","journal-title":"Redox Biol"},{"key":"2375_CR228","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/nutrit\/nuz027","volume":"78","author":"R Ilghami","year":"2020","unstructured":"Ilghami R, Barzegari A, Mashayekhi MR, Letourneur D, Crepin M, Pavon-Djavid G. The conundrum of dietary antioxidants in cancer chemotherapy. Nutr Rev. 2020;78:65\u201376.","journal-title":"Nutr Rev"},{"key":"2375_CR229","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1200\/JCO.19.01203","volume":"38","author":"CB Ambrosone","year":"2020","unstructured":"Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, et al. Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol. 2020;38:804\u201314.","journal-title":"J Clin Oncol"},{"key":"2375_CR230","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ijc.23754","volume":"123","author":"KI Block","year":"2008","unstructured":"Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123:1227\u201339.","journal-title":"Int J Cancer"},{"key":"2375_CR231","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3945\/an.113.005157","volume":"5","author":"J Lykkesfeldt","year":"2014","unstructured":"Lykkesfeldt J, Michels AJ, Frei B. Vitamin C. Adv Nutr. 2014;5:16\u20138.","journal-title":"Adv Nutr"},{"key":"2375_CR232","first-page":"443","volume":"1826","author":"J Du","year":"2012","unstructured":"Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012;1826:443\u201357.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR233","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/biom11081130","volume":"11","author":"J Reang","year":"2021","unstructured":"Reang J, Sharma PC, Thakur VK, Majeed J. Understanding the therapeutic potential of ascorbic acid in the battle to overcome cancer. Biomolecules. 2021;11:1130.","journal-title":"Biomolecules"},{"key":"2375_CR234","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","volume":"375","author":"T Jiang","year":"2016","unstructured":"Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X, Jiang C, Kang C, Li X, Chen L, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016;375:263\u201373.","journal-title":"Cancer Lett"},{"key":"2375_CR235","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ccell.2018.07.014","volume":"34","author":"N Shenoy","year":"2018","unstructured":"Shenoy N, Creagan E, Witzig T, Levine M. Ascorbic acid in cancer treatment: let the phoenix fly. Cancer Cell. 2018;34:700\u20136.","journal-title":"Cancer Cell"},{"key":"2375_CR236","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/nu12051501","volume":"12","author":"J Ka\u017amierczak-Bara\u0144ska","year":"2018","unstructured":"Ka\u017amierczak-Bara\u0144ska J, Boguszewska K, Adamus-Grabicka A, Karwowski BT. Two faces of vitamin C-antioxidative and pro-oxidative agent. Nutrients. 2018;12:1501.","journal-title":"Nutrients"},{"key":"2375_CR237","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1089\/ars.2020.8233","volume":"35","author":"C Glorieux","year":"2021","unstructured":"Glorieux C, Buc Calderon P. Vitamin C (ascorbate) and redox topics in cancer. Antioxid Redox Signal. 2021;35:1157\u201375.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR238","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s40262-022-01142-1","volume":"61","author":"P Chen","year":"2022","unstructured":"Chen P, Reed G, Jiang J, Wang Y, Sunega J, Dong R, Ma Y, Esparham A, Ferrell R, Levine M, et al. Pharmacokinetic evaluation of intravenous vitamin C: a classic pharmacokinetic study. Clin Pharmacokinet. 2022;61:1237\u201349.","journal-title":"Clin Pharmacokinet"},{"key":"2375_CR239","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/1534735414534463","volume":"13","author":"H Fritz","year":"2014","unstructured":"Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, Skidmore B, Kirchner L, Seely D. Intravenous vitamin C and cancer: a systematic review. Integr Cancer Ther. 2014;13:280\u2013300.","journal-title":"Integr Cancer Ther"},{"key":"2375_CR240","doi-asserted-by":"crossref","unstructured":"Gordon N, Gallagher PT, Neupane NP, Mandigo AC, McCann JK, Dylgjeri E, Vasilevskaya I, McNair C, Paller CJ, Kelly WK, et al. PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer. bioRxiv. 2023.","DOI":"10.1101\/2023.03.23.533944"},{"key":"2375_CR241","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13046-021-02134-y","volume":"40","author":"F B\u00f6ttger","year":"2021","unstructured":"B\u00f6ttger F, Vall\u00e9s-Mart\u00ed A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res. 2021;40:343.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR242","doi-asserted-by":"publisher","first-page":"e29794","DOI":"10.1371\/journal.pone.0029794","volume":"7","author":"DA Monti","year":"2012","unstructured":"Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S, Levine M. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One. 2012;7:e29794.","journal-title":"PLoS One"},{"key":"2375_CR243","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","volume":"71","author":"JL Welsh","year":"2013","unstructured":"Welsh JL, Wagner BA, van\u2019t Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ 2nd, et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013;71:765\u201375.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2375_CR244","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.1073\/pnas.0804226105","volume":"105","author":"Q Chen","year":"2008","unstructured":"Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008;105:11105\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR245","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2020.03.004","volume":"24","author":"J Ou","year":"2020","unstructured":"Ou J, Zhu X, Chen P, Du Y, Lu Y, Peng X, Bao S, Wang J, Zhang X, Zhang T, Pang CLK. A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer. J Adv Res. 2020;24:175\u201382.","journal-title":"J Adv Res"},{"key":"2375_CR246","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJM197909273011303","volume":"301","author":"ET Creagan","year":"1979","unstructured":"Creagan ET, Moertel CG, O\u2019Fallon JR, Schutt AJ, O\u2019Connell MJ, Rubin J, Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979;301:687\u201390.","journal-title":"N Engl J Med"},{"key":"2375_CR247","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM198501173120301","volume":"312","author":"CG Moertel","year":"1985","unstructured":"Moertel CG, Fleming TR, Creagan ET, Rubin J, O\u2019Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985;312:137\u201341.","journal-title":"N Engl J Med"},{"key":"2375_CR248","first-page":"175","volume":"6","author":"JM Poulter","year":"1984","unstructured":"Poulter JM, White WF, Dickerson JW. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol. 1984;6:175\u201382.","journal-title":"Acta Vitaminol Enzymol"},{"key":"2375_CR249","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","volume":"47","author":"J Verrax","year":"2009","unstructured":"Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med. 2009;47:32\u201340.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR250","doi-asserted-by":"publisher","first-page":"13604","DOI":"10.1073\/pnas.0506390102","volume":"102","author":"Q Chen","year":"2005","unstructured":"Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR251","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2011.03.007","volume":"50","author":"MG Espey","year":"2011","unstructured":"Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, Chen Q. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med. 2011;50:1610\u20139.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR252","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2015.06.032","volume":"87","author":"OK Serrano","year":"2015","unstructured":"Serrano OK, Parrow NL, Violet PC, Yang J, Zornjak J, Basseville A, Levine M. Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model. Free Radic Biol Med. 2015;87:193\u2013203.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR253","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","volume":"18","author":"J Xia","year":"2017","unstructured":"Xia J, Xu H, Zhang X, Allamargot C, Coleman KL, Nessler R, Frech I, Tricot G, Zhan F. Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid. EBioMedicine. 2017;18:41\u20139.","journal-title":"EBioMedicine"},{"key":"2375_CR254","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1056\/NEJM199605023341802","volume":"334","author":"GS Omenn","year":"1996","unstructured":"Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150\u20135.","journal-title":"N Engl J Med"},{"key":"2375_CR255","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.3390\/ijms232012622","volume":"23","author":"B Ramchatesingh","year":"2022","unstructured":"Ramchatesingh B, Mart\u00ednez Villarreal A, Arcuri D, Lagac\u00e9 F, Setah SA, Touma F, Al-Badarin F, Litvinov IV. The use of retinoids for the prevention and treatment of skin cancers: an updated review. Int J Mol Sci. 2022;23:12622.","journal-title":"Int J Mol Sci"},{"key":"2375_CR256","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3390\/nu13093162","volume":"13","author":"JA Kim","year":"2021","unstructured":"Kim JA, Jang JH, Lee SY. An updated comprehensive review on vitamin A and carotenoids in breast cancer: mechanisms, genetics, assessment, current evidence, and future clinical implications. Nutrients. 2021;13:3162.","journal-title":"Nutrients"},{"key":"2375_CR257","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jnci\/92.12.977","volume":"92","author":"N van Zandwijk","year":"2000","unstructured":"van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst. 2000;92:977\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"2375_CR258","doi-asserted-by":"publisher","first-page":"221ra215","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221ra215.","journal-title":"Sci Transl Med"},{"key":"2375_CR259","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12916-022-02366-5","volume":"20","author":"J Xin","year":"2022","unstructured":"Xin J, Jiang X, Ben S, Yuan Q, Su L, Zhang Z, Christiani DC, Du M, Wang M. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study. BMC Med. 2022;20:168.","journal-title":"BMC Med"},{"key":"2375_CR260","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","volume":"301","author":"SM Lippman","year":"2009","unstructured":"Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39\u201351.","journal-title":"JAMA"},{"key":"2375_CR261","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/carcin\/bgt064","volume":"34","author":"E Pierpaoli","year":"2013","unstructured":"Pierpaoli E, Viola V, Barucca A, Orlando F, Galli F, Provinciali M. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2\/neu transgenic mice. Carcinogenesis. 2013;34:1352\u201360.","journal-title":"Carcinogenesis"},{"key":"2375_CR262","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/br.2025.1944","volume":"22","author":"C Copat","year":"2025","unstructured":"Copat C, Favara C, Tomasello MF, Sica C, Grasso A, Dominguez HG, Conti GO, Ferrante M. Astaxanthin in cancer therapy and prevention (review). Biomed Rep. 2025;22:66.","journal-title":"Biomed Rep"},{"key":"2375_CR263","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","volume":"140","author":"EY Chew","year":"2022","unstructured":"Chew EY, Clemons TE, Agr\u00f3n E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W. Long-term outcomes of adding lutein\/zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28. JAMA Ophthalmol. 2022;140:692\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"2375_CR264","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/molecules23040905","volume":"23","author":"X Gong","year":"2018","unstructured":"Gong X, Smith JR, Swanson HM, Rubin LP. Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Molecules. 2018;23:905.","journal-title":"Molecules"},{"key":"2375_CR265","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.clnu.2016.06.014","volume":"36","author":"I Paur","year":"2017","unstructured":"Paur I, Lilleby W, B\u00f8hn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bj\u00f8ro T, Laake P, et al. Tomato-based randomized controlled trial in prostate cancer patients: effect on PSA. Clin Nutr. 2017;36:672\u20139.","journal-title":"Clin Nutr"},{"key":"2375_CR266","doi-asserted-by":"publisher","first-page":"109313","DOI":"10.1016\/j.jnutbio.2023.109313","volume":"116","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Fu R, Yang M, Liu W, Tong Z. Lycopene suppresses gastric cancer cell growth without affecting normal gastric epithelial cells. J Nutr Biochem. 2023;116:109313.","journal-title":"J Nutr Biochem"},{"key":"2375_CR267","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jsps.2022.09.011","volume":"30","author":"NM Alhoshani","year":"2022","unstructured":"Alhoshani NM, Al-Zharani M, Almutairi B, Aljarba NH, Al-Johani NS, Alkeraishan N, AlKahtane AA, Alarifi S, Ali D, Alkahtani S. Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells. Saudi Pharm J. 2022;30:1665\u201371.","journal-title":"Saudi Pharm J"},{"key":"2375_CR268","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/antiox9080651","volume":"9","author":"A Thyagarajan","year":"2020","unstructured":"Thyagarajan A, Forino AS, Konger RL, Sahu RP. Dietary polyphenols in cancer chemoprevention: implications in pancreatic cancer. Antioxidants (Basel). 2020;9:651.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR269","first-page":"44","volume":"59","author":"M Suganuma","year":"1999","unstructured":"Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. Synergistic effects of (\u2013)-epigallocatechin gallate with (\u2013)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 1999;59:44\u20137.","journal-title":"Cancer Res"},{"key":"2375_CR270","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/biof.5520130112","volume":"13","author":"M Suganuma","year":"2000","unstructured":"Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. BioFactors. 2000;13:67\u201372.","journal-title":"BioFactors"},{"key":"2375_CR271","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10495-010-0548-y","volume":"16","author":"MH Lee","year":"2011","unstructured":"Lee MH, Han DW, Hyon SH, Park JC. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-\u03baB. Apoptosis. 2011;16:75\u201385.","journal-title":"Apoptosis"},{"key":"2375_CR272","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1021\/jf021039l","volume":"51","author":"M Maeda-Yamamoto","year":"2003","unstructured":"Maeda-Yamamoto M, Suzuki N, Sawai Y, Miyase T, Sano M, Hashimoto-Ohta A, Isemura M. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem. 2003;51:1858\u201363.","journal-title":"J Agric Food Chem"},{"key":"2375_CR273","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1021\/jf9811525","volume":"47","author":"M Maeda-Yamamoto","year":"1999","unstructured":"Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem. 1999;47:2350\u20134.","journal-title":"J Agric Food Chem"},{"key":"2375_CR274","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cbi.2015.10.020","volume":"242","author":"LN Bodduluru","year":"2015","unstructured":"Bodduluru LN, Kasala ER, Barua CC, Karnam KC, Dahiya V, Ellutla M. Antiproliferative and antioxidant potential of hesperetin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Chem Biol Interact. 2015;242:345\u201352.","journal-title":"Chem Biol Interact"},{"key":"2375_CR275","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.intimp.2015.11.036","volume":"30","author":"LN Bodduluru","year":"2016","unstructured":"Bodduluru LN, Kasala ER, Madhana RM, Barua CC, Hussain MI, Haloi P, Borah P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NF\u03baB and PCNA expression. Int Immunopharmacol. 2016;30:102\u201310.","journal-title":"Int Immunopharmacol"},{"key":"2375_CR276","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/cas.14334","volume":"111","author":"K Iida","year":"2020","unstructured":"Iida K, Naiki T, Naiki-Ito A, Suzuki S, Kato H, Nozaki S, Nagai T, Etani T, Nagayasu Y, Ando R, et al. Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway. Cancer Sci. 2020;111:1165\u201379.","journal-title":"Cancer Sci"},{"key":"2375_CR277","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3892\/ijo.2017.4091","volume":"51","author":"KA Kang","year":"2017","unstructured":"Kang KA, Piao MJ, Ryu YS, Hyun YJ, Park JE, Shilnikova K, Zhen AX, Kang HK, Koh YS, Jeong YJ, Hyun JW. Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells. Int J Oncol. 2017;51:1169\u201378.","journal-title":"Int J Oncol"},{"key":"2375_CR278","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2006.01.021","volume":"534","author":"HW Leung","year":"2006","unstructured":"Leung HW, Kuo CL, Yang WH, Lin CH, Lee HZ. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol. 2006;534:12\u20138.","journal-title":"Eur J Pharmacol"},{"key":"2375_CR279","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13046-017-0632-z","volume":"36","author":"M Granato","year":"2017","unstructured":"Granato M, Gilardini Montani MS, Santarelli R, D\u2019Orazi G, Faggioni A, Cirone M. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death. J Exp Clin Cancer Res. 2017;36:167.","journal-title":"J Exp Clin Cancer Res"},{"key":"2375_CR280","doi-asserted-by":"publisher","first-page":"8996","DOI":"10.1038\/srep08996","volume":"5","author":"M Alhosin","year":"2015","unstructured":"Alhosin M, Le\u00f3n-Gonz\u00e1lez AJ, Dandache I, Lelay A, Rashid SK, Kevers C, Pincemail J, Fornecker LM, Mauvieux L, Herbrecht R, Schini-Kerth VB. Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2\/Bad pathway. Sci Rep. 2015;5:8996.","journal-title":"Sci Rep"},{"key":"2375_CR281","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.abb.2010.05.019","volume":"501","author":"J Cvorovic","year":"2010","unstructured":"Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys. 2010;501:151\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"2375_CR282","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2005.07.036","volume":"239","author":"HZ Lee","year":"2006","unstructured":"Lee HZ, Lin CJ, Yang WH, Leung WC, Chang SP. Aloe-emodin induced DNA damage through generation of reactive oxygen species in human lung carcinoma cells. Cancer Lett. 2006;239:55\u201363.","journal-title":"Cancer Lett"},{"key":"2375_CR283","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bcp.2015.07.017","volume":"98","author":"AJ Le\u00f3n-Gonz\u00e1lez","year":"2015","unstructured":"Le\u00f3n-Gonz\u00e1lez AJ, Auger C, Schini-Kerth VB. Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol. 2015;98:371\u201380.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR284","first-page":"268","volume":"26","author":"X Yuan","year":"2013","unstructured":"Yuan X, Zhang B, Gan L, Wang ZH, Yu BC, Liu LL, Zheng QS, Wang ZP. Involvement of the mitochondrion-dependent and the endoplasmic reticulum stress-signaling pathways in isoliquiritigenin-induced apoptosis of HeLa cell. Biomed Environ Sci. 2013;26:268\u201376.","journal-title":"Biomed Environ Sci"},{"key":"2375_CR285","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2006.03.030","volume":"247","author":"JT Hwang","year":"2007","unstructured":"Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, Park OJ. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett. 2007;247:115\u201321.","journal-title":"Cancer Lett"},{"key":"2375_CR286","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jcp.24818","volume":"230","author":"S Palit","year":"2015","unstructured":"Palit S, Kar S, Sharma G, Das PK. Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1\/JNK pathway. J Cell Physiol. 2015;230:1729\u201339.","journal-title":"J Cell Physiol"},{"key":"2375_CR287","doi-asserted-by":"publisher","first-page":"264","DOI":"10.15430\/JCP.2013.18.3.264","volume":"18","author":"GT Kim","year":"2013","unstructured":"Kim GT, Lee SH, Kim YM. Quercetin regulates sestrin 2-AMPK-mTOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells. J Cancer Prev. 2013;18:264\u201370.","journal-title":"J Cancer Prev"},{"key":"2375_CR288","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1039\/C5FO00142K","volume":"6","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Cheng G, Qiu H, Zhu L, Ren Z, Zhao W, Zhang T, Liu L. The p53-inducible gene 3 involved in flavonoid-induced cytotoxicity through the reactive oxygen species-mediated mitochondrial apoptotic pathway in human hepatoma cells. Food Funct. 2015;6:1518\u201325.","journal-title":"Food Funct"},{"key":"2375_CR289","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/annonc\/mdp499","volume":"21","author":"S Jin","year":"2010","unstructured":"Jin S, Zhang QY, Kang XM, Wang JX, Zhao WH. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann Oncol. 2010;21:263\u20138.","journal-title":"Ann Oncol"},{"key":"2375_CR290","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tox.2012.08.003","volume":"302","author":"YL Lo","year":"2012","unstructured":"Lo YL, Wang W, Ho CT. 7,3\u2019,4\u2019-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species. Toxicology. 2012;302:221\u201332.","journal-title":"Toxicology"},{"key":"2375_CR291","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.bcp.2010.08.013","volume":"80","author":"S Rakshit","year":"2010","unstructured":"Rakshit S, Mandal L, Pal BC, Bagchi J, Biswas N, Chaudhuri J, Chowdhury AA, Manna A, Chaudhuri U, Konar A, et al. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells. Biochem Pharmacol. 2010;80:1662\u201375.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR292","first-page":"227","volume":"40","author":"KK Kim","year":"2012","unstructured":"Kim KK, Singh AP, Singh RK, Demartino A, Brard L, Vorsa N, Lange TS, Moore RG. Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells. Int J Oncol. 2012;40:227\u201335.","journal-title":"Int J Oncol"},{"key":"2375_CR293","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2014.07.012","volume":"280","author":"SR Gundala","year":"2014","unstructured":"Gundala SR, Yang C, Mukkavilli R, Paranjpe R, Brahmbhatt M, Pannu V, Cheng A, Reid MD, Aneja R. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharmacol. 2014;280:86\u201396.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2375_CR294","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11010-015-2330-5","volume":"402","author":"C Rana","year":"2015","unstructured":"Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of PI3-K\/Akt\/PTEN pathway and activation of mitochondrial intrinsic apoptosis by diclofenac and curcumin in colon cancer. Mol Cell Biochem. 2015;402:225\u201341.","journal-title":"Mol Cell Biochem"},{"key":"2375_CR295","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2174\/15680096113139990035","volume":"13","author":"C Luo","year":"2013","unstructured":"Luo C, Li Y, Wang H, Cui Y, Feng Z, Li H, Li Y, Wang Y, Wurtz K, Weber P, et al. Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells. Curr Cancer Drug Targets. 2013;13:625\u201339.","journal-title":"Curr Cancer Drug Targets"},{"key":"2375_CR296","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1039\/C4FO00187G","volume":"5","author":"L Sun","year":"2014","unstructured":"Sun L, Luo C, Liu J. Hydroxytyrosol induces apoptosis in human colon cancer cells through ROS generation. Food Funct. 2014;5:1909\u201314.","journal-title":"Food Funct"},{"key":"2375_CR297","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1124\/jpet.110.171983","volume":"336","author":"P Guha","year":"2011","unstructured":"Guha P, Dey A, Sen R, Chatterjee M, Chattopadhyay S, Bandyopadhyay SK. Intracellular GSH depletion triggered mitochondrial Bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line. J Pharmacol Exp Ther. 2011;336:206\u201314.","journal-title":"J Pharmacol Exp Ther"},{"key":"2375_CR298","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ijc.24942","volume":"126","author":"R Balansky","year":"2010","unstructured":"Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. Int J Cancer. 2010;126:1047\u201354.","journal-title":"Int J Cancer"},{"key":"2375_CR299","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3835(97)00454-0","volume":"124","author":"CC Conaway","year":"1998","unstructured":"Conaway CC, Jiao D, Kelloff GJ, Steele VE, Rivenson A, Chung FL. Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco-nitrosamine-induced lung tumors in A\/J mice. Cancer Lett. 1998;124:85\u201393.","journal-title":"Cancer Lett"},{"key":"2375_CR300","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/antiox10020169","volume":"10","author":"Y Kwon","year":"2021","unstructured":"Kwon Y. Possible beneficial effects of N-acetylcysteine for treatment of triple-negative breast cancer. Antioxidants (Basel). 2021;10:169.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR301","doi-asserted-by":"crossref","first-page":"308re308","DOI":"10.1126\/scitranslmed.aad3740","volume":"7","author":"K Le Gal","year":"2015","unstructured":"Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Aky\u00fcrek LM, Lindahl P, Nilsson J, Bergo MO. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7:308re308.","journal-title":"Sci Transl Med"},{"key":"2375_CR302","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.3390\/cancers14194918","volume":"14","author":"T Capeloa","year":"2022","unstructured":"Capeloa T, Van de Velde JA, d\u2019Hose D, Lipari SG, Derouane F, Hamelin L, Bedin M, Vazeille T, Duhoux FP, Murphy MP, et al. Inhibition of mitochondrial redox signaling with MitoQ prevents metastasis of human pancreatic cancer in mice. Cancers (Basel). 2022;14:4918.","journal-title":"Cancers (Basel)"},{"key":"2375_CR303","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/antiox10020163","volume":"10","author":"K Le Gal","year":"2021","unstructured":"Le Gal K, Wiel C, Ibrahim MX, Henricsson M, Sayin VI, Bergo MO. Mitochondria-targeted antioxidants MitoQ and MitoTEMPO do not influence BRAF-driven malignant melanoma and KRAS-driven lung cancer progression in mice. Antioxidants (Basel). 2021;10:163.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR304","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1080\/15384101.2018.1496748","volume":"17","author":"E Titova","year":"2018","unstructured":"Titova E, Shagieva G, Ivanova O, Domnina L, Domninskaya M, Strelkova O, Khromova N, Kopnin P, Chernyak B, Skulachev V, Dugina V. Mitochondria-targeted antioxidant SkQ1 suppresses fibrosarcoma and rhabdomyosarcoma tumour cell growth. Cell Cycle. 2018;17:1797\u2013811.","journal-title":"Cell Cycle"},{"key":"2375_CR305","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ijc.30054","volume":"139","author":"AV Bazhin","year":"2016","unstructured":"Bazhin AV, Yang Y, D\u2019Haese JG, Werner J, Philippov PP, Karakhanova S. The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer. Int J Cancer. 2016;139:130\u20139.","journal-title":"Int J Cancer"},{"key":"2375_CR306","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ygyno.2011.04.051","volume":"122","author":"Z Jiang","year":"2011","unstructured":"Jiang Z, Fletcher NM, Ali-Fehmi R, Diamond MP, Abu-Soud HM, Munkarah AR, Saed GM. Modulation of redox signaling promotes apoptosis in epithelial ovarian cancer cells. Gynecol Oncol. 2011;122:418\u201323.","journal-title":"Gynecol Oncol"},{"key":"2375_CR307","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2013.01.002","volume":"57","author":"JH Doroshow","year":"2013","unstructured":"Doroshow JH, Gaur S, Markel S, Lu J, van Balgooy J, Synold TW, Xi B, Wu X, Juhasz A. Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts. Free Radic Biol Med. 2013;57:162\u201375.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR308","doi-asserted-by":"publisher","first-page":"e14665","DOI":"10.1371\/journal.pone.0014665","volume":"6","author":"S Garrido-Urbani","year":"2011","unstructured":"Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet X, Michalik L, et al. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPAR\u03b1 mediated mechanism. PLoS One. 2011;6:e14665.","journal-title":"PLoS One"},{"key":"2375_CR309","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/antiox11030513","volume":"11","author":"MB Demircan","year":"2022","unstructured":"Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schr\u00f6der K, Heidel FH, B\u00f6hmer FD. Combined activity of the redox-modulating compound setanaxib (GKT137831) with cytotoxic agents in the killing of acute myeloid leukemia cells. Antioxidants (Basel). 2022;11:513.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR310","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.freeradbiomed.2009.07.001","volume":"47","author":"ZN Rabbani","year":"2009","unstructured":"Rabbani ZN, Spasojevic I, Zhang X, Moeller BJ, Haberle S, Vasquez-Vivar J, Dewhirst MW, Vujaskovic Z, Batinic-Haberle I. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethy lpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor. Free Radic Biol Med. 2009;47:992\u20131004.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR311","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/antiox8100490","volume":"8","author":"JG Costa","year":"2019","unstructured":"Costa JG, Saraiva N, Batinic-Haberle I, Castro M, Oliveira NG, Fernandes AS. The SOD mimic MnTnHex-2-PyP5+ reduces the viability and migration of 786-O human renal cancer cells. Antioxidants (Basel). 2019;8:490.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR312","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/s22072643","volume":"22","author":"FS Manciu","year":"2022","unstructured":"Manciu FS, Guerrero J, Bennet KE, Chang SY, Rahman M, Martinez Lopez LV, Chantigian S, Castellanos M, Manciu M. Assessing nordihydroguaiaretic acid therapeutic effect for glioblastoma multiforme. Sensors (Basel). 2022;22:2643.","journal-title":"Sensors (Basel)"},{"key":"2375_CR313","doi-asserted-by":"publisher","first-page":"734785","DOI":"10.1093\/ecam\/nep076","volume":"2011","author":"S Rahman","year":"2011","unstructured":"Rahman S, Ansari RA, Rehman H, Parvez S, Raisuddin S. Nordihydroguaiaretic acid from creosote bush (Larrea tridentata) mitigates 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory and oxidative stress responses of tumor promotion cascade in mouse skin. Evid Based Complement Alternat Med. 2011;2011:734785.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2375_CR314","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/0008-5472.CAN-05-0071","volume":"65","author":"JR Graff","year":"2005","unstructured":"Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, et al. The protein kinase Cbeta-selective inhibitor, enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res. 2005;65:7462\u20139.","journal-title":"Cancer Res"},{"key":"2375_CR315","doi-asserted-by":"publisher","first-page":"3253696","DOI":"10.1155\/2019\/3253696","volume":"2019","author":"SM Messerli","year":"2019","unstructured":"Messerli SM, Schaefer AM, Zhuang Y, Soltys BJ, Keime N, Jin J, Ma L, Hsia CJC, Miskimins WK. Use of antimetastatic SOD3-mimetic albumin as a primer in triple negative breast cancer. J Oncol. 2019;2019:3253696.","journal-title":"J Oncol"},{"key":"2375_CR316","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/exd.14564","volume":"31","author":"AJ Cohen-Nowak","year":"2022","unstructured":"Cohen-Nowak AJ, Cohen AJ, Correia ED, Portocarrero CP, South AP, Nikbakht N. Omaveloxolone attenuates squamous cell carcinoma growth and disease severity in an epidermolysis bullosa mouse model. Exp Dermatol. 2022;31:1083\u20138.","journal-title":"Exp Dermatol"},{"key":"2375_CR317","doi-asserted-by":"publisher","first-page":"617714","DOI":"10.3389\/fphar.2021.617714","volume":"12","author":"K Chen","year":"2021","unstructured":"Chen K, Wu S, Ye S, Huang H, Zhou Y, Zhou H, Wu S, Mao Y, Shangguan F, Lan L, Chen B. Dimethyl fumarate induces metabolic crisie to suppress pancreatic carcinoma. Front Pharmacol. 2021;12:617714.","journal-title":"Front Pharmacol"},{"key":"2375_CR318","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.3390\/ijms23126773","volume":"23","author":"R Gonnella","year":"2022","unstructured":"Gonnella R, Zarrella R, Santarelli R, Germano CA, Gilardini Montani MS, Cirone M. Mechanisms of sensitivity and resistance of primary effusion lymphoma to dimethyl fumarate (DMF). Int J Mol Sci. 2022;23:6773.","journal-title":"Int J Mol Sci"},{"key":"2375_CR319","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1113\/JP284155","volume":"602","author":"IV da Silva","year":"2024","unstructured":"da Silva IV, Pimp\u00e3o C, Paccetti-Alves I, Thomas SR, Barateiro A, Casini A, Soveral G. Blockage of aquaporin-3 peroxiporin activity by organogold compounds affects melanoma cell adhesion, proliferation and migration. J Physiol. 2024;602:3111\u201329.","journal-title":"J Physiol"},{"key":"2375_CR320","doi-asserted-by":"publisher","first-page":"e2319682121","DOI":"10.1073\/pnas.2319682121","volume":"121","author":"P Huang","year":"2024","unstructured":"Huang P, \u00c5backa H, Wilson CJ, Wind ML, R\u0171tzler M, Hagstr\u00f6m-Andersson A, Gourdon P, de Groot BL, Venskutonyt\u0117 R, Lindkvist-Petersson K. Molecular basis for human aquaporin inhibition. Proc Natl Acad Sci U S A. 2024;121:e2319682121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR321","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1124\/mol.115.101618","volume":"89","author":"M Kourghi","year":"2016","unstructured":"Kourghi M, Pei JV, De Ieso ML, Flynn G, Yool AJ. Bumetanide derivatives AqB007 and AqB011 selectively block the aquaporin-1 ion channel conductance and slow cancer cell migration. Mol Pharmacol. 2016;89:133\u201340.","journal-title":"Mol Pharmacol"},{"key":"2375_CR322","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/cells7070081","volume":"7","author":"E Smith","year":"2018","unstructured":"Smith E, Palethorpe HM, Tomita Y, Pei JV, Townsend AR, Price TJ, Young JP, Yool AJ, Hardingham JE. The purified extract from the medicinal plant Bacopa monnieri, Bacopaside II, inhibits growth of colon cancer cells in vitro by inducing cell cycle arrest and apoptosis. Cells. 2018;7:81.","journal-title":"Cells"},{"key":"2375_CR323","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-nutr-082018-124228","volume":"41","author":"WS Blaner","year":"2021","unstructured":"Blaner WS, Shmarakov IO, Traber MG. Vitamin A and vitamin E: will the real antioxidant please stand up? Annu Rev Nutr. 2021;41:105\u201331.","journal-title":"Annu Rev Nutr"},{"key":"2375_CR324","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.3390\/nu14204329","volume":"14","author":"J Donnelly","year":"2022","unstructured":"Donnelly J, Appathurai A, Yeoh HL, Driscoll K, Faisal W. Vitamin E in cancer treatment: a review of clinical applications in randomized control trials. Nutrients. 2022;14:4329.","journal-title":"Nutrients"},{"key":"2375_CR325","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","volume":"98","author":"K Jomova","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024;98:1323\u201367.","journal-title":"Arch Toxicol"},{"key":"2375_CR326","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/sj.bjc.6600604","volume":"87","author":"DS Michaud","year":"2002","unstructured":"Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer. 2002;87:960\u20135.","journal-title":"Br J Cancer"},{"key":"2375_CR327","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1055-9965.EPI-06-0861","volume":"16","author":"U Peters","year":"2007","unstructured":"Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007;16:962\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2375_CR328","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/1534735416684947","volume":"17","author":"M Datta","year":"2018","unstructured":"Datta M, Shaw EG, Lesser GJ, Case LD, Vitolins MZ, Schneider C, Frizzell B, Sullivan C, Lively M, Franzmann E, Hu JJ. A randomized double-blind placebo-controlled trial of fruit and vegetable concentrates on intermediate biomarkers in head and neck cancer. Integr Cancer Ther. 2018;17:115\u201323.","journal-title":"Integr Cancer Ther"},{"key":"2375_CR329","doi-asserted-by":"publisher","first-page":"105479","DOI":"10.1016\/j.phrs.2021.105479","volume":"166","author":"A Donoso","year":"2021","unstructured":"Donoso A, Gonz\u00e1lez-Dur\u00e1n J, Mu\u00f1oz AA, Gonz\u00e1lez PA, Agurto-Mu\u00f1oz C. Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials. Pharmacol Res. 2021;166:105479.","journal-title":"Pharmacol Res"},{"key":"2375_CR330","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/01635589509514415","volume":"24","author":"J Levy","year":"1995","unstructured":"Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer. 1995;24:257\u201366.","journal-title":"Nutr Cancer"},{"key":"2375_CR331","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.3390\/nu14235152","volume":"14","author":"A Kapa\u0142a","year":"2022","unstructured":"Kapa\u0142a A, Szlendak M, Motacka E. The anti-cancer activity of lycopene: a systematic review of human and animal studies. Nutrients. 2022;14:5152.","journal-title":"Nutrients"},{"key":"2375_CR332","doi-asserted-by":"publisher","first-page":"e1627","DOI":"10.1002\/ctm2.1627","volume":"14","author":"MB Lilly","year":"2024","unstructured":"Lilly MB, Wu C, Ke Y, Chen WP, Soloff AC, Armeson K, Yokoyama NN, Li X, Song L, Yuan Y, et al. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients. Clin Transl Med. 2024;14:e1627.","journal-title":"Clin Transl Med"},{"key":"2375_CR333","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.3390\/ijms241310663","volume":"24","author":"A Lyubitelev","year":"2023","unstructured":"Lyubitelev A, Studitsky V. Inhibition of cancer development by natural plant polyphenols: molecular mechanisms. Int J Mol Sci. 2023;24:10663.","journal-title":"Int J Mol Sci"},{"key":"2375_CR334","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1021\/np9904509","volume":"63","author":"PG Pietta","year":"2000","unstructured":"Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000;63:1035\u201342.","journal-title":"J Nat Prod"},{"key":"2375_CR335","doi-asserted-by":"publisher","first-page":"12422","DOI":"10.1080\/10408398.2022.2101428","volume":"63","author":"SX Wu","year":"2023","unstructured":"Wu SX, Xiong RG, Huang SY, Zhou DD, Saimaiti A, Zhao CN, Shang A, Zhang YJ, Gan RY, Li HB. Effects and mechanisms of resveratrol for prevention and management of cancers: an updated review. Crit Rev Food Sci Nutr. 2023;63:12422\u201340.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2375_CR336","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","volume":"4","author":"LM Howells","year":"2011","unstructured":"Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2013safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila). 2011;4:1419\u201325.","journal-title":"Cancer Prev Res (Phila)"},{"key":"2375_CR337","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-014-0223-0","volume":"12","author":"HH Chow","year":"2014","unstructured":"Chow HH, Garland LL, Heckman-Stoddard BM, Hsu CH, Butler VD, Cordova CA, Chew WM, Cornelison TL. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med. 2014;12:223.","journal-title":"J Transl Med"},{"key":"2375_CR338","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/CMAR.S4544","volume":"1","author":"AV Nguyen","year":"2009","unstructured":"Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, Holcombe RF. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009;1:25\u201337.","journal-title":"Cancer Manag Res"},{"key":"2375_CR339","doi-asserted-by":"publisher","first-page":"112442","DOI":"10.1016\/j.biopha.2021.112442","volume":"146","author":"H Slika","year":"2022","unstructured":"Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, Shaito A, Ghaddar T, Kobeissy F, Eid AH. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442.","journal-title":"Biomed Pharmacother"},{"key":"2375_CR340","doi-asserted-by":"publisher","first-page":"806470","DOI":"10.3389\/fphar.2022.806470","volume":"13","author":"M Rudrapal","year":"2022","unstructured":"Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, Alshabrmi FM, Palai S, Deb PK, Devi R. Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. 2022;13:806470.","journal-title":"Front Pharmacol"},{"key":"2375_CR341","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/nu8080515","volume":"8","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen YM, Li HB. Natural polyphenols for prevention and treatment of cancer. Nutrients. 2016;8:515.","journal-title":"Nutrients"},{"issue":"5","key":"2375_CR342","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ame2.12465","volume":"7","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Deng X, Xie W, Li H, Li Y, Deng Z. Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review. Animal Model Exp Med. 2024;7(5):653\u201372.","journal-title":"Animal Model Exp Med."},{"key":"2375_CR343","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1039\/D2RA08280B","volume":"13","author":"J Brankovi\u0107","year":"2023","unstructured":"Brankovi\u0107 J, Milovanovi\u0107 VM, Petrovi\u0107 ZD, Simijonovi\u0107 D, Petrovi\u0107 VP. Pyrazolone-type compounds (part II): in vitro and in silico evaluation of antioxidant potential; structure-activity relationship. RSC Adv. 2023;13:2884\u201395.","journal-title":"RSC Adv"},{"key":"2375_CR344","first-page":"213","volume":"1","author":"M Metwally","year":"2012","unstructured":"Metwally M, Suleiman YA, Gouda M, Harmal AN, Khalil A. Synthesis, antitumor and antioxidant evaluation of some new antipyrine based azo dyes incorporating pyrazolone moiety. Int J Mod Org Chem. 2012;1:213\u201325.","journal-title":"Int J Mod Org Chem"},{"key":"2375_CR345","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3164\/jcbn.17-62","volume":"62","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Tanaka M, Yuki S, Hirai M, Yamamoto Y. How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis? J Clin Biochem Nutr. 2018;62:20\u201338.","journal-title":"J Clin Biochem Nutr"},{"key":"2375_CR346","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jbt.21780","volume":"30","author":"M Apaydin","year":"2016","unstructured":"Apaydin M, Erbas O, Taskiran D. Protection by edaravone, a radical scavenger, against manganese-induced neurotoxicity in rats. J Biochem Mol Toxicol. 2016;30:217\u201323.","journal-title":"J Biochem Mol Toxicol"},{"key":"2375_CR347","first-page":"2437","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang Y, Zhang G, Lin Z, Du S. Protective effect of edaravone on blood-brain barrier by affecting NRF-2\/HO-1 signaling pathway. Exp Ther Med. 2019;18:2437\u201342.","journal-title":"Exp Ther Med"},{"key":"2375_CR348","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.3390\/cimb44100335","volume":"44","author":"D Duarte","year":"2022","unstructured":"Duarte D, Guerreiro I, Vale N. Novel strategies for cancer combat: drug combination using repurposed drugs induces synergistic growth inhibition of MCF-7 breast and HT-29 colon cancer cells. Curr Issues Mol Biol. 2022;44:4930\u201349.","journal-title":"Curr Issues Mol Biol"},{"key":"2375_CR349","doi-asserted-by":"publisher","first-page":"105967","DOI":"10.1016\/j.intimp.2019.105967","volume":"77","author":"C Bailly","year":"2019","unstructured":"Bailly C. Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers. Int Immunopharmacol. 2019;77:105967.","journal-title":"Int Immunopharmacol"},{"key":"2375_CR350","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1124\/jpet.107.131391","volume":"324","author":"T Arai","year":"2008","unstructured":"Arai T, Nonogawa M, Makino K, Endo N, Mori H, Miyoshi T, Yamashita K, Sasada M, Kakuyama M, Fukuda K. The radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) reacts with a pterin derivative and produces a cytotoxic substance that induces intracellular reactive oxygen species generation and cell death. J Pharmacol Exp Ther. 2008;324:529\u201338.","journal-title":"J Pharmacol Exp Ther"},{"key":"2375_CR351","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1378\/chest.107.5.1437","volume":"107","author":"N van Zandwijk","year":"1995","unstructured":"van Zandwijk N. N-acetylcysteine for lung cancer prevention. Chest. 1995;107:1437\u201341.","journal-title":"Chest"},{"key":"2375_CR352","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre B, Barayeu U, Ezeri\u0146a D, Dick TP. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species. Pharmacol Ther. 2021;228:107916.","journal-title":"Pharmacol Ther"},{"key":"2375_CR353","doi-asserted-by":"publisher","first-page":"108945","DOI":"10.1016\/j.cbi.2020.108945","volume":"317","author":"Y Miao","year":"2020","unstructured":"Miao Y, Wu Y, Jin Y, Lei M, Nan J, Wu X. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice. Chem Biol Interact. 2020;317:108945.","journal-title":"Chem Biol Interact"},{"key":"2375_CR354","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","volume":"1201","author":"RA Smith","year":"2010","unstructured":"Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci. 2010;1201:96\u2013103.","journal-title":"Ann N Y Acad Sci"},{"key":"2375_CR355","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/cancers14061516","volume":"14","author":"T Capeloa","year":"2022","unstructured":"Capeloa T, Krzystyniak J, d\u2019Hose D, Canas Rodriguez A, Payen VL, Zampieri LX, Van de Velde JA, Benyahia Z, Pranzini E, Vazeille T, et al. MitoQ inhibits human breast cancer cell migration, invasion and clonogenicity. Cancers (Basel). 2022;14:1516.","journal-title":"Cancers (Basel)"},{"key":"2375_CR356","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1134\/S0006297908120018","volume":"73","author":"YN Antonenko","year":"2008","unstructured":"Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc). 2008;73:1273\u201387.","journal-title":"Biochemistry (Mosc)"},{"issue":"Pt 1","key":"2375_CR357","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1042\/bj2900041","volume":"290","author":"BV O\u2019Donnell","year":"1993","unstructured":"O\u2019Donnell BV, Tew DG, Jones OT, England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J. 1993;290(Pt 1):41\u20139.","journal-title":"Biochem J"},{"key":"2375_CR358","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1021\/jm100773e","volume":"53","author":"B Laleu","year":"2010","unstructured":"Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem. 2010;53:7715\u201330.","journal-title":"J Med Chem"},{"key":"2375_CR359","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.redox.2016.12.011","volume":"11","author":"J Morry","year":"2017","unstructured":"Morry J, Ngamcherdtrakul W, Yantasee W. Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol. 2017;11:240\u201353.","journal-title":"Redox Biol"},{"key":"2375_CR360","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/ars.2020.8046","volume":"33","author":"MM Konat\u00e9","year":"2020","unstructured":"Konat\u00e9 MM, Antony S, Doroshow JH. Inhibiting the activity of NADPH oxidase in cancer. Antioxid Redox Signal. 2020;33:435\u201354.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR361","doi-asserted-by":"publisher","first-page":"107664","DOI":"10.1016\/j.pharmthera.2020.107664","volume":"217","author":"Y Liu","year":"2021","unstructured":"Liu Y, Lang F, Yang C. NRF2 in human neoplasm: cancer biology and potential therapeutic target. Pharmacol Ther. 2021;217:107664.","journal-title":"Pharmacol Ther"},{"key":"2375_CR362","doi-asserted-by":"publisher","first-page":"9372182","DOI":"10.1155\/2019\/9372182","volume":"2019","author":"N Robledinos-Ant\u00f3n","year":"2019","unstructured":"Robledinos-Ant\u00f3n N, Fern\u00e1ndez-Gin\u00e9s R, Manda G, Cuadrado A. Activators and inhibitors of NRF2: a review of their potential for clinical development. Oxid Med Cell Longev. 2019;2019:9372182.","journal-title":"Oxid Med Cell Longev"},{"key":"2375_CR363","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2011.11.003","volume":"52","author":"AI Rojo","year":"2012","unstructured":"Rojo AI, Medina-Campos ON, Rada P, Z\u00fa\u00f1iga-Toal\u00e1 A, L\u00f3pez-Gazc\u00f3n A, Espada S, Pedraza-Chaverri J, Cuadrado A. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3. Free Radic Biol Med. 2012;52:473\u201387.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR364","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/neuonc\/nor230","volume":"14","author":"SA Grossman","year":"2012","unstructured":"Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro Oncol. 2012;14:511\u20137.","journal-title":"Neuro Oncol"},{"key":"2375_CR365","doi-asserted-by":"publisher","first-page":"101630","DOI":"10.1016\/j.xcrm.2024.101630","volume":"5","author":"MS Ahluwalia","year":"2024","unstructured":"Ahluwalia MS, Ozair A, Rudek M, Ye X, Holdhoff M, Lieberman FS, Piotrowski AF, Nabors B, Desai A, Lesser G, et al. A multicenter, phase 1, adult brain tumor consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR). Cell Rep Med. 2024;5:101630.","journal-title":"Cell Rep Med"},{"key":"2375_CR366","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/164_2020_381","volume":"264","author":"D Lastra","year":"2021","unstructured":"Lastra D, Fern\u00e1ndez-Gin\u00e9s R, Manda G, Cuadrado A. Perspectives on the clinical development of NRF2-targeting drugs. Handb Exp Pharmacol. 2021;264:93\u2013141.","journal-title":"Handb Exp Pharmacol"},{"key":"2375_CR367","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1200\/JCO.2015.65.7171","volume":"34","author":"M Crump","year":"2016","unstructured":"Crump M, Lepp\u00e4 S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, Schnell F, Rifkin R, Mackensen A, et al. Randomized, double-blind, phase III trial of enzastaurin versus placebo in patients achieving remission after first-line therapy for high-risk diffuse large B-cell lymphoma. J Clin Oncol. 2016;34:2484\u201392.","journal-title":"J Clin Oncol"},{"key":"2375_CR368","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1038\/s41598-020-63482-x","volume":"10","author":"MS Ball","year":"2020","unstructured":"Ball MS, Bhandari R, Torres GM, Martyanov V, ElTanbouly MA, Archambault K, Whitfield ML, Liby KT, Pioli PA. CDDO-me alters the tumor microenvironment in estrogen receptor negative breast cancer. Sci Rep. 2020;10:6560.","journal-title":"Sci Rep"},{"key":"2375_CR369","doi-asserted-by":"publisher","first-page":"e0122942","DOI":"10.1371\/journal.pone.0122942","volume":"10","author":"BL Probst","year":"2015","unstructured":"Probst BL, Trevino I, McCauley L, Bumeister R, Dulubova I, Wigley WC, Ferguson DA. RTA 408, a novel synthetic triterpenoid with broad anticancer and anti-inflammatory activity. PLoS One. 2015;10:e0122942.","journal-title":"PLoS One"},{"key":"2375_CR370","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.redox.2015.12.005","volume":"8","author":"X Liu","year":"2016","unstructured":"Liu X, Ward K, Xavier C, Jann J, Clark AF, Pang IH, Wu H. The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation. Redox Biol. 2016;8:98\u2013109.","journal-title":"Redox Biol"},{"key":"2375_CR371","doi-asserted-by":"publisher","first-page":"1264842","DOI":"10.3389\/fphar.2023.1264842","volume":"14","author":"G Bresciani","year":"2023","unstructured":"Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Novel potential pharmacological applications of dimethyl fumarate-an overview and update. Front Pharmacol. 2023;14:1264842.","journal-title":"Front Pharmacol"},{"key":"2375_CR372","doi-asserted-by":"publisher","first-page":"706448","DOI":"10.3389\/fonc.2021.706448","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Jia Y, Xu Y, Li K. DMF activates NRF2 to inhibit the pro-invasion ability of TAMs in breast cancer. Front Oncol. 2021;11:706448.","journal-title":"Front Oncol"},{"key":"2375_CR373","doi-asserted-by":"publisher","first-page":"e004458","DOI":"10.1136\/jitc-2021-004458","volume":"10","author":"S Renken","year":"2022","unstructured":"Renken S, Nakajima T, Magalhaes I, Mattsson J, Lundqvist A, Arn\u00e9r ESJ, Kiessling R, Wickstr\u00f6m SL. Targeting of Nrf2 improves antitumoral responses by human NK cells, TI L and CAR T cells during oxidative stress. J Immunother Cancer. 2022;10:e004458.","journal-title":"J Immunother Cancer"},{"key":"2375_CR374","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/ars.2016.6889","volume":"27","author":"SW Shin","year":"2017","unstructured":"Shin SW, Choi C, Lee GH, Son A, Kim SH, Park HC, Batinic-Haberle I, Park W. Mechanism of the antitumor and radiosensitizing effects of a manganese porphyrin, MnHex-2-PyP. Antioxid Redox Signal. 2017;27:1067\u201382.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR375","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.neuron.2022.08.009","volume":"110","author":"A Jang","year":"2022","unstructured":"Jang A, Petrova B, Cheong TC, Zawadzki ME, Jones JK, Culhane AJ, Shipley FB, Chiarle R, Wong ET, Kanarek N, Lehtinen MK. Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy. Neuron. 2022;110:3288-3301.e3288.","journal-title":"Neuron"},{"key":"2375_CR376","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbagen.2009.03.006","volume":"1790","author":"R Brigelius-Floh\u00e9","year":"2009","unstructured":"Brigelius-Floh\u00e9 R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta. 2009;1790:1555\u201368.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR377","first-page":"3289","volume":"2013","author":"R Brigelius-Floh\u00e9","year":"1830","unstructured":"Brigelius-Floh\u00e9 R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 1830;2013:3289\u2013303.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR378","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.2012.06574.x","volume":"1259","author":"R Brigelius-Floh\u00e9","year":"2012","unstructured":"Brigelius-Floh\u00e9 R, Kipp AP. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann N Y Acad Sci. 2012;1259:19\u201325.","journal-title":"Ann N Y Acad Sci"},{"key":"2375_CR379","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1158\/0008-5472.CAN-08-1321","volume":"68","author":"A Banning","year":"2008","unstructured":"Banning A, Kipp A, Schmitmeier S, L\u00f6winger M, Florian S, Krehl S, Thalmann S, Thierbach R, Steinberg P, Brigelius-Floh\u00e9 R. Glutathione peroxidase 2 inhibits cyclooxygenase-2-mediated migration and invasion of HT-29 adenocarcinoma cells but supports their growth as tumors in nude mice. Cancer Res. 2008;68:9746\u201353.","journal-title":"Cancer Res"},{"key":"2375_CR380","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13578-022-00944-x","volume":"12","author":"H Xie","year":"2022","unstructured":"Xie H, Qiang P, Wang Y, Xia F, Liu P, Li M. Discovery and mechanism studies of a novel ATG4B inhibitor ebselen by drug repurposing and its anti-colorectal cancer effects in mice. Cell Biosci. 2022;12:206.","journal-title":"Cell Biosci"},{"key":"2375_CR381","doi-asserted-by":"publisher","first-page":"e2407506121","DOI":"10.1073\/pnas.2407506121","volume":"121","author":"JR Wei","year":"2024","unstructured":"Wei JR, Zhang B, Zhang Y, Chen WM, Zhang XP, Zeng TT, Li Y, Zhu YH, Guan XY, Li L. QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. Proc Natl Acad Sci U S A. 2024;121:e2407506121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR382","doi-asserted-by":"publisher","first-page":"18418","DOI":"10.18632\/oncotarget.4099","volume":"6","author":"PD Hanavan","year":"2015","unstructured":"Hanavan PD, Borges CR, Katchman BA, Faigel DO, Ho TH, Ma CT, Sergienko EA, Meurice N, Petit JL, Lake DF. Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines. Oncotarget. 2015;6:18418\u201328.","journal-title":"Oncotarget"},{"key":"2375_CR383","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.actbio.2022.09.026","volume":"153","author":"L Zhong","year":"2022","unstructured":"Zhong L, Xia Y, He T, Wenjie S, Jinxia A, Lijun Y, Hui G. Polymeric photothermal nanoplatform with the inhibition of aquaporin 3 for anti-metastasis therapy of breast cancer. Acta Biomater. 2022;153:505\u201317.","journal-title":"Acta Biomater"},{"key":"2375_CR384","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/cancers16152714","volume":"16","author":"V Charlestin","year":"2024","unstructured":"Charlestin V, Tan E, Arias-Matus CE, Wu J, Miranda-Vergara MC, Lee M, Wang M, Nannapaneni DT, Tennakoon P, Blagg BSJ, et al. Evaluation of the mammalian aquaporin inhibitors Auphen and Z433927330 in treating breast cancer. Cancers (Basel). 2024;16:2714.","journal-title":"Cancers (Basel)"},{"key":"2375_CR385","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1074\/jbc.RA118.006083","volume":"294","author":"Y Sonntag","year":"2019","unstructured":"Sonntag Y, Gena P, Maggio A, Singh T, Artner I, Oklinski MK, Johanson U, Kjellbom P, Nieland JD, Nielsen S, et al. Identification and characterization of potent and selective aquaporin-3 and aquaporin-7 inhibitors. J Biol Chem. 2019;294:7377\u201387.","journal-title":"J Biol Chem"},{"key":"2375_CR386","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fchem.2018.00135","volume":"6","author":"ML De Ieso","year":"2018","unstructured":"De Ieso ML, Yool AJ. Mechanisms of aquaporin-facilitated cancer invasion and metastasis. Front Chem. 2018;6:135.","journal-title":"Front Chem"},{"key":"2375_CR387","doi-asserted-by":"publisher","first-page":"12635","DOI":"10.1038\/s41598-019-49045-9","volume":"9","author":"ML De Ieso","year":"2019","unstructured":"De Ieso ML, Pei JV, Nourmohammadi S, Smith E, Chow PH, Kourghi M, Hardingham JE, Yool AJ. Combined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel blocker Bacopaside II amplifies inhibition of colon cancer cell migration. Sci Rep. 2019;9:12635.","journal-title":"Sci Rep"},{"key":"2375_CR388","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.3390\/ijms21207753","volume":"21","author":"JSK Stankovic","year":"2020","unstructured":"Stankovic JSK, Selakovic D, Mihailovic V, Rosic G. Antioxidant supplementation in the treatment of neurotoxicity induced by platinum-based chemotherapeutics-a review. Int J Mol Sci. 2020;21:7753.","journal-title":"Int J Mol Sci"},{"key":"2375_CR389","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1021\/acsami.4c16810","volume":"17","author":"Y Xia","year":"2025","unstructured":"Xia Y, Gui H, Li X, Wu Y, Liu J, Liu J. X-ray responsive antioxidant drug-free hydrogel for treatment of radiation skin injury. ACS Appl Mater Interfaces. 2025;17:5671\u201383.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2375_CR390","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antiox12020517","volume":"12","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants (Basel). 2023;12:517.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR391","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/antiox11050965","volume":"11","author":"PJ Barnes","year":"2022","unstructured":"Barnes PJ. Oxidative stress in chronic obstructive pulmonary disease. Antioxidants (Basel). 2022;11:965.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR392","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41580-023-00645-4","volume":"25","author":"B Halliwell","year":"2024","unstructured":"Halliwell B. Understanding mechanisms of antioxidant action in health and disease. Nat Rev Mol Cell Biol. 2024;25:13\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR393","doi-asserted-by":"publisher","first-page":"e12824","DOI":"10.1111\/jpi.12824","volume":"73","author":"J Florido","year":"2022","unstructured":"Florido J, Martinez-Ruiz L, Rodriguez-Santana C, L\u00f3pez-Rodr\u00edguez A, Hidalgo-Guti\u00e9rrez A, Cottet-Rousselle C, Lamarche F, Schlattner U, Guerra-Librero A, Aranda-Mart\u00ednez P, et al. Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport. J Pineal Res. 2022;73:e12824.","journal-title":"J Pineal Res"},{"key":"2375_CR394","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2021.11.002","volume":"29","author":"S Jain","year":"2022","unstructured":"Jain S, Hu C, Kluza J, Ke W, Tian G, Giurgiu M, Bleilevens A, Campos AR, Charbono A, Stickeler E, et al. Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I. Cell Chem Biol. 2022;29:436-450.e415.","journal-title":"Cell Chem Biol"},{"key":"2375_CR395","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, Chandel NS. Metformin inhibits mitochondrial complex I of cancer cells to reduce t umorigenesis. Elife. 2014;3:e02242.","journal-title":"Elife"},{"key":"2375_CR396","doi-asserted-by":"publisher","first-page":"112686","DOI":"10.1016\/j.biopha.2022.112686","volume":"147","author":"MA Altinoz","year":"2022","unstructured":"Altinoz MA, Ozpinar A. Oxamate targeting aggressive cancers with special emphasis to brain tumors. Biomed Pharmacother. 2022;147:112686.","journal-title":"Biomed Pharmacother"},{"key":"2375_CR397","doi-asserted-by":"publisher","first-page":"e85576","DOI":"10.1371\/journal.pone.0085576","volume":"9","author":"WK Miskimins","year":"2014","unstructured":"Miskimins WK, Ahn HJ, Kim JY, Ryu S, Jung YS, Choi JY. Synergistic anti-cancer effect of phenformin and oxamate. PLoS One. 2014;9:e85576.","journal-title":"PLoS One"},{"key":"2375_CR398","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.apsb.2021.07.008","volume":"12","author":"J Shi","year":"2022","unstructured":"Shi J, Ju R, Gao H, Huang Y, Guo L, Zhang D. Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability. Acta Pharm Sin B. 2022;12:759\u201373.","journal-title":"Acta Pharm Sin B"},{"key":"2375_CR399","doi-asserted-by":"publisher","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","volume":"8","author":"R Marullo","year":"2013","unstructured":"Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, Doetsch PW. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One. 2013;8:e81162.","journal-title":"PLoS One"},{"key":"2375_CR400","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih M, B\u00f6pple K, Dong M, Gai\u00dfler A, Heine S, Olayioye MA, Aulitzky WE, Essmann F. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10:851.","journal-title":"Cell Death Dis"},{"key":"2375_CR401","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ijc.1220","volume":"92","author":"K Iwama","year":"2001","unstructured":"Iwama K, Nakajo S, Aiuchi T, Nakaya K. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer. 2001;92:518\u201326.","journal-title":"Int J Cancer"},{"key":"2375_CR402","doi-asserted-by":"publisher","first-page":"37832","DOI":"10.1074\/jbc.M301546200","volume":"278","author":"H Pelicano","year":"2003","unstructured":"Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, Keating MJ, Huang P. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem. 2003;278:37832\u20139.","journal-title":"J Biol Chem"},{"key":"2375_CR403","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1073\/pnas.0701549104","volume":"104","author":"J Lu","year":"2007","unstructured":"Lu J, Chew EH, Holmgren A. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci U S A. 2007;104:12288\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR404","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1021\/bi00387a006","volume":"26","author":"BK Sinha","year":"1987","unstructured":"Sinha BK, Katki AG, Batist G, Cowan KH, Myers CE. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry. 1987;26:3776\u201381.","journal-title":"Biochemistry"},{"key":"2375_CR405","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0024-3205(03)00566-6","volume":"73","author":"WP Tsang","year":"2003","unstructured":"Tsang WP, Chau SPY, Kong SK, Fung KP, Kwok TT. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci. 2003;73:2047\u201358.","journal-title":"Life Sci"},{"key":"2375_CR406","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.lfs.2004.05.040","volume":"76","author":"H Mizutani","year":"2005","unstructured":"Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 2005;76:1439\u201353.","journal-title":"Life Sci"},{"key":"2375_CR407","doi-asserted-by":"publisher","first-page":"2189106","DOI":"10.1080\/10717544.2023.2189106","volume":"30","author":"Y Tu","year":"2023","unstructured":"Tu Y, Zhang W, Fan G, Zou C, Zhang J, Wu N, Ding J, Zou WQ, Xiao H, Tan S. Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy. Drug Deliv. 2023;30:2189106.","journal-title":"Drug Deliv"},{"key":"2375_CR408","doi-asserted-by":"publisher","first-page":"121856","DOI":"10.1016\/j.biomaterials.2022.121856","volume":"290","author":"L Cao","year":"2022","unstructured":"Cao L, Tian H, Fang M, Xu Z, Tang D, Chen J, Yin J, Xiao H, Shang K, Han H, Li X. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy. Biomaterials. 2022;290:121856.","journal-title":"Biomaterials"},{"key":"2375_CR409","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.7150\/thno.45511","volume":"11","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhan G, Zhang Z, Yong T, Yang X, Gan L. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors. Theranostics. 2021;11:1937\u201352.","journal-title":"Theranostics"},{"key":"2375_CR410","doi-asserted-by":"publisher","first-page":"6620306","DOI":"10.1155\/2021\/6620306","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y, Yao Y. Antioxidative stress: inhibiting reactive oxygen species production as a cause of radioresistance and chemoresistance. Oxid Med Cell Longev. 2021;2021:6620306.","journal-title":"Oxid Med Cell Longev"},{"key":"2375_CR411","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski S, Knap B, Przystupski D, Saczko J, K\u0119dzierska E, Knap-Czop K, Kotli\u0144ska J, Michel O, Kotowski K, Kulbacka J. Photodynamic therapy \u2013 mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098\u2013107.","journal-title":"Biomed Pharmacother"},{"key":"2375_CR412","doi-asserted-by":"publisher","first-page":"041322","DOI":"10.1063\/5.0060424","volume":"8","author":"LM Chong","year":"2021","unstructured":"Chong LM, Tng DJH, Tan LLY, Chua MLK, Zhang Y. Recent advances in radiation therapy and photodynamic therapy. Appl Phys Rev. 2021;8:041322.","journal-title":"Appl Phys Rev"},{"key":"2375_CR413","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11427-017-9262-x","volume":"61","author":"X Pan","year":"2018","unstructured":"Pan X, Wang H, Wang S, Sun X, Wang L, Wang W, Shen H, Liu H. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Sci China Life Sci. 2018;61:415\u201326.","journal-title":"Sci China Life Sci"},{"key":"2375_CR414","doi-asserted-by":"publisher","first-page":"e2300234","DOI":"10.1002\/adhm.202300234","volume":"12","author":"Z He","year":"2023","unstructured":"He Z, Du J, Miao Y, Li Y. Recent developments of inorganic nanosensitizers for sonodynamic therapy. Adv Healthc Mater. 2023;12:e2300234.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR415","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1039\/C7CS00471K","volume":"47","author":"H Lin","year":"2018","unstructured":"Lin H, Chen Y, Shi J. Nanoparticle-triggered in situ catalytic chemical reactions for tumour -specific therapy. Chem Soc Rev. 2018;47:1938\u201358.","journal-title":"Chem Soc Rev"},{"key":"2375_CR416","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, Stockwell BR. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 2014;3:e02523.","journal-title":"Elife"},{"key":"2375_CR417","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"2375_CR418","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447:864\u20138.","journal-title":"Nature"},{"key":"2375_CR419","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, Uchida K, O\u2019Connor OA, Stockwell BR. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol. 2019;26:623-633.e629.","journal-title":"Cell Chem Biol"},{"key":"2375_CR420","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/bs.podrm.2018.11.003","volume":"44","author":"AA Abdelgalil","year":"2019","unstructured":"Abdelgalil AA, Alkahtani HM, Al-Jenoobi FI. Sorafenib. Profiles Drug Subst Excip Relat Methodol. 2019;44:239\u201366.","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"2375_CR421","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nm.4232","volume":"23","author":"SL Cramer","year":"2017","unstructured":"Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, Triplett K, Lamb C, Alters SE, Rowlinson S, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat Med. 2017;23:120\u20137.","journal-title":"Nat Med"},{"key":"2375_CR422","first-page":"8735","volume":"15","author":"S Nishizawa","year":"2018","unstructured":"Nishizawa S, Araki H, Ishikawa Y, Kitazawa S, Hata A, Soga T, Hara T. Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors. Oncol Lett. 2018;15:8735\u201343.","journal-title":"Oncol Lett"},{"key":"2375_CR423","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1741-7015-10-80","volume":"10","author":"P Gupta","year":"2012","unstructured":"Gupta P, Srivastava SK. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models. BMC Med. 2012;10:80.","journal-title":"BMC Med"},{"key":"2375_CR424","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1089\/ars.2011.4170","volume":"15","author":"G Chen","year":"2011","unstructured":"Chen G, Chen Z, Hu Y, Huang P. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by \u03b2-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid Redox Signal. 2011;15:2911\u201321.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR425","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bcp.2012.11.017","volume":"85","author":"WJ Wu","year":"2013","unstructured":"Wu WJ, Zhang Y, Zeng ZL, Li XB, Hu KS, Luo HY, Yang J, Huang P, Xu RH. \u03b2-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochem Pharmacol. 2013;85:486\u201396.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR426","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1471-2407-10-269","volume":"10","author":"X Wu","year":"2010","unstructured":"Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q, Xu K. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer. 2010;10:269.","journal-title":"BMC Cancer"},{"key":"2375_CR427","doi-asserted-by":"publisher","first-page":"2360427","DOI":"10.1155\/2018\/2360427","volume":"2018","author":"Y Xiang","year":"2018","unstructured":"Xiang Y, Ye W, Huang C, Yu D, Chen H, Deng T, Zhang F, Lou B, Zhang J, Shi K, et al. Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway. Oxid Med Cell Longev. 2018;2018:2360427.","journal-title":"Oxid Med Cell Longev"},{"key":"2375_CR428","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","volume":"103","author":"K Tsuchida","year":"2017","unstructured":"Tsuchida K, Tsujita T, Hayashi M, Ojima A, Keleku-Lukwete N, Katsuoka F, Otsuki A, Kikuchi H, Oshima Y, Suzuki M, Yamamoto M. Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radic Biol Med. 2017;103:236\u201347.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR429","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.3390\/ijms25137011","volume":"25","author":"EJ Jeong","year":"2024","unstructured":"Jeong EJ, Choi JJ, Lee SY, Kim YS. The effects of ML385 on head and neck squamous cell carcinoma: implications for NRF2 inhibition as a therapeutic strategy. Int J Mol Sci. 2024;25:7011.","journal-title":"Int J Mol Sci"},{"key":"2375_CR430","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s11094-025-03301-7","volume":"58","author":"H Yang","year":"2025","unstructured":"Yang H, Zheng W, Lin H, Huang H. ML385 Suppresses Hypoxia-Induced Drug Resistance and Cancer Stemness of Breast Cancer Cells by Blocking the Nrf2\/HO-1 Pathway. Pharm Chem J. 2025;58:1506\u201313.","journal-title":"Pharm Chem J"},{"key":"2375_CR431","first-page":"4765","volume":"7","author":"Y Tan","year":"2014","unstructured":"Tan Y, Bi L, Zhang P, Wang F, Lin F, Ni W, Wu J, Jiang L. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide. Int J Clin Exp Pathol. 2014;7:4765\u201373.","journal-title":"Int J Clin Exp Pathol"},{"key":"2375_CR432","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11060-005-9101-1","volume":"77","author":"GN Wu","year":"2006","unstructured":"Wu GN, Ford JM, Alger JR. MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain. J Neurooncol. 2006;77:95\u2013103.","journal-title":"J Neurooncol"},{"key":"2375_CR433","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ijrobp.2007.04.017","volume":"69","author":"JM Ford","year":"2007","unstructured":"Ford JM, Seiferheld W, Alger JR, Wu G, Endicott TJ, Mehta M, Curran W, Phan SC. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2007;69:831\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2375_CR434","doi-asserted-by":"publisher","first-page":"106589","DOI":"10.1016\/j.bioorg.2023.106589","volume":"138","author":"M Zhong","year":"2023","unstructured":"Zhong M, Chen L, Tao Y, Zhao J, Chang B, Zhang F, Tu J, Cai W, Zhang B. Synthesis and evaluation of Piperine analogs as thioredoxin reductase inhibitors to cause oxidative stress-induced cancer cell apoptosis. Bioorgan Chem. 2023;138:106589.","journal-title":"Bioorgan Chem"},{"key":"2375_CR435","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3816\/CGC.2008.n.011","volume":"6","author":"RJ Amato","year":"2008","unstructured":"Amato RJ, Jac J, Hernandez-McClain J. Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. Clin Genitourin Cancer. 2008;6:73\u20138.","journal-title":"Clin Genitourin Cancer"},{"key":"2375_CR436","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2004-03-0964","volume":"105","author":"AM Evens","year":"2005","unstructured":"Evens AM, Lecane P, Magda D, Prachand S, Singhal S, Nelson J, Miller RA, Gartenhaus RB, Gordon LI. Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells. Blood. 2005;105:1265\u201373.","journal-title":"Blood"},{"key":"2375_CR437","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s10495-005-0887-2","volume":"10","author":"J Chen","year":"2005","unstructured":"Chen J, Ramos J, Sirisawad M, Miller R, Naumovski L. Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis. Apoptosis. 2005;10:1131\u201342.","journal-title":"Apoptosis"},{"key":"2375_CR438","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/ph17101394","volume":"17","author":"SC An","year":"2024","unstructured":"An SC, Jun HH, Kim KM, Kim I, Choi S, Yeo H, Lee S, An HJ. Auranofin as a novel anticancer drug for anaplastic thyroid cancer. Pharmaceuticals (Basel). 2024;17:1394.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2375_CR439","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.3390\/cancers15215136","volume":"15","author":"FH Abdalbari","year":"2023","unstructured":"Abdalbari FH, Martinez-Jaramillo E, Forgie BN, Tran E, Zorychta E, Goyeneche AA, Sabri S, Telleria CM. Auranofin induces lethality driven by reactive oxygen species in high-grade serous ovarian cancer cells. Cancers (Basel). 2023;15:5136.","journal-title":"Cancers (Basel)"},{"key":"2375_CR440","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/pharmaceutics14122761","volume":"14","author":"L Freire Boullosa","year":"2022","unstructured":"Freire Boullosa L, Van Loenhout J, Hermans C, Lau HW, Merlin C, Marcq E, Takhsha FS, Martinet W, De Meyer GRY, Lardon F, et al. Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model. Pharmaceutics. 2022;14:2761.","journal-title":"Pharmaceutics"},{"key":"2375_CR441","doi-asserted-by":"publisher","first-page":"101004","DOI":"10.1016\/j.neo.2024.101004","volume":"53","author":"R Wang","year":"2024","unstructured":"Wang R, Zhong L, Wang T, Sun T, Yang J, Liu X, Wu Y, Guo Q, Gao Y, Zhao K. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production. Neoplasia. 2024;53:101004.","journal-title":"Neoplasia"},{"key":"2375_CR442","doi-asserted-by":"publisher","first-page":"16678","DOI":"10.1074\/jbc.RA120.013893","volume":"295","author":"T Onodera","year":"2020","unstructured":"Onodera T, Momose I, Adachi H, Yamazaki Y, Sawa R, Ohba SI, Kawada M. Human pancreatic cancer cells under nutrient deprivation are vulnerable to redox system inhibition. J Biol Chem. 2020;295:16678\u201390.","journal-title":"J Biol Chem"},{"key":"2375_CR443","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","volume":"74","author":"W Fiskus","year":"2014","unstructured":"Fiskus W, Saba N, Shen M, Ghias M, Liu J, Gupta SD, Chauhan L, Rao R, Gunewardena S, Schorno K, et al. Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia. Cancer Res. 2014;74:2520\u201332.","journal-title":"Cancer Res"},{"key":"2375_CR444","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.7150\/jca.40744","volume":"11","author":"W Wu","year":"2020","unstructured":"Wu W, Yang Z, Xiao X, An T, Li B, Ouyang J, Li H, Wang C, Zhang Y, Zhang H, et al. A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancer. J Cancer. 2020;11:3013\u20139.","journal-title":"J Cancer"},{"key":"2375_CR445","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/aps.2016.114","volume":"38","author":"SF Ye","year":"2017","unstructured":"Ye SF, Li J, Ji SM, Zeng HH, Lu W. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model. Acta Pharmacol Sin. 2017;38:223\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"2375_CR446","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.freeradbiomed.2007.03.035","volume":"43","author":"GT Wondrak","year":"2007","unstructured":"Wondrak GT. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med. 2007;43:178\u201390.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR447","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2011.09.005","volume":"313","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Ma Y, Cheng YF, Li WJ, Zhang Z, Chen S-Y. Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells. Cancer Lett. 2011;313:201\u201310.","journal-title":"Cancer Lett"},{"key":"2375_CR448","doi-asserted-by":"publisher","first-page":"39414","DOI":"10.1074\/jbc.M406576200","volume":"279","author":"AJ Lambert","year":"2004","unstructured":"Lambert AJ, Brand MD. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoreductase (complex I). J Biol Chem. 2004;279:39414\u201320.","journal-title":"J Biol Chem"},{"key":"2375_CR449","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/BJ20140620","volume":"462","author":"HR Bridges","year":"2014","unstructured":"Bridges HR, Jones AJ, Pollak MN, Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J. 2014;462:475\u201387.","journal-title":"Biochem J"},{"key":"2375_CR450","doi-asserted-by":"publisher","first-page":"106114","DOI":"10.1016\/j.phrs.2022.106114","volume":"177","author":"J Feng","year":"2022","unstructured":"Feng J, Wang X, Ye X, Ares I, Lopez-Torres B, Mart\u00ednez M, Mart\u00ednez-Larra\u00f1aga MR, Wang X, Anad\u00f3n A, Mart\u00ednez MA. Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications. Pharmacol Res. 2022;177:106114.","journal-title":"Pharmacol Res"},{"key":"2375_CR451","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10495-007-0082-8","volume":"12","author":"P Bragado","year":"2007","unstructured":"Bragado P, Armesilla A, Silva A, Porras A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis. 2007;12:1733\u201342.","journal-title":"Apoptosis"},{"key":"2375_CR452","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0169-409X(01)00128-4","volume":"49","author":"K Jung","year":"2001","unstructured":"Jung K, Reszka R. Mitochondria as subcellular targets for clinically useful anthracyclines. Adv Drug Deliv Rev. 2001;49:87\u2013105.","journal-title":"Adv Drug Deliv Rev"},{"key":"2375_CR453","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ymthe.2020.12.035","volume":"29","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Hofer T, Costa A, Lu D, Batkai S, Gupta SK, Bolesani E, Zweigerdt R, Megias D, Streckfuss-B\u00f6meke K, et al. Telomerase therapy attenuates cardiotoxic effects of doxorubicin. Mol Ther. 2021;29:1395\u2013410.","journal-title":"Mol Ther"},{"key":"2375_CR454","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2006.11.013","volume":"42","author":"S Deng","year":"2007","unstructured":"Deng S, Kruger A, Kleschyov AL, Kalinowski L, Daiber A, Wojnowski L. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH. Free Radic Biol Med. 2007;42:466\u201373.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR455","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells12040659","volume":"12","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Gieleci\u0144ska A, Mujwar S, Ko\u0142at D, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Celik I, Kontek R. Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells. 2023;12:659.","journal-title":"Cells"},{"key":"2375_CR456","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","volume":"327","author":"EI Azzam","year":"2012","unstructured":"Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327:48\u201360.","journal-title":"Cancer Lett"},{"key":"2375_CR457","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","volume":"119","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J. Reactive Oxygen Species (ROS)-based nanomedicine. Chem Rev. 2019;119:4881\u2013985.","journal-title":"Chem Rev"},{"key":"2375_CR458","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","volume":"39","author":"H Wang","year":"2018","unstructured":"Wang H, Mu X, He H, Zhang XD. Cancer radiosensitizers. Trends Pharmacol Sci. 2018;39:24\u201348.","journal-title":"Trends Pharmacol Sci"},{"key":"2375_CR459","first-page":"250","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250\u201381.","journal-title":"CA Cancer J Clin"},{"key":"2375_CR460","first-page":"26","volume":"9","author":"QL Guo","year":"2022","unstructured":"Guo QL, Dai XL, Yin MY, Cheng HW, Qian HS, Wang H, Zhu DM, Wang X-W. Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives. Mil Med Res. 2022;9:26.","journal-title":"Mil Med Res"},{"issue":"26","key":"2375_CR461","doi-asserted-by":"publisher","first-page":"e2300821","DOI":"10.1002\/adhm.202300821","volume":"12","author":"MM Pan","year":"2023","unstructured":"Pan MM, Li P, Yu YP, et al. Bimetallic Ions Functionalized Metal-Organic-Framework Nanozyme for Tumor Microenvironment Regulating and Enhanced Photodynamic Therapy for Hypoxic Tumor. Adv Healthc Mater. 2023;12(26):e2300821.","journal-title":"Adv Healthc Mater."},{"key":"2375_CR462","doi-asserted-by":"publisher","first-page":"1900132","DOI":"10.1002\/adhm.201900132","volume":"8","author":"M Lan","year":"2019","unstructured":"Lan M, Zhao S, Liu W, Lee CS, Zhang W, Wang P. Photosensitizers for photodynamic therapy. Adv Healthc Mater. 2019;8:1900132.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR463","doi-asserted-by":"publisher","first-page":"16971","DOI":"10.1021\/jacs.8b11593","volume":"140","author":"G Lan","year":"2018","unstructured":"Lan G, Ni K, Veroneau SS, Song Y, Lin W. Nanoscale metal-organic layers for radiotherapy-radiodynamic therapy. J Am Chem Soc. 2018;140:16971\u20135.","journal-title":"J Am Chem Soc"},{"key":"2375_CR464","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.7150\/thno.78649","volume":"13","author":"S Zhu","year":"2023","unstructured":"Zhu S, Yan F, Yang L, Li B, Xue R, Yu W, Wang Y, Huang L, Wang L, Han R, Jiang Y. Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response. Theranostics. 2023;13:1042\u201358.","journal-title":"Theranostics"},{"key":"2375_CR465","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12951-022-01537-z","volume":"20","author":"F Jiang","year":"2022","unstructured":"Jiang F, Lee C, Zhang W, Jiang W, Cao Z, Chong HB, Yang W, Zhan S, Li J, Teng Y, et al. Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid. J Nanobiotechnol. 2022;20:330.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR466","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.1021\/acs.nanolett.9b03682","volume":"19","author":"X Zhong","year":"2019","unstructured":"Zhong X, Wang X, Zhan G, Tang YA, Yao Y, Dong Z, Hou L, Zhao H, Zeng S, Hu J, et al. NaCeF4:Gd, Tb scintillator as an X-ray responsive photosensitizer for multimodal imaging-guided synchronous radio\/radiodynamic therapy. Nano Lett. 2019;19:8234\u201344.","journal-title":"Nano Lett"},{"key":"2375_CR467","doi-asserted-by":"publisher","first-page":"e2007888","DOI":"10.1002\/adma.202007888","volume":"33","author":"J Liu","year":"2021","unstructured":"Liu J, Hu F, Wu M, Tian L, Gong F, Zhong X, Chen M, Liu Z, Liu B. Bioorthogonal coordination polymer nanoparticles with aggregation-induced emission for deep tumor-penetrating radio- and radiodynamic therapy. Adv Mater. 2021;33:e2007888.","journal-title":"Adv Mater"},{"key":"2375_CR468","doi-asserted-by":"publisher","first-page":"106437","DOI":"10.1016\/j.ultsonch.2023.106437","volume":"96","author":"YL Loke","year":"2023","unstructured":"Loke YL, Beishenaliev A, Wang P-W, Lin CY, Chang CY, Foo YY, Faruqu FN, Leo BF, Misran M, Chung LY, et al. ROS-generating alginate-coated gold nanorods as biocompatible nanosonosensitisers for effective sonodynamic therapy of cancer. Ultrason Sonochem. 2023;96:106437.","journal-title":"Ultrason Sonochem"},{"key":"2375_CR469","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.1021\/acsnano.3c01308","volume":"17","author":"X Qu","year":"2023","unstructured":"Qu X, Yin F, Pei M, Chen Q, Zhang Y, Lu S, Zhang X, Liu Z, Li X, Chen H, et al. Modulation of intratumoral Fusobacterium nucleatum to enhance sonodynamic therapy for colorectal cancer with reduced phototoxic skin injury. ACS Nano. 2023;17:11466\u201380.","journal-title":"ACS Nano"},{"key":"2375_CR470","doi-asserted-by":"publisher","first-page":"215592","DOI":"10.1016\/j.canlet.2022.215592","volume":"532","author":"KM Nowak","year":"2022","unstructured":"Nowak KM, Schwartz MR, Breza VR, Price RJ. Sonodynamic therapy: rapid progress and new opportunities for non-invasive tumor cell killing with sound. Cancer Lett. 2022;532:215592.","journal-title":"Cancer Lett"},{"key":"2375_CR471","doi-asserted-by":"publisher","first-page":"1700378","DOI":"10.1002\/ppsc.201700378","volume":"35","author":"P Wang","year":"2018","unstructured":"Wang P, Wang X, Ma L, Sahi S, Li L, Wang X, Wang Q, Chen Y, Chen W, Liu Q. Nanosonosensitization by Using Copper-Cysteamine Nanoparticles Augmented Sonodynamic Cancer Treatment. Part Part Syst Charact. 2018;35:1700378.","journal-title":"Part Part Syst Charact."},{"key":"2375_CR472","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/anie.201805664","volume":"58","author":"Z Tang","year":"2019","unstructured":"Tang Z, Liu Y, He M, Bu W. Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions. Angew Chem Int Ed Engl. 2019;58:946\u201356.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2375_CR473","doi-asserted-by":"publisher","first-page":"e2103868","DOI":"10.1002\/smll.202103868","volume":"18","author":"C Jia","year":"2022","unstructured":"Jia C, Guo Y, Wu FG. Chemodynamic therapy via Fenton and Fenton-like nanomaterials: strategies and recent advances. Small. 2022;18:e2103868.","journal-title":"Small"},{"key":"2375_CR474","doi-asserted-by":"publisher","first-page":"100778","DOI":"10.1016\/j.drup.2021.100778","volume":"58","author":"A Valente","year":"2021","unstructured":"Valente A, Podolski-Reni\u0107 A, Poetsch I, Filipovi\u0107 N, L\u00f3pez \u00d3, Turel I, Heffeter P. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resist Updat. 2021;58:100778.","journal-title":"Drug Resist Updat"},{"key":"2375_CR475","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"J Lu","year":"2014","unstructured":"Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75\u201387.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR476","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","volume":"30","author":"SC Lu","year":"2009","unstructured":"Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30:42\u201359.","journal-title":"Mol Aspects Med"},{"key":"2375_CR477","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1038\/s41467-021-27414-1","volume":"12","author":"JL Parker","year":"2021","unstructured":"Parker JL, Deme JC, Kolokouris D, Kuteyi G, Biggin PC, Lea SM, Newstead S. Molecular basis for redox control by the human cystine\/glutamate antiporter system xc. Nat Commun. 2021;12:7147.","journal-title":"Nat Commun"},{"key":"2375_CR478","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu J, Xia X, Huang P. xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther. 2020;28:2358\u201366.","journal-title":"Mol Ther"},{"key":"2375_CR479","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. System Xc-\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292.","journal-title":"Front Pharmacol"},{"key":"2375_CR480","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/OTT.S254995","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y. The role of erastin in ferroptosis and its prospects in cancer therapy. Onco Targets Ther. 2020;13:5429\u201341.","journal-title":"Onco Targets Ther"},{"key":"2375_CR481","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14181","volume":"110","author":"M Yu","year":"2019","unstructured":"Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W, Lv S, Li W. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci. 2019;110:3173\u201382.","journal-title":"Cancer Sci"},{"key":"2375_CR482","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1016\/j.bmcl.2015.07.018","volume":"25","author":"MH Larraufie","year":"2015","unstructured":"Larraufie MH, Yang WS, Jiang E, Thomas AG, Slusher BS, Stockwell BR. Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility. Bioorg Med Chem Lett. 2015;25:4787\u201392.","journal-title":"Bioorg Med Chem Lett"},{"key":"2375_CR483","doi-asserted-by":"publisher","unstructured":"Cao X, Li M, Liu Q, Zhao J, Lu X, Wang J. Inorganic Sonosensitizers for Sonodynamic Therapy in Cancer Treatment Abstract. Small. 2023;19(42). https:\/\/doi.org\/10.1002\/smll.v19.42. https:\/\/doi.org\/10.1002\/smll.202303195.","DOI":"10.1002\/smll.v19.42"},{"key":"2375_CR484","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12951-023-01998-w","volume":"21","author":"Z Rao","year":"2023","unstructured":"Rao Z, Xia Y, Jia Q, Zhu Y, Wang L, Liu G, Liu X, Yang P, Ning P, Zhang R, et al. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination. J Nanobiotechnol. 2023;21:265.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR485","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12951-022-01604-5","volume":"20","author":"Y Gao","year":"2022","unstructured":"Gao Y, Li Y, Cao H, Jia H, Wang D, Ren C, Wang Z, Yang C, Liu J. Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis. J Nanobiotechnol. 2022;20:390.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR486","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgr255","volume":"33","author":"Y Zhang","year":"2012","unstructured":"Zhang Y. The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. Carcinogenesis. 2012;33:2\u20139.","journal-title":"Carcinogenesis"},{"key":"2375_CR487","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/ijms20051027","volume":"20","author":"B Upadhyaya","year":"2019","unstructured":"Upadhyaya B, Liu Y, Dey M. Phenethyl isothiocyanate exposure promotes oxidative stress and suppresses Sp1 transcription factor in cancer stem cells. Int J Mol Sci. 2019;20:1027.","journal-title":"Int J Mol Sci"},{"key":"2375_CR488","first-page":"405","volume":"1846","author":"P Gupta","year":"2014","unstructured":"Gupta P, Wright SE, Kim SH, Srivastava SK. Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms. Biochim Biophys Acta. 2014;1846:405\u201324.","journal-title":"Biochim Biophys Acta"},{"key":"2375_CR489","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1021\/acs.est.6b04981","volume":"51","author":"C Slawik","year":"2017","unstructured":"Slawik C, Rickmeyer C, Brehm M, B\u00f6hme A, Sch\u00fc\u00fcrmann G. Glutathione adduct patterns of Michael-acceptor carbonyls. Environ Sci Technol. 2017;51:4018\u201326.","journal-title":"Environ Sci Technol"},{"key":"2375_CR490","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1039\/C9BM01354G","volume":"7","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhou Z, Liu Y, Li Y, Huang X, Qian C, Sun M. H2O2-activated oxidative stress amplifier capable of GSH scavenging for enhancing tumor photodynamic therapy. Biomater Sci. 2019;7:5359\u201368.","journal-title":"Biomater Sci"},{"key":"2375_CR491","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.1022c01090","author":"H Wang","year":"2023","unstructured":"Wang H, Chen T, Ren H, Liu W, Nan F, Ge J, Wang P. Metal-organic Frameworks@Au nanoreactor as an oxidative stress amplifier for enhanced tumor photodynamic therapy through the alleviation of hypoxemia and the depletion of glutathione. ACS Appl Biomater. 2023. https:\/\/doi.org\/10.1021\/acsabm.1022c01090.","journal-title":"ACS Appl Biomater"},{"key":"2375_CR492","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/biom13020353","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Liang L, Matsumoto M, Iwata K, Umemura A, He F. Reactive oxygen species and NRF2 signaling, friends or foes in cancer? Biomolecules. 2023;13:353.","journal-title":"Biomolecules"},{"key":"2375_CR493","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","volume":"22","author":"S Menegon","year":"2016","unstructured":"Menegon S, Columbano A, Giordano S. The dual roles of NRF2 in cancer. Trends Mol Med. 2016;22:578\u201393.","journal-title":"Trends Mol Med"},{"key":"2375_CR494","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.7150\/ijbs.82401","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xu HX, Zhu JQ, Dou YX, Xian YF, Lin ZX. Natural Nrf2 inhibitors: a review of their potential for cancer treatment. Int J Biol Sci. 2023;19:3029\u201341.","journal-title":"Int J Biol Sci"},{"key":"2375_CR495","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1089\/ars.2020.8146","volume":"34","author":"E Panieri","year":"2021","unstructured":"Panieri E, Saso L. Inhibition of the NRF2\/KEAP1 axis: a promising therapeutic strategy to alter redox balance of cancer cells. Antioxid Redox Signal. 2021;34:1428\u201383.","journal-title":"Antioxid Redox Signal"},{"key":"2375_CR496","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jpp\/rgae017","volume":"76","author":"W Xi","year":"2024","unstructured":"Xi W, Zhao C, Wu Z, Ye T, Zhao R, Jiang X, Ling S. Brusatol\u2019s anticancer activity and its molecular mechanism: a research update. J Pharm Pharmacol. 2024;76:753\u201362.","journal-title":"J Pharm Pharmacol"},{"key":"2375_CR497","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/ph16060850","volume":"16","author":"D Gjorgieva Ackova","year":"2023","unstructured":"Gjorgieva Ackova D, Maksimova V, Smilkov K, Buttari B, Arese M, Saso L. Alkaloids as natural NRF2 inhibitors: chemoprevention and cytotoxic action in cancer. Pharmaceuticals (Basel). 2023;16:850.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2375_CR498","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.3390\/ijms22158223","volume":"22","author":"V Krajka-Ku\u017aniak","year":"2021","unstructured":"Krajka-Ku\u017aniak V, Baer-Dubowska W. Modulation of Nrf2 and NF-\u03baB signaling pathways by naturally occurring compounds in relation to cancer prevention and therapy. Are combinations better than single compounds? Int J Mol Sci. 2021;22:8223.","journal-title":"Int J Mol Sci"},{"key":"2375_CR499","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S, et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol. 2016;11:3214\u201325.","journal-title":"ACS Chem Biol"},{"key":"2375_CR500","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12032-024-02483-6","volume":"41","author":"L Yan","year":"2024","unstructured":"Yan L, Hu H, Feng L, Li Z, Zheng C, Zhang J, Yin X, Li B. ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma. Med Oncol. 2024;41:309.","journal-title":"Med Oncol"},{"key":"2375_CR501","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.3390\/ijms251910257","volume":"25","author":"M Juszczak","year":"2024","unstructured":"Juszczak M, Tokarz P, Wo\u017aniak K. Potential of NRF2 inhibitors-retinoic acid, K67, and ML-385-in overcoming doxorubicin resistance in promyelocytic leukemia cells. Int J Mol Sci. 2024;25:10257.","journal-title":"Int J Mol Sci"},{"key":"2375_CR502","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10637-012-9846-2","volume":"31","author":"AF Baker","year":"2013","unstructured":"Baker AF, Adab KN, Raghunand N, Chow H, Stratton SP, Squire SW, Boice M, Pestano LA, Kirkpatrick DL, Dragovich T. A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers. Invest New Drugs. 2013;31:631\u201341.","journal-title":"Invest New Drugs"},{"key":"2375_CR503","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0006-2952(97)00597-2","volume":"55","author":"DL Kirkpatrick","year":"1998","unstructured":"Kirkpatrick DL, Kuperus M, Dowdeswell M, Potier N, Donald LJ, Kunkel M, Berggren M, Angulo M, Powis G. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol. 1998;55:987\u201394.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR504","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ddr.22045","volume":"84","author":"R Akhlaq","year":"2023","unstructured":"Akhlaq R, Khan T, Ahmed T, Musharraf SG, Ali A. PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro. Drug Dev Res. 2023;84:556\u201360.","journal-title":"Drug Dev Res"},{"key":"2375_CR505","first-page":"1528","volume":"7","author":"GZ Li","year":"2015","unstructured":"Li GZ, Liang HF, Liao B, Zhang L, Ni YA, Zhou HH, Zhang EL, Zhang BX, Chen XP. PX-12 inhibits the growth of hepatocelluar carcinoma by inducing S-phase arrest, ROS-dependent apoptosis and enhances 5-FU cytotoxicity. Am J Transl Res. 2015;7:1528\u201340.","journal-title":"Am J Transl Res"},{"key":"2375_CR506","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/ijo.2013.2152","volume":"44","author":"BR You","year":"2014","unstructured":"You BR, Shin HR, Park WH. PX-12 inhibits the growth of A549 lung cancer cells via G2\/M phase arrest and ROS-dependent apoptosis. Int J Oncol. 2014;44:301\u20138.","journal-title":"Int J Oncol"},{"key":"2375_CR507","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-06-2250","volume":"13","author":"RK Ramanathan","year":"2007","unstructured":"Ramanathan RK, Kirkpatrick DL, Belani CP, Friedland D, Green SB, Chow HH, Cordova CA, Stratton SP, Sharlow ER, Baker A, Dragovich T. A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clin Cancer Res. 2007;13:2109\u201314.","journal-title":"Clin Cancer Res"},{"key":"2375_CR508","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00280-010-1343-8","volume":"67","author":"RK Ramanathan","year":"2011","unstructured":"Ramanathan RK, Abbruzzese J, Dragovich T, Kirkpatrick L, Guillen JM, Baker AF, Pestano LA, Green S, Von Hoff DD. A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. Cancer Chemother Pharmacol. 2011;67:503\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2375_CR509","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10637-011-9739-9","volume":"30","author":"RK Ramanathan","year":"2012","unstructured":"Ramanathan RK, Stephenson JJ, Weiss GJ, Pestano LA, Lowe A, Hiscox A, Leos RA, Martin JC, Kirkpatrick L, Richards DA. A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy. Invest New Drugs. 2012;30:1591\u20136.","journal-title":"Invest New Drugs"},{"key":"2375_CR510","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1074\/jbc.M511373200","volume":"281","author":"SI Hashemy","year":"2006","unstructured":"Hashemy SI, Ungerstedt JS, Zahedi Avval F, Holmgren A. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem. 2006;281:10691\u20137.","journal-title":"J Biol Chem"},{"key":"2375_CR511","doi-asserted-by":"publisher","first-page":"116218","DOI":"10.1016\/j.ejmech.2024.116218","volume":"268","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zhou X, Nie Q, Zhang J. Inhibition of the thioredoxin system for radiosensitization therapy of cancer. Eur J Med Chem. 2024;268:116218.","journal-title":"Eur J Med Chem"},{"key":"2375_CR512","first-page":"739","volume":"5","author":"DI Rosenthal","year":"1999","unstructured":"Rosenthal DI, Nurenberg P, Becerra CR, Frenkel EP, Carbone DP, Lum BL, Miller R, Engel J, Young S, Miles D, Renschler MF. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. Clin Cancer Res. 1999;5:739\u201345.","journal-title":"Clin Cancer Res"},{"key":"2375_CR513","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.212.3.r99se10755","volume":"212","author":"J Viala","year":"1999","unstructured":"Viala J, Vanel D, Meingan P, Lartigau E, Carde P, Renschler M. Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases. Radiology. 1999;212:755\u20139.","journal-title":"Radiology"},{"key":"2375_CR514","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1200\/JCO.2001.19.7.2074","volume":"19","author":"P Carde","year":"2001","unstructured":"Carde P, Timmerman R, Mehta MP, Koprowski CD, Ford J, Tishler RB, Miles D, Miller RA, Renschler MF. Multicenter phase Ib\/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. J Clin Oncol. 2001;19:2074\u201383.","journal-title":"J Clin Oncol"},{"key":"2375_CR515","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1200\/JCO.2002.07.500","volume":"20","author":"MP Mehta","year":"2002","unstructured":"Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol. 2002;20:3445\u201353.","journal-title":"J Clin Oncol"},{"key":"2375_CR516","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/JCO.2003.12.122","volume":"21","author":"MP Mehta","year":"2003","unstructured":"Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol. 2003;21:2529\u201336.","journal-title":"J Clin Oncol"},{"key":"2375_CR517","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","volume":"22","author":"CA Meyers","year":"2004","unstructured":"Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22:157\u201365.","journal-title":"J Clin Oncol"},{"key":"2375_CR518","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ijrobp.2014.12.050","volume":"91","author":"DG Brachman","year":"2015","unstructured":"Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP. Phase 1\/2 trials of temozolomide, motexafin gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. Int J Radiat Oncol Biol Phys. 2015;91:961\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2375_CR519","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.ijrobp.2012.09.004","volume":"85","author":"KA Bradley","year":"2013","unstructured":"Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G, Pollack IF. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children\u2019s oncology group phase 2 study. Int J Radiat Oncol Biol Phys. 2013;85:e55-60.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2375_CR520","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10637-009-9364-z","volume":"29","author":"AM Traynor","year":"2011","unstructured":"Traynor AM, Thomas JP, Ramanathan RK, Mody TD, Alberti D, Wilding G, Bailey HH. Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies. Invest New Drugs. 2011;29:316\u201322.","journal-title":"Invest New Drugs"},{"key":"2375_CR521","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/JTO.0b013e31820a443f","volume":"6","author":"MJ Edelman","year":"2011","unstructured":"Edelman MJ, Otterson G, Leach J, Malpass T, Salgia R, Jones D, Mody TD, Govindan R. Multicenter phase II trial of motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer. J Thorac Oncol. 2011;6:786\u20139.","journal-title":"J Thorac Oncol"},{"key":"2375_CR522","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1021\/acs.chemrev.2c00649","volume":"123","author":"RT Mertens","year":"2023","unstructured":"Mertens RT, Gukathasan S, Arojojoye AS, Olelewe C, Awuah SG. Next generation gold drugs and probes: chemistry and biomedical applications. Chem Rev. 2023;123:6612\u201367.","journal-title":"Chem Rev"},{"key":"2375_CR523","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/med.20168","volume":"30","author":"S Nobili","year":"2010","unstructured":"Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. Med Res Rev. 2010;30:550\u201380.","journal-title":"Med Res Rev"},{"key":"2375_CR524","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/cancers11060780","volume":"11","author":"I M\u00e1rmol","year":"2019","unstructured":"M\u00e1rmol I, Quero J, Rodr\u00edguez-Yoldi MJ, Cerrada E. Gold as a possible alternative to platinum-based chemotherapy for colon cancer treatment. Cancers (Basel). 2019;11:780.","journal-title":"Cancers (Basel)"},{"key":"2375_CR525","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/med.21872","volume":"42","author":"T Gamberi","year":"2022","unstructured":"Gamberi T, Chiappetta G, Fiaschi T, Modesti A, Sorbi F, Magherini F. Upgrade of an old drug: auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness. Med Res Rev. 2022;42:1111\u201346.","journal-title":"Med Res Rev"},{"key":"2375_CR526","doi-asserted-by":"publisher","first-page":"e202100773","DOI":"10.1002\/cmdc.202100773","volume":"17","author":"B Rousselle","year":"2022","unstructured":"Rousselle B, Massot A, Privat M, Dondaine L, Trommenschlager A, Bouyer F, Bayardon J, Ghiringhelli F, Bettaieb A, Goze C, et al. Conception and evaluation of fluorescent phosphine-gold complexes: from synthesis to in vivo investigations. ChemMedChem. 2022;17:e202100773.","journal-title":"ChemMedChem"},{"key":"2375_CR527","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.7150\/thno.52077","volume":"11","author":"Y Xia","year":"2021","unstructured":"Xia Y, Chen J, Yu Y, Wu F, Shen X, Qiu C, Zhang T, Hong L, Zheng P, Shao R, et al. Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors. Theranostics. 2021;11:4335\u201350.","journal-title":"Theranostics"},{"key":"2375_CR528","doi-asserted-by":"publisher","first-page":"113572","DOI":"10.1016\/j.jconrel.2025.02.068","volume":"381","author":"M Gao","year":"2025","unstructured":"Gao M, Song Y, Liang J, Chen T, Luo J, Du P, Wang H, Leng H, Wang Z, Ma X, et al. Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. J Control Release. 2025;381:113572.","journal-title":"J Control Release"},{"key":"2375_CR529","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/antiox13101201","volume":"13","author":"F Jamali","year":"2024","unstructured":"Jamali F, Lan K, Daniel P, Petrecca K, Sabri S, Abdulkarim B. Synergistic dual targeting of thioredoxin and glutathione systems irrespective of p53 in glioblastoma stem cells. Antioxidants (Basel). 2024;13:1201.","journal-title":"Antioxidants (Basel)"},{"key":"2375_CR530","doi-asserted-by":"publisher","first-page":"103245","DOI":"10.1016\/j.redox.2024.103245","volume":"75","author":"M Yang","year":"2024","unstructured":"Yang M, Liu J, Li J, Wen S, Hu Y, Lu W, Liu J, Huang P, Liu P. The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism. Redox Biol. 2024;75:103245.","journal-title":"Redox Biol"},{"key":"2375_CR531","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.freeradbiomed.2011.11.034","volume":"52","author":"L Wang","year":"2012","unstructured":"Wang L, Yang Z, Fu J, Yin H, Xiong K, Tan Q, Jin H, Li J, Wang T, Tang W, et al. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent. Free Radic Biol Med. 2012;52:898\u2013908.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR532","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1074\/jbc.C400496200","volume":"280","author":"HA Woo","year":"2005","unstructured":"Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, Rhee SG. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem. 2005;280:3125\u20138.","journal-title":"J Biol Chem"},{"key":"2375_CR533","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.17219\/acem\/139130","volume":"30","author":"H Ran","year":"2021","unstructured":"Ran H, Liu H, Wu P. Echinatin mitigates H2O2-induced oxidative damage and apoptosis in lens epithelial cells via the Nrf2\/HO-1 pathway. Adv Clin Exp Med. 2021;30:1195\u2013203.","journal-title":"Adv Clin Exp Med"},{"key":"2375_CR534","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.biopha.2016.06.040","volume":"83","author":"X Zheng","year":"2016","unstructured":"Zheng X, Zhang Y, Zhang L, Xu W, Ma W, Sun R, Zeng H. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation. Biomed Pharmacother. 2016;83:212\u201320.","journal-title":"Biomed Pharmacother"},{"key":"2375_CR535","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2017.07.020","volume":"275","author":"X Zheng","year":"2017","unstructured":"Zheng X, Xu W, Sun R, Yin H, Dong C, Zeng H. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells. Chem Biol Interact. 2017;275:74\u201385.","journal-title":"Chem Biol Interact"},{"key":"2375_CR536","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.redox.2017.09.014","volume":"14","author":"X Zheng","year":"2018","unstructured":"Zheng X, Ma W, Sun R, Yin H, Lin F, Liu Y, Xu W, Zeng H. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity. Redox Biol. 2018;14:237\u201349.","journal-title":"Redox Biol"},{"key":"2375_CR537","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1631\/jzus.B1700219","volume":"19","author":"Q Zou","year":"2018","unstructured":"Zou Q, Chen YF, Zheng XQ, Ye SF, Xu BY, Liu YX, Zeng HH. Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression. J Zhejiang Univ Sci B. 2018;19:689\u201398.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2375_CR538","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4049\/jimmunol.2200389","volume":"210","author":"X Su","year":"2023","unstructured":"Su X, Yin H, Bai M, Liu J, Liu R, Zeng H, Wen J. A novel TrxR1 inhibitor regulates NK and CD8+ T cell infiltration and cytotoxicity, enhancing the efficacy of anti-PD-1 immunotherapy against hepatocarcinoma. J Immunol. 2023;210:681\u201395.","journal-title":"J Immunol"},{"key":"2375_CR539","doi-asserted-by":"publisher","first-page":"e2412802","DOI":"10.1002\/smll.202412802","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, Wang N, Li H, Zhang X, Meng L, Yu Y, Wang S, Deng L. Biomineralization of copper-celastrol nanohybrids for synergistic antitumor therapy. Small. 2025;21:e2412802.","journal-title":"Small"},{"key":"2375_CR540","doi-asserted-by":"publisher","first-page":"125289","DOI":"10.1016\/j.ijpharm.2025.125289","volume":"671","author":"Y Liu","year":"2025","unstructured":"Liu Y, Song J, Guo Y, Li S, Yuan M, Tang J, Wang Y, Li M, Guo Y, Guo L. Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: anti-hepatocellular carcinoma and reduced hepatotoxicity. Int J Pharm. 2025;671:125289.","journal-title":"Int J Pharm"},{"key":"2375_CR541","doi-asserted-by":"crossref","unstructured":"Ma C, Wang F, Wang Y, Wu F, Zhang X, Ding C, Zhao J, Ma Y, Li W, Liu W. Discovery of the novel celastrol-based PROTACs for the treatment of non-small cell lung cancer. Mol Divers. 2025.","DOI":"10.1007\/s11030-025-11140-7"},{"key":"2375_CR542","doi-asserted-by":"publisher","first-page":"2464189","DOI":"10.1080\/10717544.2025.2464189","volume":"32","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang J, Li X, Zhao L, Zhao J, Su M, Wu X, Zeng H. Synergistic effect of pH-sensitive PEGylated RG3-chitosan prodrug nanoparticles encapsulated celastrol on pancreatic cancer. Drug Deliv. 2025;32:2464189.","journal-title":"Drug Deliv"},{"key":"2375_CR543","doi-asserted-by":"publisher","first-page":"156514","DOI":"10.1016\/j.phymed.2025.156514","volume":"139","author":"J Huang","year":"2025","unstructured":"Huang J, Shi J, Ma N, Li Y, Jin W, Zhang H, Zhang X, Luo N, Ding Y, Xie Q, et al. Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer. Phytomedicine. 2025;139:156514.","journal-title":"Phytomedicine"},{"key":"2375_CR544","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12951-025-03154-y","volume":"23","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang J, Lai C, Wang W, Huang Y, Bao X, Yan H, Sun X, Liu Q, Chen D, et al. Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer. J Nanobiotechnology. 2025;23:183.","journal-title":"J Nanobiotechnology"},{"key":"2375_CR545","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/35030140","volume":"407","author":"P Huang","year":"2000","unstructured":"Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer c ells. Nature. 2000;407:390\u20135.","journal-title":"Nature"},{"key":"2375_CR546","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/abbi.2001.2455","volume":"392","author":"R Kachadourian","year":"2001","unstructured":"Kachadourian R, Liochev SI, Cabelli DE, Patel MN, Fridovich I, Day BJ. 2-methoxyestradiol does not inhibit superoxide dismutase. Arch Biochem Biophys. 2001;392:349\u201353.","journal-title":"Arch Biochem Biophys"},{"key":"2375_CR547","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1158\/0008-5472.CAN-14-1084","volume":"74","author":"P Kesarwani","year":"2014","unstructured":"Kesarwani P, Al-Khami AA, Scurti G, Thyagarajan K, Kaur N, Husain S, Fang Q, Naga OS, Simms P, Beeson G, et al. Promoting thiol expression increases the durability of antitumor T-cell functions. Cancer Res. 2014;74:6036\u201347.","journal-title":"Cancer Res"},{"key":"2375_CR548","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","volume":"138","author":"JB Lee","year":"2021","unstructured":"Lee JB, Khan DH, Hurren R, Xu M, Na Y, Kang H, Mirali S, Wang X, Gronda M, Jitkova Y, et al. Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood. 2021;138:234\u201345.","journal-title":"Blood"},{"key":"2375_CR549","doi-asserted-by":"publisher","first-page":"e2301928","DOI":"10.1002\/advs.202301928","volume":"10","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang Y, Lu Z, Wan J, Jiang L, Song D, Wei C, Gao C, Shi G, Zhou J, et al. PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti-PD-1 immunotherapy. Adv Sci (Weinh). 2023;10:e2301928.","journal-title":"Adv Sci (Weinh)"},{"key":"2375_CR550","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1172\/JCI137585","volume":"130","author":"Y Yang","year":"2020","unstructured":"Yang Y, Neo SY, Chen Z, Cui W, Chen Y, Guo M, Wang Y, Xu H, Kurzay A, Alici E, et al. Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells. J Clin Invest. 2020;130:5508\u201322.","journal-title":"J Clin Invest"},{"key":"2375_CR551","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","volume":"183","author":"L Kalafati","year":"2020","unstructured":"Kalafati L, Kourtzelis I, Schulte-Schrepping J, Li X, Hatzioannou A, Grinenko T, Hagag E, Sinha A, Has C, Dietz S, et al. Innate immune training of granulopoiesis promotes anti-tumor activity. Cell. 2020;183:771-785.e712.","journal-title":"Cell"},{"key":"2375_CR552","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijc.31316","volume":"143","author":"N Sampson","year":"2018","unstructured":"Sampson N, Brunner E, Weber A, Puhr M, Sch\u00e4fer G, Szyndralewiez C, Klocker H. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions. Int J Cancer. 2018;143:383\u201395.","journal-title":"Int J Cancer"},{"key":"2375_CR553","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","volume":"80","author":"K Ford","year":"2020","unstructured":"Ford K, Hanley CJ, Mellone M, Szyndralewiez C, Heitz F, Wiesel P, Wood O, Machado M, Lopez MA, Ganesan AP, et al. NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors. Cancer Res. 2020;80:1846\u201360.","journal-title":"Cancer Res"},{"key":"2375_CR554","doi-asserted-by":"publisher","first-page":"e2100712","DOI":"10.1002\/advs.202100712","volume":"8","author":"D Ding","year":"2021","unstructured":"Ding D, Zhong H, Liang R, Lan T, Zhu X, Huang S, Wang Y, Shao J, Shuai X, Wei B. Multifunctional nanodrug mediates synergistic photodynamic therapy and MDSCs-targeting immunotherapy of colon cancer. Adv Sci (Weinh). 2021;8:e2100712.","journal-title":"Adv Sci (Weinh)"},{"key":"2375_CR555","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.1021\/acsnano.1c04068","volume":"15","author":"M Jiang","year":"2021","unstructured":"Jiang M, Li X, Zhang J, Lu Y, Shi Y, Zhu C, Liu Y, Qin B, Luo Z, Du Y, et al. Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under hypoxia to sensitize immunotherapy. ACS Nano. 2021;15:14522\u201334.","journal-title":"ACS Nano"},{"key":"2375_CR556","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.actbio.2023.02.006","volume":"160","author":"Y Cao","year":"2023","unstructured":"Cao Y, Qiao B, Chen Q, Xie Z, Dou X, Xu L, Ran H, Zhang L, Wang Z. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy. Acta Biomater. 2023;160:239\u201351.","journal-title":"Acta Biomater"},{"key":"2375_CR557","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51\u201372.","journal-title":"Annu Rev Immunol"},{"key":"2375_CR558","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"2375_CR559","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","volume":"153","author":"F Radogna","year":"2018","unstructured":"Radogna F, Diederich M. Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy. Biochem Pharmacol. 2018;153:12\u201323.","journal-title":"Biochem Pharmacol"},{"key":"2375_CR560","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1021\/acs.nanolett.8b03568","volume":"18","author":"C Shi","year":"2018","unstructured":"Shi C, Liu T, Guo Z, Zhuang R, Zhang X, Chen X. Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Lett. 2018;18:7330\u201342.","journal-title":"Nano Lett"},{"key":"2375_CR561","doi-asserted-by":"publisher","first-page":"17425","DOI":"10.1002\/anie.201909729","volume":"58","author":"M Wen","year":"2019","unstructured":"Wen M, Ouyang J, Wei C, Li H, Chen W, Liu YN. Artificial enzyme catalyzed cascade reactions: antitumor immunotherapy reinforced by NIR-II light. Angew Chem Int Ed Engl. 2019;58:17425\u201332.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2375_CR562","doi-asserted-by":"publisher","first-page":"e2401851","DOI":"10.1002\/adhm.202401851","volume":"14","author":"Y Teng","year":"2025","unstructured":"Teng Y, Yang Z, Peng Y, Yang Y, Chen S, Li J, Gao D, Sun W, Wu Z, Zhou Y, et al. Endoplasmic reticulum stress nano-orchestrators for precisely regulated immunogenic cell death as potent cancer vaccines. Adv Healthc Mater. 2025;14:e2401851.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR563","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"2375_CR564","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12951-021-01169-9","volume":"19","author":"R He","year":"2021","unstructured":"He R, Zang J, Zhao Y, Liu Y, Ruan S, Zheng X, Chong G, Xu D, Yang Y, Yang Y, et al. Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition. J Nanobiotechnol. 2021;19:426.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR565","doi-asserted-by":"publisher","first-page":"15471","DOI":"10.1021\/acsnano.2c08013","volume":"16","author":"Z Li","year":"2022","unstructured":"Li Z, Chu Z, Yang J, Qian H, Xu J, Chen B, Tian T, Chen H, Xu Y, Wang F. Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy. ACS Nano. 2022;16:15471\u201383.","journal-title":"ACS Nano"},{"key":"2375_CR566","doi-asserted-by":"publisher","first-page":"143ra199","DOI":"10.1126\/scitranslmed.3003807","volume":"4","author":"L Menger","year":"2012","unstructured":"Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med. 2012;4:143ra199.","journal-title":"Sci Transl Med"},{"key":"2375_CR567","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.redox.2022.102351","volume":"54","author":"Z Xu","year":"2022","unstructured":"Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li F, Yang Z, Lu Y, Liu W. Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biol. 2022;54:102351.","journal-title":"Redox Biol"},{"key":"2375_CR568","doi-asserted-by":"publisher","first-page":"e2202710","DOI":"10.1002\/adhm.202202710","volume":"12","author":"J Wan","year":"2023","unstructured":"Wan J, Zhang X, Li Z, Mo F, Tang D, Xiao H, Wang J, Rong G, Liu T. Oxidative stress amplifiers as immunogenic cell death nanoinducers disrupting mitochondrial redox homeostasis for cancer immunotherapy. Adv Healthc Mater. 2023;12:e2202710.","journal-title":"Adv Healthc Mater"},{"key":"2375_CR569","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.3390\/ijms23084117","volume":"23","author":"BJ Mossakowska","year":"2022","unstructured":"Mossakowska BJ, Shahmoradi Ghahe S, Cysewski D, Fabisiewicz A, Tudek B, Siedlecki JA. Mechanisms of resistance to photodynamic therapy (PDT) in vulvar cancer. Int J Mol Sci. 2022;23:4117.","journal-title":"Int J Mol Sci"},{"key":"2375_CR570","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4161\/auto.28679","volume":"10","author":"MF Wei","year":"2014","unstructured":"Wei MF, Chen MW, Chen KC, Lou PJ, Lin SYF, Hung SC, Hsiao M, Yao CJ, Shieh MJ. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 2014;10:1179\u201392.","journal-title":"Autophagy"},{"key":"2375_CR571","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.18632\/oncotarget.6601","volume":"7","author":"KF Hui","year":"2016","unstructured":"Hui KF, Yeung PL, Chiang AK. Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib. Oncotarget. 2016;7:4454\u201367.","journal-title":"Oncotarget"},{"key":"2375_CR572","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41419-024-06558-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Zhang W, Xing Z, Hu S, Zhang G, Wang T, Wang T, Fan Q, Chen G, Cheng J, et al. Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11. Cell Death Dis. 2024;15:168.","journal-title":"Cell Death Dis"},{"key":"2375_CR573","doi-asserted-by":"publisher","first-page":"e2006892","DOI":"10.1002\/adma.202006892","volume":"33","author":"LH Fu","year":"2021","unstructured":"Fu LH, Wan Y, Qi C, He J, Li C, Yang C, Xu H, Lin J, Huang P. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33:e2006892.","journal-title":"Adv Mater"},{"key":"2375_CR574","doi-asserted-by":"publisher","first-page":"e2300280","DOI":"10.1002\/smll.202300280","volume":"19","author":"H Xiao","year":"2023","unstructured":"Xiao H, Li X, Li B, Yang S, Qin J, Han S, Ren J, Shuai X. Nanodrug inducing autophagy inhibition and mitochondria dysfunction for potentiating tumor photo-immunotherapy. Small. 2023;19:e2300280.","journal-title":"Small"},{"key":"2375_CR575","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/acsami.1c14135","volume":"14","author":"M Chen","year":"2022","unstructured":"Chen M, Yang J, Zhou L, Hu X, Wang C, Chai K, Li R, Feng L, Sun Y, Dong C, Shi S. Dual-responsive and ROS-augmented nanoplatform for chemo\/photodynamic\/chemodynamic combination therapy of triple negative breast cancer. ACS Appl Mater Interfaces. 2022;14:57\u201368.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2375_CR576","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/D0CS00718H","volume":"50","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev. 2021;50:6013\u201341.","journal-title":"Chem Soc Rev"},{"key":"2375_CR577","doi-asserted-by":"publisher","first-page":"e2101840","DOI":"10.1002\/advs.202101840","volume":"8","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhang T, Ma X, Yang QC, Yang LL, Yang SC, Liang M, Xu Z, Sun ZJ. Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy. Adv Sci (Weinh). 2021;8:e2101840.","journal-title":"Adv Sci (Weinh)"},{"key":"2375_CR578","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-022-00894-3","volume":"7","author":"X Wang","year":"2022","unstructured":"Wang X, Ding H, Li Z, Peng Y, Tan H, Wang C, Huang G, Li W, Ma G, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Signal Transduct Target Ther. 2022;7:74.","journal-title":"Signal Transduct Target Ther"},{"key":"2375_CR579","doi-asserted-by":"publisher","first-page":"8587","DOI":"10.7150\/thno.62572","volume":"11","author":"C Ji","year":"2021","unstructured":"Ji C, Si J, Xu Y, Zhang W, Yang Y, He X, Xu H, Mou X, Ren H, Guo H. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation. Theranostics. 2021;11:8587\u2013604.","journal-title":"Theranostics"},{"key":"2375_CR580","doi-asserted-by":"publisher","first-page":"eaau6584","DOI":"10.1126\/sciimmunol.aau6584","volume":"4","author":"D Wang","year":"2019","unstructured":"Wang D, Wang T, Yu H, Feng B, Zhou L, Zhou F, Hou B, Zhang H, Luo M, Li Y. Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Sci Immunol. 2019;4:eaau6584.","journal-title":"Sci Immunol"},{"key":"2375_CR581","doi-asserted-by":"publisher","first-page":"e2106010","DOI":"10.1002\/adma.202106010","volume":"34","author":"M Wang","year":"2022","unstructured":"Wang M, Chang M, Li C, Chen Q, Hou Z, Xing B, Lin J. Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic cascade cancer starvation\/chemodynamic \/immunotherapy. Adv Mater. 2022;34:e2106010.","journal-title":"Adv Mater"},{"key":"2375_CR582","first-page":"57","volume":"14","author":"J Li","year":"2022","unstructured":"Li J, Wang S, Lin X, Cao Y, Cai Z, Wang J, Zhang Z, Liu X, Wu M, Yao C. Red blood cell-mimic nanocatalyst triggering radical storm to augment cancer immunotherapy. Nanomicro Lett. 2022;14:57.","journal-title":"Nanomicro Lett"},{"key":"2375_CR583","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2023.01.038","volume":"355","author":"M Gong","year":"2023","unstructured":"Gong M, Huang Y, Feng H, Lin J, Huang A, Hu J, Tang Q, Zhu X, Han S, Lu J, Wang J. A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration. J Control Release. 2023;355:68\u201384.","journal-title":"J Control Release"},{"key":"2375_CR584","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jconrel.2023.02.040","volume":"356","author":"M He","year":"2023","unstructured":"He M, Wang M, Xu T, Zhang M, Dai H, Wang C, Ding D, Zhong Z. Reactive oxygen species-powered cancer immunotherapy: current status and challenges. J Control Release. 2023;356:623\u201348.","journal-title":"J Control Release"},{"key":"2375_CR585","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s43657-023-00140-y","volume":"4","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zheng T, Wang R, Lin X, Hu Z, Zhao Z, Dai Z, Sun D. Synergistically augmenting cancer immunotherapy by physical manipulation of pyroptosis induction. Phenomics. 2024;4:298\u2013312.","journal-title":"Phenomics"},{"key":"2375_CR586","doi-asserted-by":"publisher","first-page":"109888","DOI":"10.1016\/j.cbi.2022.109888","volume":"358","author":"I Pantic","year":"2022","unstructured":"Pantic I, Paunovic J, Pejic S, Drakulic D, Todorovic A, Stankovic S, Vucevic D, Cumic J, Radosavljevic T. Artificial intelligence approaches to the biochemistry of oxidative stress: current state of the art. Chem Biol Interact. 2022;358:109888.","journal-title":"Chem Biol Interact"},{"key":"2375_CR587","doi-asserted-by":"publisher","first-page":"1084531","DOI":"10.3389\/fimmu.2023.1084531","volume":"14","author":"M Xu","year":"2023","unstructured":"Xu M, Zhou H, Hu P, Pan Y, Wang S, Liu L, Liu X. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning. Front Immunol. 2023;14:1084531.","journal-title":"Front Immunol"},{"key":"2375_CR588","first-page":"325","volume":"9","author":"L Ho Thanh Lam","year":"2020","unstructured":"Ho Thanh Lam L, Le NH, Van Tuan L, Tran Ban H, Nguyen Khanh Hung T, Nguyen NTK, Huu Dang L, Le NQK. Machine learning model for identifying antioxidant proteins using features calculated from primary sequences. Biology (Basel). 2020;9:325.","journal-title":"Biology (Basel)"},{"key":"2375_CR589","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/2472630320962716","volume":"26","author":"SO Idowu","year":"2021","unstructured":"Idowu SO, Fatokun AA. Artificial Intelligence (AI) to the rescue: deploying machine learning to bridge the biorelevance gap in antioxidant assays. SLAS Technol. 2021;26:16\u201325.","journal-title":"SLAS Technol"},{"key":"2375_CR590","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/ijms24032792","volume":"24","author":"M Mirzaei","year":"2023","unstructured":"Mirzaei M, Furxhi I, Murphy F, Mullins M. Employing supervised algorithms for the prediction of nanomaterial\u2019s antioxidant efficiency. Int J Mol Sci. 2023;24:2792.","journal-title":"Int J Mol Sci"},{"key":"2375_CR591","doi-asserted-by":"publisher","first-page":"e1663","DOI":"10.1002\/wnan.1663","volume":"13","author":"L Dong","year":"2021","unstructured":"Dong L, Li W, Sun L, Yu L, Chen Y, Hong G. Energy-converting biomaterials for cancer therapy: category, efficiency, and biosafety. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13:e1663.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"2375_CR592","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12951-025-03177-5","volume":"23","author":"J Chen","year":"2025","unstructured":"Chen J, Feng C, Lan Y, Chen X, Peng Z, Huang Z, Wang R, Zhang W, Ye Y, Mao Z, et al. Bidirectional regulation of reactive oxygen species for radiosensitization in nasopharyngeal carcinoma. J Nanobiotechnol. 2025;23:96.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR593","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12951-024-02710-2","volume":"22","author":"S Zhu","year":"2024","unstructured":"Zhu S, Huo L, Zeng J, Chen R, Sun Y, Tan M, Fan M, Liu M, Zhao J, Huang G, et al. Differentiated management of ROS level in tumor and kidney to alleviate Cis-platinum induced acute kidney injury with improved efficacy. J Nanobiotechnol. 2024;22:436.","journal-title":"J Nanobiotechnol"},{"key":"2375_CR594","doi-asserted-by":"publisher","first-page":"22055","DOI":"10.1021\/acsnano.4c05266","volume":"18","author":"R Nie","year":"2024","unstructured":"Nie R, Zhang J, Jia Q, Li Y, Tao W, Qin G, Liu X, Tao Y, Zhang Y, Li P. Structurally oriented carbon dots as ROS nanomodulators for dynamic chronic inflammation and infection elimination. ACS Nano. 2024;18:22055\u201370.","journal-title":"ACS Nano"},{"key":"2375_CR595","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1016\/j.biomaterials.2014.01.026","volume":"35","author":"JR Martin","year":"2014","unstructured":"Martin JR, Gupta MK, Page JM, Yu F, Davidson JM, Guelcher SA, Duvall CL. A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species. Biomaterials. 2014;35:3766\u201376.","journal-title":"Biomaterials"},{"key":"2375_CR596","doi-asserted-by":"publisher","first-page":"1902785","DOI":"10.1002\/adfm.201902785","volume":"30","author":"Y Chao","year":"2020","unstructured":"Chao Y, Chen Q, Liu Z. Smart injectable hydrogels for cancer immunotherapy. Adv Func Mater. 2020;30:1902785.","journal-title":"Adv Func Mater"},{"key":"2375_CR597","doi-asserted-by":"publisher","first-page":"2402367","DOI":"10.1002\/adfm.202402367","volume":"34","author":"AI Robby","year":"2024","unstructured":"Robby AI, Yang JH, Jin EJ, Park SY. Tumor microenvironment-selective sol-gel mineralization of ROS-responsive stretchable and conductive hydrogel. Adv Funct Mater. 2024;34:2402367.","journal-title":"Adv Funct Mater"},{"key":"2375_CR598","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-023-01512-7","volume":"16","author":"J Liu","year":"2023","unstructured":"Liu J, Han X, Zhang T, Tian K, Li Z, Luo F. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. J Hematol Oncol. 2023;16:116.","journal-title":"J Hematol Oncol"},{"key":"2375_CR599","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1089\/biores.2019.0028","volume":"9","author":"DG Ivanova","year":"2020","unstructured":"Ivanova DG, Yaneva ZL. Antioxidant properties and redox-modulating activity of chitosan and its derivatives: biomaterials with application in cancer therapy. Biores Open Access. 2020;9:64\u201372.","journal-title":"Biores Open Access"},{"key":"2375_CR600","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2967\/jnumed.120.256974","volume":"62","author":"HE Greenwood","year":"2021","unstructured":"Greenwood HE, Witney TH. Latest advances in imaging oxidative stress in cancer. J Nucl Med. 2021;62:1506\u201310.","journal-title":"J Nucl Med"},{"key":"2375_CR601","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1039\/D2CS00172A","volume":"52","author":"Y Geng","year":"2023","unstructured":"Geng Y, Wang Z, Zhou J, Zhu M, Liu J, James TD. Recent progress in the development of fluorescent probes for imaging pathological oxidative stress. Chem Soc Rev. 2023;52:3873\u2013926.","journal-title":"Chem Soc Rev"},{"key":"2375_CR602","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2217\/nnm-2021-0129","volume":"16","author":"G Yang","year":"2021","unstructured":"Yang G, Wang W, Song J, Zhang J. Bioresponsive self-illuminating nanoparticles for luminescence imaging of inflammation and oxidative stress. Nanomedicine (Lond). 2021;16:1737\u201340.","journal-title":"Nanomedicine (Lond)"},{"key":"2375_CR603","doi-asserted-by":"publisher","first-page":"eaat2953","DOI":"10.1126\/sciadv.aat2953","volume":"5","author":"X Xu","year":"2019","unstructured":"Xu X, An H, Zhang D, Tao H, Dou Y, Li X, Huang J, Zhang J. A self-illuminating nanoparticle for inflammation imaging and cancer therapy. Sci Adv. 2019;5:eaat2953.","journal-title":"Sci Adv"},{"key":"2375_CR604","doi-asserted-by":"publisher","first-page":"e2100045","DOI":"10.1002\/smll.202100045","volume":"17","author":"X Yan","year":"2021","unstructured":"Yan X, Lin W, Liu H, Pu W, Li J, Wu P, Ding J, Luo G, Zhang J. Wavelength-tunable, long lifetime, and biocompatible luminescent nanoparticles based on a vitamin E-derived material for inflammation and tumor imaging. Small. 2021;17:e2100045.","journal-title":"Small"},{"key":"2375_CR605","doi-asserted-by":"publisher","first-page":"e202214505","DOI":"10.1002\/anie.202214505","volume":"62","author":"Y Cui","year":"2023","unstructured":"Cui Y, Wang X, Jiang Z, Zhang C, Liang Z, Chen Y, Liu Z, Guo Z. A photoacoustic probe with blood-brain barrier crossing ability for imaging oxidative stress dynamics in the mouse brain. Angew Chem Int Ed Engl. 2023;62:e202214505.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2375_CR606","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1021\/acs.analchem.0c04116","volume":"93","author":"D Lazarova","year":"2021","unstructured":"Lazarova D, Semkova S, Zlateva G, Tatsuya H, Aoki I, Bakalova R. Quantum sensors to track total redox-status and oxidative stress in cells and tissues using electron-paramagnetic resonance, magnetic resonance imaging, and optical imaging. Anal Chem. 2021;93:2828\u201337.","journal-title":"Anal Chem"},{"key":"2375_CR607","doi-asserted-by":"publisher","first-page":"e1800310","DOI":"10.1002\/smll.201800310","volume":"14","author":"J Balke","year":"2018","unstructured":"Balke J, Volz P, Neumann F, Brodwolf R, Wolf A, Pischon H, Radbruch M, Mundhenk L, Gruber AD, Ma N, Alexiev U. Visualizing oxidative cellular stress induced by nanoparticles in the subcytotoxic range using fluorescence lifetime imaging. Small. 2018;14:e1800310.","journal-title":"Small"},{"key":"2375_CR608","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2967\/jnumed.113.126664","volume":"55","author":"JM Webster","year":"2014","unstructured":"Webster JM, Morton CA, Johnson BF, Yang H, Rishel MJ, Lee BD, Miao Q, Pabba C, Yapp DT, Schaffer P. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid. J Nucl Med. 2014;55:657\u201364.","journal-title":"J Nucl Med"},{"key":"2375_CR609","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.1039\/D3CC00878A","volume":"59","author":"J Li","year":"2023","unstructured":"Li J, Pan L, Pan W, Li N, Tang B. Recent progress of oxidative stress associated biomarker detection. Chem Commun (Camb). 2023;59:7361\u201374.","journal-title":"Chem Commun (Camb)"},{"key":"2375_CR610","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.1002\/anie.202102377","volume":"60","author":"J Liu","year":"2021","unstructured":"Liu J, Liu M, Zhang H, Guo W. High-contrast fluorescence diagnosis of cancer cells\/tissues based on \u03b2-lapachone-triggered ROS amplification specific in cancer cells. Angew Chem Int Ed Engl. 2021;60:12992\u20138.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2375_CR611","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1021\/acs.analchem.8b00994","volume":"90","author":"F Liu","year":"2018","unstructured":"Liu F, Wang Z, Wang W, Luo JG, Kong L. Red-emitting fluorescent probe for detection of \u03b3-glutamyltranspeptidase and its application of real-time imaging under oxidative stress in cells and in vivo. Anal Chem. 2018;90:7467\u201373.","journal-title":"Anal Chem"},{"key":"2375_CR612","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2019.12.012","volume":"37","author":"EC Cheung","year":"2020","unstructured":"Cheung EC, DeNicola GM, Nixon C, Blyth K, Labuschagne CF, Tuveson DA, Vousden KH. Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer. Cancer Cell. 2020;37:168-182.e164.","journal-title":"Cancer Cell"},{"key":"2375_CR613","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR614","doi-asserted-by":"publisher","first-page":"1536388","DOI":"10.3389\/fphar.2025.1536388","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Li A, Wang Z, Guo X, Zhang G, Litzow MR, Liu Q. Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Front Pharmacol. 2025;16:1536388.","journal-title":"Front Pharmacol"},{"key":"2375_CR615","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. 2019;307:41\u20138.","journal-title":"Toxicol Lett"},{"key":"2375_CR616","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/0008-5472.CAN-16-1817","volume":"77","author":"GS Chiu","year":"2017","unstructured":"Chiu GS, Maj MA, Rizvi S, Dantzer R, Vichaya EG, Laumet G, Kavelaars A, Heijnen CJ. Pifithrin-\u03bc prevents cisplatin-induced chemobrain by preserving neuronal mitochondrial function. Cancer Res. 2017;77:742\u201352.","journal-title":"Cancer Res"},{"key":"2375_CR617","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"2375_CR618","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181:151\u201367.","journal-title":"Cell"},{"key":"2375_CR619","doi-asserted-by":"publisher","first-page":"55584","DOI":"10.1021\/acsami.0c15920","volume":"12","author":"M Modak","year":"2020","unstructured":"Modak M, Bobbala S, Lescott C, Liu YG, Nandwana V, Dravid VP, Scott EA. Magnetic nanostructure-loaded bicontinuous nanospheres support multicargo intracellular delivery and oxidation-responsive morphological transitions. ACS Appl Mater Interfaces. 2020;12:55584\u201395.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2375_CR620","doi-asserted-by":"publisher","first-page":"8190","DOI":"10.1074\/jbc.M311412200","volume":"279","author":"N Inukai","year":"2004","unstructured":"Inukai N, Yamaguchi Y, Kuraoka I, Yamada T, Kamijo S, Kato J, Tanaka K, Handa H. A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. J Biol Chem. 2004;279:8190\u20135.","journal-title":"J Biol Chem"},{"key":"2375_CR621","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.07.014","volume":"190","author":"E Petsouki","year":"2022","unstructured":"Petsouki E, Cabrera SNS, Heiss EH. AMPK and NRF2: interactive players in the same team for cellular homeostasis? Free Radic Biol Med. 2022;190:75\u201393.","journal-title":"Free Radic Biol Med"},{"key":"2375_CR622","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","volume":"41","author":"O Elhanani","year":"2023","unstructured":"Elhanani O, Ben-Uri R, Keren L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell. 2023;41:404\u201320.","journal-title":"Cancer Cell"},{"key":"2375_CR623","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, Yuan W, Gu X, Hu J, Yang S. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Ther. 2024;9:236.","journal-title":"Signal Transduct Target Ther"},{"key":"2375_CR624","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1074\/jbc.275.8.5323","volume":"275","author":"J Nakamura","year":"2000","unstructured":"Nakamura J, La DK, Swenberg JA. 5\u2019-nicked apurinic\/apyrimidinic sites are resistant to beta-elimination by beta-polymerase and are persistent in human cultured cells after oxidative stress. J Biol Chem. 2000;275:5323\u20138.","journal-title":"J Biol Chem"},{"key":"2375_CR625","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.7150\/thno.46728","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao Y, Luo W, Chen S, Lin F, Zhang X, Fan S, Shen X, Wang Y, Liang G. Celastrol induces ROS-mediated apoptosis via directly targeting peroxi redoxin-2 in gastric cancer cells. Theranostics. 2020;10:10290\u2013308.","journal-title":"Theranostics"},{"key":"2375_CR626","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-020-00979-y","volume":"13","author":"K Lei","year":"2020","unstructured":"Lei K, Gu X, Alvarado AG, Du Y, Luo S, Ahn EH, Kang SS, Ji B, Liu X, Mao H, et al. Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma. J Hematol Oncol. 2020;13:141.","journal-title":"J Hematol Oncol"},{"key":"2375_CR627","doi-asserted-by":"publisher","first-page":"R646","DOI":"10.1152\/ajpregu.00247.2017","volume":"313","author":"M Assi","year":"2017","unstructured":"Assi M. The differential role of reactive oxygen species in early and late stages of cancer. Am J Physiol Regul Integr Comp Physiol. 2017;313:R646-r653.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2375_CR628","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/1878-0261.12936","volume":"15","author":"M Liu","year":"2021","unstructured":"Liu M, Fan Y, Li D, Han B, Meng Y, Chen F, Liu T, Song Z, Han Y, Huang L, et al. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 2021;15:2084\u2013105.","journal-title":"Mol Oncol"},{"key":"2375_CR629","doi-asserted-by":"publisher","first-page":"133","DOI":"10.14348\/molcells.2023.0028","volume":"46","author":"T Suzuki","year":"2023","unstructured":"Suzuki T, Takahashi J, Yamamoto M. Molecular basis of the KEAP1-NRF2 signaling pathway. Mol Cells. 2023;46:133\u201341.","journal-title":"Mol Cells"},{"key":"2375_CR630","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2017.12.008","volume":"15","author":"G Selvaggio","year":"2018","unstructured":"Selvaggio G, Coelho P, Salvador A. Mapping the phenotypic repertoire of the cytoplasmic 2-Cys peroxiredoxin - thioredoxin system. 1. Understanding commonalities and differences among cell types. Redox Biol. 2018;15:297\u2013315.","journal-title":"Redox Biol"},{"key":"2375_CR631","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41580-022-00474-x","volume":"23","author":"E Petermann","year":"2022","unstructured":"Petermann E, Lan L, Zou L. Sources, resolution and physiological relevance of R-loops and RNA-DNA hybrids. Nat Rev Mol Cell Biol. 2022;23:521\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2375_CR632","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","volume":"28","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Muramatsu A, Saito R, Iso T, Shibata T, Kuwata K, Kawaguchi SI, Iwawaki T, Adachi S, Suda H, et al. Molecular mechanism of cellular oxidative stress sensing by Keap1. Cell Rep. 2019;28:746-758.e744.","journal-title":"Cell Rep"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02375-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02375-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02375-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:23:55Z","timestamp":1757445835000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02375-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":632,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02375-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}